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TOELICHTING 
Om ook voor mensen die grotendeels onbekend zijn met de biochemie 
enigszins duidelijk te maken waar het in dit proefschrift over gaat, wil 
ik in het kort een toelichting geven op de achtergronden en de grote lij-
nen van het hier beschreven onderzoek. 
In de cellen van alle levende wezens vindt voortdurend een groot 
aantal scheikundige reakties plaats waarbij bepaalde stoffen in andere 
worden omgezet. Voor het verloop van deze reakties zorgen eiwitten ge-
naamd enzymen. Voor ieder soort reaktie is een ander enzym aanwezig. Zo 
zorgen bijvoorbeeld de spijsverterings-enzymen voor de afbraak van voed-
sel tot voor het lichaam bruikbare bestanddelen. Alle eiwitten, dus ook 
enzymen, zijn opgebouwd uit onderdelen, genaamd aminozuren, waarvan er 
zo'n twintig verschillende bestaan. Al deze aminozuren hebben namen, b.v. 
glycine, alanine, serine, meestal afgekort tot drie letters: Gly, Ala, 
Ser. De aminozuren in een eiwit zijn in een bepaalde volgorde aan elkaar 
gekoppeld, ongeveer als kralen aan een ketting. Verschillende eiwitten 
hebben ieder hun eigen specifieke aminozuur-volgorde. In het erfelijk 
materiaal van iedere cel (de zogenaamde nucleïnezuren, die een onderdeel 
vormen van de chromosomen) is de informatie vastgelegd die de volgorde 
van de aminozuren in de verschillende eiwitten bepaalt, en die ook be-
paalt welke eiwitten door de cel zullen worden geproduceerd. Deze infor-
matie wordt van geslacht tot geslacht overgeërfd. 
Enzymen zijn dus eiwitten opgebouwd uit ketens van aminozuren. En-
zymen kunnen uit één eiwit-keten bestaan, maar ook uit meerdere ketens. 
Deze ketens kunnen identiek zijn of verschillend. De keten van aminozuren 
is meestal opgerold tot een soort kluwen (ruimtelijke struktuur). Ver-
schillende eiwitten hebben niet alleen een specifieke aminozuur-volgorde, 
maar ook een specifieke ruimtelijke struktuur. Voor een goed begrip van 
de werking van een bepaald enzym is het van belang om de aminozuur-
volgorde en de ruimtelijke struktuur te kennen. 
Het enzym waar het in dit proefschrift over gaat heet "leucine-
aminopeptidase", afgekort LAP. Het komt voor in de ooglens van verschil-
lende dieren, maar ook in andere weefsels. Door proeven met het geïso-
leerde enzym is vastgesteld, dat LAP in staat is om van eiwitketens tel-
kens eén aminozuur af te splitsen. Het kan op deze manier hele eiwit-
ketens afbreken. Wat echter de precieze funktie van dit enzym in de oog-
lens is, blijft vooralsnog onduidelijk. Evenmin is bekend, waarom in de 
ooglens van runderen relatief veel LAP voorkomt, en in ooglenzen van 
andere dieren heel weimg. Om een beter inzicht te krijgen in het ver-
loop van de processen die in de ooglens optreden, en in het ontstaan van 
oogziekten als "staar" (een vertroebeling van de ooglens die vooral op 
latere leeftijd leidt tot blindheid), worden de eiwitten en de enzymen 
die in de ooglens voorkomen op grote schaal bestudeerd. Van de belang-
rijkste eiwitten van de ooglens, de zogenaamde crystallines, is al veel 
bekend, maar de enzymen in dit weefsel zijn nog m e t diepgaand onder-
zocht. 
Het hoofddoel van het hier beschreven onderzoek was de opheldering 
van de aminozuur-volgorde van LAP. We hebben aangetoond dat LAP uit zes 
eiwit-ketens bestaat, en dat deze zes eiwit-ketens allemaal hetzelfde 
zijn (hoofdstuk 3). Uit de grootte van deze eiwit-ketens kon gekonklu-
deerd worden dat iedere keten opgebouwd is uit ongeveer 490 aminozuren. 
Welke aminozuren in deze keten voorkomen, en hoeveel van ieder, is aan-
gegeven in tabel 3.2 (pag. 31). 
Alvorens de aminozuur-volgorde in een eiwit-keten bepaald kan wor-
den, moet de "kluwen" zoals het eiwit in z'n natuurlijke vorm voorkomt, 
ontrold worden tot een langgerekte keten. Bij het bepalen van de amino-
zuur-volgorde van eiwitten kunnen we gebruik maken van een tecnmek (de 
zogenaamde Edman afbraak) waarbij vanaf het uiteinde van de keten iedere 
keer één aminozuur afgesplitst wordt. Door nu telkens wanneer een amino-
zuur afgesplitst is te bepalen welk aminozuur dit is, zou theoretisch 
de hele aminozuurvolgorde in een eiwit bepaald kunnen worden. In de 
praktijk komen we echter meestal niet verder dan 40 tot 60 aminozuren 
Een eiwit-keten van bijna 500 aminozuren moet daarom eerst in stukken 
"geknipt" worden. De eiwit-keten van LAP is nu op twee mameren in grote 
brokstukken geknipt, namelijk achter ieder methiomne-aminozuur (hoofd-
stuk 4) en tussen de aminozuren asparagine en glycine (hoofdstuk 5). 
De aldus verkregen fragmenten zijn vervolgens met behulp van een aantal 
eiwit-splιtsende enzymen in een groot aantal kleine stukjes (peptiden) 
geknipt. Door nu van al deze peptiden de aminozuur-volgorde te bepalen, 
kan de volledige aminozuur-volgorde van de grote fragmenten, en uiteinde­
lijk van de hele eiwit-keten van LAP afgeleid worden 
De in dit proefschrift beschreven onderzoekingen hebben geleid tot 
de opheldering van ongeveer 65% van de aminozuur-volgorde van de eiwit-
keten van LAP. Het resterende gedeelte werd onlangs zo goed als voltooid 
door Theo Cuypers, zodat de (bijna) volledige aminozuur-volgorde nu 
bekend is (zie het addendum). 
Hoofdstuk 6 en 7 beschrijven onderzoekingen aan LAP zoals het in de 
natuurlijke vorm voorkomt, dus waarin de eiwitketens opgerold zijn tot 
een "kluwen". Deze onderzoekingen hadden tot doel wat meer te weten te 
komen over de ruimtelijke struktuur van LAP. Sommige aminozuren in de 
kluwen van eiwit-ketens van LAP bevinden zich aan het oppervlak, andere 
in het minder toegankelijke binnenste. In hoofdstuk 6 is aangetoond dat 
het mogelijk is om in de eiwit-keten van LAP de binding tussen de amino-
zuren 137 en 138 door te "knippen" met een eiwit-splitsend enzym (tryp-
sine). De eiwit-kluwen blijft desondanks één geheel, en het LAP kan nog 
op dezelfde wijze zijn werking uitoefenen. Er zijn twee mogelijkheden 
voor de plaats van aminozuren 137 en 133 in de ruimtelijke struktuur van 
LAP : 
1. het gedeelte van de eiwit-keten rond de plaatsen 137 en 138 
steekt naar buiten als een soort staart of lus, 
2. er zijn twee afzonderlijke kluwens aanwezig, en het gebied rond 
de plaatsen 137 en 138 vormt de verbinding tussen deze twee klu-
wens. Deze verbinding kan dan gemakkelijk verbroken worden, maar 
de twee kluwens blijven toch aan elkaar "geplakt" zitten, waar-
door het enzym nog werkzaam is. 
De tweede mogelijkheid lijkt waarschijnlijker, omdat dergelijke grote 
eiwitten als LAP vaker uit duidelijk te onderscheiden "domeinen" bestaan, 
en omdat men onder de elektronennn kroskoop gezien heeft dat LAP uit een 
groter en een kleiner gedeelte bestaat. 
Terwijl de meeste aminozuren in de eiwit-keten van een enzym voor-
namelijk dienst doen voor de handhaving van de juiste ruimtelijke struk-
tuur, zijn een aantal aminozuren van belang voor de specifieke werking 
van het enzym. Ze vormen tesamen het aktieve centrum. Sommige van deze 
aminozuren zijn betrokken bij de binding van metaal-ionen die voor de 
werking van het enzym noodzakelijk zijn, andere zorgen ervoor dat de stof 
waarop het enzym zijn werking uitoefent, op de juiste manier in het 
aktieve centrum gebonden wordt. Zo zal b.v. het uiteinde van de eiwit-
keten waar LAP een aminozuur van afsplitst, in het aktieve centrum van 
LAP gebonden moeten worden. Voor een goed begrip van het werkings-
mechanisme van LAP is het van belang te weten welke aminozuren een 
onderdeel vormen van het aktieve centrum en wat hun funktie daarin is 
(voor een model van het aktieve centrum van LAP zie fig. 7.1, pag. 102). 
Dit kan onderzocht worden door op een bepaalde manier veranderingen aan 
te brengen in de aminozuren in het aktieve centrum, en dan na te gaan of 
de werking van het enzym door deze veranderingen gewijzigd is. Een derge-
lijk onderzoek is beschreven in hoofdstuk 7. 
Het direkte nut van de in dit proefschrift beschreven onderzoekingen 
is op dit moment nog m e t aan te geven. De processen in de cellen van 
levende wezens zijn meestal zo ingewikkeld dat ze alleen volledig te be-
grijpen zijn wanneer de resultaten van jarenlange studies in vele labo-
ratoria gekombineerd worden. De hier beschreven resultaten geven een be-
langrijk inzicht in de struktuur van LAP en kunnen een basis vormen voor 
onderzoekingen aan verwante enzymen, die in zeer veel weefsels voorkomen 
(zoals nier, lever, hersenen, voortplantings-organen, bloed). Bestudering 
van deze enzymen kan misschien bijdragen tot een beter begrip van hun 
funktie in de cel, en van de rol die zij spelen bij bepaalde ziekten. 
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CHAPTER 1 . INTRODUCTION 
1.1 H-CÓÍOAXCOZ background 
In 1929 Linderstr0m-Lang (1929) showed that extracts of hog intesti-
nal mucosa contained an enzyme which rapidly hydrolyzed leucylglycine and 
leucyldiglycine. After a partial purification of this enzyme further 
information concerning its specificity was obtained (Johnson et al., 
1936, Smith and Bergmann, 1944). It was suggested that the enzyme be 
called leucine aminopeptidase (LAP) because L-leucinamide, in addition to 
leucyl peptides, were hydrolyzed, whereas N-acylated substrates were 
resistant. This name has persisted, although it is now clearly recognized 
that hydrolysis is not restricted to leucyl compounds. When Spackman 
et al. (1955) purified LAP from pig kidney to a high degree, the chemical 
and physical properties of this enzyme were described, as well as its 
action on several peptides, proteins and synthetic substrates (Smith and 
Hill, 1960). In 1958 it was recognized that the proteolytic system of 
bovine eye lens contained a relatively stable LAP (Hanson and Methfessel, 
1958), and crystallization of this enzyme was achieved for the first time 
from this tissue (Hanson et al., 1965). The lens enzyme appeared to be 
identical to LAP from pig kidney (Hanson et al., 1967b). However, bovine 
lens was a better source of LAP, because in this tissue it is the predo-
minant proteolytic enzyme, whereas in kidney it occurs together with a 
large number of other strongly active proteases (Hanson, 1962). 
1.2 Leucxne arrn.noре.ріл.а<и e. ¡¡-tum bou-сиг -iettò 
The activity of LAP in lens was found to be species-dependent (Fitt-
kau et al., 1961). For instance, pig and sheep lenses had LAP activities 
of 45% and 24% of the activity in bovine lens, and lenses of horse, rat 
and man had LAP activities of only a few per cents of the bovine value. 
The properties of LAP from bovine lens have been reviewed by Hanson and 
Frohne (1977). LAP splits off N-terminal L-amino acids from peptides. In 
addition, it hydrolyzes amino acid amides, arylamides and hydrazides. 
It has its highest activity toward hydrophobic and aliphatic residues. 
The N-terminal residue must have an L-configuration, and has to possess 
a free α-amino group. Peptide bonds involving proline with its imino 
group, and g-aspartyl and γ-glutamyl bonds resist hydrolysis 
1 
The pH-optimum lies between 9.0 and 10.0 depending upon substrate and 
activating metal ion. The temperature optimum is 40 С LAP can be used 
for the structural analysis of proteins and peptides (Smith and Hill, 
I960; Light, 1972). 
The molecular weight of the native enzyme is 326,000 (Kretschmer and 
Hanson, 1965, Melbey and Carpenter, 1971). In view of its large size LAP 
was expected to consist of subumts. Although it was initially believed 
that LAP was composed of ten subumts of MW 32,600 (Kretschmer, 1968, 
Kretschmer and Hanson, 1968), it is now firmly established that LAP con­
sists of six subumts of MW 54,000 (Melbey and Carpenter, 1971), arranged 
as a trimer of dimers (Carpenter and Harrington, 1972) LAP is a zinc 
metalloenzyme (Bottger et al , 1968, Kettmann and Hanson, 1970, Ludewig 
et al., 1971) containing two zinc ions per subumt (Vahl and Carpenter, 
1971, Carpenter and Vahl, 1973). These authors suggested that LAP has two 
non-equivalent metal binding sites per subumt a specificity (or struc­
tural) site which must be occupied by zinc in order to obtain an active 
enzyme, and an activation site which can be occupied by zinc, manganese 
or magnesium, resulting in enzymes with different specific activities. 
The nature of the ion in the activation site has a pronounced effect on 
the maximum velocity of the reaction, and a minor effect on the Michaelis 
constant In later experiments Thompson and Carpenter (1976) were able to 
replace both zinc ions by cobalt ions. Cobalt substitution at the activa­
tion site clearly affected activity, but cobalt substitution at the 
structural site had no effect. LAP is strongly inhibited by chelating 
agents like EDTA It is not inhibited by lodoacetamide and p-chloromercu-
ribenzoate, indicating the absence of a thiol group directly associated 
with enzymatic activity. An agent which strongly inhibits the so-called 
serine proteases, namely di-isopropyl fluorophosphate, has no effect on 
the activity of LAP. 
Lens LAP is a stable enzyme. It can be stored at 4 0C in 0.1 M Tris-
HC1 buffer, pH 8.0, for long periods of time without loss of activity. 
Lyophilization leads to inactivation LAP is stable between pH values 
6 to 11. It is also remarkably stable against denaturing agents like urea 
(Frohne and Hanson, 1969a, Melbey and Carpenter, 1971). Only prolonged 
incubation at pH 9 in 7 M urea could cause a dissociation of LAP into 
subumts. Spin label studies of conformational changes in LAP induced by 
urea point to an extremely stable protein structure (Lassmann et al., 
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1975). Similar results were obtained by studies of the behavior of LAP in 
guanidine-HCl (Kleine and Lehmann, 1976; Lassmann et al., 1977) and by 
investigations of the temperature stability of LAP (Lassmann et al., 
1976). 
Two reports of the amino acid composition of LAP have appeared 
(Kettmann et al., 1968; Carpenter and Vahl, 1973). Lap is rich in hydro­
phobic amino acids, and histidine, cysteine, tyrosine and tryptophan 
occur in low frequency. Disagreement exists on the content of several 
amino acids, especially that of cysteine, isoleucine and tryptophan. De­
termination of the N-terminal residue(s) of LAP by Fittkau et al. (1964) 
and by Kettmann et al. (1968) yielded several amino acids, indicating the 
presence of more than one type of polypeptide chain. Up till now there is 
no proof that the six subunits of LAP are identical. 
Several molecular models for bovine lens LAP have been proposed. 
Based on electron microscopic studies Kretschmer (1968) concluded that 
LAP was a decamer composed of two planar pentameric rings which formed a 
cylinder. However, cross-linking studies of Carpenter and Harrington 
(1972) indicated that LAP was a hexamer composed of a trimer of dimers. 
Low angle X-ray scattering studies of LAP in solution (Damashun et al., 
1973) supported a hexameric structure with an octahedral arrangement of 
spherical subunits. Vangermann et al. (1977) interpreted LAP images as 
resulting from a coiled trigonal prism or a deformed octahedron. Kiselev 
et al. (1977) concluded that the subunits were arranged with 32 symmetry 
at the vertices of a distorted triangular prism. The unit cell parameters, 
calculated from X-ray diffraction data of LAP crystals, were a = b = 132 
8, с = 122 8, and the space group was P6322 (Jurnak et al., 1977). These 
data indicated that there were two protein molecules per unit cell. 
Bilobal rather than spherical subunits were proposed by Taylor et al. 
(1979). They suggested a quaternary structure for LAP composed of six 
asymmetric bilobal subunits arranged in such a way that the principal 
lobes are eclipsed and the minor lobes are staggered. Their model bears 
strong resemblance to the structure proposed for aspartate carbamoyl-
transferase (Richards and Williams, 1972; Evans et al., 1973). 
1.3 Епгутел cloòely lílated tu LAP 
Aminopeptidases (α-aminoacyl peptide hydrolases, EC 3.4.11) with pro­
perties identical or similar to those of LAP from bovine lens appear to be 
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widely distributed in animal tissues, in plants and microorganisms. 
Aminopeptidases in plants and microorganisms have been reviewed by Senk-
spiel et al. (1976). Aminopeptidases in animal tissues have been studied 
to varying degrees, but in many cases a precise classification is not yet 
possible. This is especially so, because many tissues contain amino-
peptidases with overlapping specificities. Aminopeptidase activities 
previously attributed to the "classical" leucine aminopeptidase, were 
later shown to belong to other enzymes. Substantial evidence is available 
indicating that LAP from bovine lens is identical to LAP purified from 
pig kidney (Himmelhoch, 1970, Moseley and Melius, 1967, Shen and Melius, 
1977). This includes molecular weight, subumt structure, substrate spe-
cificity, metal ion activation and amino acid analysis. The amino acid 
composition of pig kidney LAP is listed in table 1. LAP from lens and 
kidney behave similarly towards antibodies prepared for crystalline LAP 
(Hanson et al., 1967b). Certain organ or species differences are indica-
ted by the formation of spurs in immuno-electrophoresis. LAP has been 
classified as EC 3.4.11.1. 
Early investigations of the aminopeptidases of pig kidney indicated 
that beside the well-characterized LAP another aminopeptidase was present 
in the particulate fraction (Pfleiderer et al., 1964, Pfleiderer, 1970, 
Wachsmuth et al., 1966). This enzyme was clearly different from LAP in 
pH optimum, substrate specificity, and activation by metal ions (Hanson 
et al., 1967a,b). It did not precipitate with antibodies to LAP. Particu-
late aminopeptidase (aminopeptidase M) is a metallo-glycoprotein contain-
ing two zinc ions per molecule. Its molecular weight is 280,000, twenty 
per cent of which is contributed by carbohydrate (Wacker et al., 1971). 
The amino acid composition of pig kidney aminopeptidase M is given in 
table 1. The enzyme is active on the arylamides of amino acids, especi-
ally the alanyl derivatives. The pH optimum lies between 7 0 and 8.0. 
Cobalt ions show a marked activation, while manganese and magnesium ions 
are inhibitory or indifferent. The enzyme is strongly inhibited by 
chelating agents. Solubilization of the enzyme from pig kidney with 
Triton X-100 yielded an aggregate that decomposed into free aminopepti-
dase (MW 280,000) either upon autolysis at pH 5 or after exposure to 
trypsin. After dissociation, the enzyme resulting from autolysis yielded 
a single subumt of MW 140,000, while the trypsin-treated enzyme produced 
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Table 1 The amino acid composition of several aminopeptidases 
Values are expressed as residues per subunit or per molecule. Va-
lues between brackets represent molar percentages. The composition 
of lens LAP was taken from Carpenter and Vahl (1973), of kidney 
LAP from Shen and Melius (1977), of pig kidney aminopeptidase M 
from Wacker et al. (1971), and of human alanine aminopeptidase 
(HLA) from Little et al. (1977). 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
lens LAP 
47(9.5) 
25(5.0) 
28(5.6) 
52(10.5) 
26(5.2) 
42(8.5) 
53(10.7) 
8(1.6) 
33(6.7) 
11(2.2) 
29(5.8) 
39(7.9) 
10(2.0) 
20(4.0) 
8(1.6) 
34(6.9) 
21(4.2) 
10(2.0) 
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kidney LAP 
54(10.2) 
26(4.9) 
33(6.2) 
52(9.8) 
29(5.5) 
68(12.8) 
57(10.8) 
2(0.4) 
32(6.0) 
11(2.1) 
23(4.3) 
38(7.2) 
10(1.9) 
20(3.8) 
11(2.1) 
34(6.4) 
23(4.3) 
7(1.3) 
530 
aminopeptidase 
250(12.1) 
141(6.8) 
146(7.1) 
245(11.8) 
101(4.9) 
92(4.4) 
146(7.1) 
12(0.6) 
122(5.9) 
50(2.4) 
99(4.8) 
205(9.9) 
85(4.1) 
98(4.7) 
42(2.0) 
84(4.1) 
68(3.3) 
83(4.0) 
2069 
M HLA 
90(10.1) 
49(5.5) 
52(5.8) 
92(10.3) 
39(4.4) 
43 4.8) 
60(6.7) 
5(0.6) 
53(5.9) 
15(1.7) 
38(4.3) 
86(9.6) 
36(4.0) 
38(4.3) 
17(1.9) 
41(4.6) 
36(4.0) 
18(2.0) 
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three fragments of MW 140,000, 95,000 and 48,000. Only the 140,000 MW 
subunit could be reactivated to an active enzyme. The existence of a 
hydrophobic portion of approximate MW 10,000 anchoring the enzyme to the 
membrane has been postulated (Wacker et al., 1976). Aminopeptidase M has 
been classified as EC 3.4.11.2. 
Similar properties have been reported for pig intestinal and renal 
brush border aminopeptidase (Desnuelle, 1979; Maroux et al., 1977). 
These enzymes have a molecular weight of 280,000, and they contain 23% 
carbohydrate and two zinc ions per molecule. They are highly active 
toward L-alanine-ß-naphthylamide. Both the intestinal and the renal 
aminopeptidase were shown to be amphipathic molecules consisting of a 
short, hydrophobic peptide of about 80 residues anchoring the enzyme to 
the membrane, and a large, enzymatically active, hydrophilic part 
(Vannier et al., 1976). The hydrophobic anchor represents the N-terminal 
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part of the molecule: 
microvillous 
membrane 
Ala-
hydrophobic 
anchor 
-Val-
lumen 
—Ser Ala-
t I 
Τ τ 
catalytic domain 
-C00H 
(T=trypsin) 
Another enzyme which was initially confused with LAP is human ala­
nine aminopeptidase (HLA), recently reviewed by Little et al. (1977). It 
has its highest activity toward L-alanine-ß-naphthylamide. It is a zinc 
metalloenzyme which also forms a cobalt metal-enzyme complex. HLA is far 
more active on L-leucine-ß-naphthylamide than on leucylglycine, whereas 
LAP is maximally active on leucylglycine. HLA is most active toward sub-
strates with N-terminal alanyl residues, while LAP is more active on sub-
strates with N-terminal leucine. HLA is one of several electrophoreti-
cally distinct "isoenzymes" which occur in human blood. The other circu-
lating isoenzymes of the HLA-family are derived from pancreas, kidney and 
duodenum (Behal et al., 1965). HLA is a glycoprotein of MW 235,000 and 
contains 17.5% carbohydrate (Starnes and Behal, 1974). It dissociates 
into subunits of MW 118,000 in denaturing solvents. It contains one zinc 
ion per subunit. The pH optimum is 6.8. The enzyme is activated by cobalt 
ions and inhibited by puromycin (Garner and Behal, 1974). The amino acid 
composition of HLA is listed in table 1. 
The unclear situation in this class of enzymes (EC 3.4.11.2) has 
been caused in part by the fact that L-leucine-ß-naphthylamide, which had 
been commonly used as substrate in the detection of LAP, was actually 
hydrolyzed more effectively by another group of enzymes. Patterson et al. 
(1963) suggested the temporary use of the term "arylamidase" to denote 
enzymes that were active on the arylamides of amino acids. This term has 
been frequently used by subsequent workers. Enzymes hydrolyzing aryl-
amides have been detected in brain (Marks et al., 1968; Hayashi and 
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Oshima, 1977), pancreas (Behal et al., 1965), liver (Behal et al., 1965, 
Tamura et al., 1973), kidney (Lehky et al., 1973), pituitary (Ellis and 
Perry, 1966), muscle (Parsons and Pennington, 1976) and blood (Tamura et 
al., 1973). Several arylamidases have been purified and partially charac-
terized (see review by Appel, 1970). Arylamidases from pig reproductive 
tract were glycoproteins of MW 480,000, consisting of six subumts (Basha 
et al., 1978). In their kinetic properties these enzymes resembled pig 
kidney aminopeptidase M. Hayashi and Oshima (1977) characterized an aryl-
amidase from the supernatant fraction of monkey brain. This enzyme con-
sisted of one polypeptide chain of MW 92,000. Best substrate was L-ala-
mne-ß-naphthylamide, and the pH optimum was 7.0. It was inhibited by 
EDTA, and activity could be restored by the addition of zinc, cobalt or 
manganese ions. Other inhibitors were p-chloromercunbenzoate and puro-
mycin. This enzyme was thought to be different from bovine brain amino-
peptidases, which have so far been characterized (Simmons and Brecher, 
1973). These enzymes were no arylamidases since they were inactive 
toward amino acid p-mtroamlides and ß-naphthylanndes. 
Inhibition by puromycin is believed to be a general characteristic of 
arylamidases. This phenomenon was first reported by Ellis and Perry (1964) 
for pituitary arylamidase, and was subsequently noted for other aryl-
amidases (Marks et al., 1968, Suszkiw and Brecher, 1970, Ellis and Perry, 
1966). Investigations of different tissues have indicated a diversity in 
the subcellular distribution of arylamidases. The arylamidase from rat 
muscle appeared to be present largely in the cytoplasm (Parsons and Pen-
nington, 1976). Both soluble and bound forms occurred in brain (Marks et 
al., 1968, Hayashi and Oshima, 1977). Two distinct enzymes in the pitui-
tary had a predominantly cytoplasmic and microsomal distribution, respec-
tively (Ellis and Perry, 1966). 
Both the particulate aminopeptidases and the arylamidases have been 
classified as EC 3.4.11.2, but up till now it is not clear whether they 
represent the same group of enzymes. The arylamidases are also of clini-
cal importance. Although they are different from the classical leucine 
aminopeptidase, they are mostly referred to as LAP in serum (Vaedtke, 
1970a,b, 1971). 
1.4 Phyi-Lolug-Lcal i-tgiix^ -tcance о^  LAP -m the гуг. Inni 
Many questions concerning the physiological role of LAP in the eye 
lens still remain unanswered. These include 
1. what is the role of LAP in the protein breakdown of the lens7 
2. why are there such large differences in LAP activities in the 
lenses of different species7 
3. what are the natural substrates for LAP in the lens7 
4. what is the meaning of LAP in relation to structural changes in 
the lens, especially in aging7 
5. does LAP play a role in cataractogenesis7 
Although the breakdown of proteins has been the subject of many investi­
gations, the situation in the eye lens is not clear (see reviews by 
Harding and Dilley, 1976, and by Bloemendal, 1977). The lens contains few 
lysozymes they have only been detected in the epithelial cells. Hence 
the lens lacks proteinases with acid pH optima, normally associated with 
lysozymes. Blow et al. (1975) and van Heymngen and Trayhurn (1976) 
demonstrated the presence of a neutral proteinase in bovine as well as in 
human lens. The activity of neutral proteinase in human lens was only 
25% of that found in bovine lens. Normal and cataractous human lenses had 
roughly the same neutral proteinase activity. Bovine lens appeared to 
contain no carboxypeptidase, but it had a high activity of aminopeptidase 
(see review by Hanson, 1968). The major portion of this activity is pro­
bably attributable to LAP. Van Kamp (1973) reported that the LAP activity 
in bovine lens was highest in that part of the lens where the last 
synthetic activity is believed to take place. He suggested that LAP plays 
a role in the destruction of the protein synthesizing apparatus. However, 
we must emphasize that in this study the LAP activity was measured by 
means of a Boehrmger test kit specific for serum LAP, and this may well 
reflect an activity totally different from the activity of lens LAP. 
Because a-crystallin chains, and also the principal chain ßBp of the 
ß-crystallins, are N-terminally acetylated (van der Ouderaa et al., 1973, 
1974; Onessen, unpublished results), they resist attack by LAP. 
No agreement has been reached on the extent of protein breakdown in lens 
by different workers. Negligible rates of protein turnover were reported 
as well as very slow turnover rates (Fulhorst and Young, 1966, Coulter 
et al., 1971, Delcour and Papaconstantinou, 1972). In vitro experiments 
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on the autolysis of lens proteins revealed a slow but definite proteo­
lysis (van Heyningen and Waley, 1962, van Heymngen and Trayhurn, 1976) 
The average length of the peptides from cataractous human lens resulting 
from autolysis was not greater than from bovine lens, this was rather 
unexpected because there is little or no LAP activity in human lens. 
Although various in vitro experiments have indicated proteolytic activi­
ties in lens homogenates, it remains unclear to what extent, if at all, 
these enzymes function in vivo One oossible action of proteolysis in 
bovine lens is the production of the degraded α-crystal 1 in chains that 
have been described by van Kleef (van Kleef et al , 1974a,b, van Kleef, 
1975). These chains result from post-synthetic modification in the course 
of aging of the lens. If an enzyme is responsible for this degradation, 
it must be capable of the very specific splitting of the peptide bonds 
Asp-Ala, Asn-Glu, Thr-Ala, Ser-Ala and Ser-Ser onlv at the positions 
indicated by van Kleef. It is of interest to note that these are all 
peptide bonds considered to be chemically labile (Hill, 1965) Other 
arguments against an enzymatic process for the degradation of a-crystal-
lin were discussed by van Kleef (1975). At present there is no convincing 
evidence for or against enzymatic breakdown of α-crystal 1 in rather than 
chemical degradation. Nevertheless, the peotide products of degradation 
may well be broken down, for instance, by the action of LAP, since these 
oligopeptides have not been detected (van Kleef, 1975). Whether degrada­
tion of B-crystallins occurs upon aging is not known with certainty. A 
decrease of γ-crystallins upon aging of the human lens has been reported 
(Jedzimak et al., 1978), but polypeptides with molecular weights of less 
than approximately 10,000 have never been found. An important fact may be 
that γ-crystallins have free N-termim, whereas a- and в-crystallins are 
N-terminally acetylated. 
It has been suggested that increased proteolysis might account for 
the loss of protein in certain types of cataract (Barber, 1973). Calcium 
ions being activators of the neutral proteinase, an increase in concen­
tration of these ions might be responsible for increased proteolysis (van 
Heymngen, 1976). However, cataractous lenses show no higher calcium 
levels than normal lenses, and similar neutral proteinase activities were 
found in homogenates of normal and cataractous human lenses (Trayhurn and 
van Heymngen, 1976). The physiological significance of LAP in relation 
to cataract was discussed by Thompson and Carpenter (1976). Determination 
of the levels of various metals in healthy and cataractous lens tissue 
(Swanson and Truesdale, 1971) showed that cataractous tissue had vir-
tually no Zn , lower levels of Mg and increased levels of Co and 
Cd when compared to healthy tissue. This could imply that LAP in cata-
ractous lenses, where the ratio of Co*" to Zn is approximately 100,000, 
has a cobalt ion at the structural site, resulting in a more active 
enzyme. However, Arnaud et al. (1968) reported a substantial decrease in 
LAP activity in the course of experimental cataract in rat lens. At pre-
sent there is no evidence indicating that increased proteolysis plays a 
role in cataractogenesis. 
Thus, the meaning of the abundance of LAP in bovine lens, as well as 
the role of proteinases and peptidases in eye lens, is still unclear, and 
remains an intriguing problem. 
1.5 /ttm o{¡ thz pKUCnt ¿nvutAgixtiun 
While the structure and reaction mechanism of many proteolytic 
enzymes are now known in detail, the aminopeptidases represent a class of 
enzymes still poorly understood. No X-ray structural analysis and no pri-
mary structure determination has been reported for any of the amino-
peptidases. We have therefore undertaken an investigation of the amino 
acid sequence of LAP from bovine eye lens. The results of this investiga-
tion were obtained in close cooperation with H.Th. Cuypers. 
Chapter 2 describes the experimental procedures that were used in the 
investigations presented in this thesis. 
Chapter 3 describes the isolation and characterization of LAP from bovine 
lens. In order to determine whether the polypeptide chains of LAP are 
identical or different, the subunits of LAP were investigated by gel 
electrophoresis, amino acid analysis and determination of the N-terminal 
amino acid sequence. 
To obtain fragments suitable for sequence determination, the polypep-
tide chain of LAP was cleaved with cyanogen bromide and hydroxylamine. 
Chapter 4 describes the amino acid sequence determination of several 
cyanogen bromide fragments. The largest of these is the N-terminal frag-
ment comprising 171 amino acid residues. Several other fragments origi-
nated from the C-terminal part of the polypeptide chain. They overlap 
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for a large part with the C-terminal hydroxy!ami ne fragment described in 
chapter 5 The amino acid sequence data of LAP presented in this thesis 
are the first report of the primary structure determination of a member 
of the class of aminopeptidases. In order to make the sequence results 
more comprehensible, the complete amino acid sequence of LAP from bovine 
lens, which was completed recently by H. Th Cuypers, is presented as an 
addendum at the end of this thesis. 
Limited proteolysis of native LAP was performed with two objectives 
to obtain large fragments that could be useful in the alignment of the 
cyanogen bromide fragments, and to obtain information on the structure of 
native LAP. In chapter 6 the results of limited tryptic digestion of 
native LAP are described. Possible implications for the structure of na­
tive LAP are also discussed. 
Chapter 7 describes a study of the action of L-phenylalamne chloromethyl 
2+ 2+ ketone on Mn - and Mg -activated LAP This investigation was undertaken 
in order to determine the suitability of this inhibitor as an active site 
directed reagent in the identification of amino acid residues involved in 
catalytic function. 
1.6 SViatcgy 0(5 amena acxd iiqumce. (1еІелтл.па.ілоп 
In an article called "The decline and fall of protein chemistry7" 
Malcolm (1978) predicted that it will not be long before protein 
sequencing will be replaced by nucleic acid sequencing. Although it must 
certainly be acknowledged that the techniques of nucleic acid sequencing 
have developed so quickly that is is now much easier than protein 
sequencing, other factors also are important. In many cases it is still 
less difficult to obtain the gene product in pure form and in amounts 
sufficient for sequence analysis than to obtain the corresponding 
messenger RNA or the gene itself. 
Since the major part of this thesis is concerned with the amino acid 
sequence determination of LAP, several factors important in the sequence 
determination of such a large protein are discussed in this section. 
Because some excellent reviews exist on the field of protein sequencing 
(Hirs, 1967, Hirs and Timasheff, 1972, Needleman, 1970), we will restrict 
ourselves to the problems inherent in the sequencing of large proteins, 
and the factors that determined the strategy employed. The sequence of 
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amino acids in large proteins can only be determined when a selective 
cleavage leads to smaller fragments which are separable by column chroma-
tography and amenable to individual enzymatic digestion. This is especi-
ally true for proteins with molecular weights higher than 50,000. The use 
of chemical reagents permitting selective cleavages makes possible and 
simplifies the arduous task of sequencing such large proteins. The 
cleavage of methionyl bonds by cyanogen bromide is a highly specific and 
therefore widely used method (Gross, 1967). Another method, which is 
however less widely applicable, is the cleavage of Asn-Gly bonds by 
hydroxylamine (Bornstein and Balian, 1977). Enzymatic cleavage methods 
are not generally used for the production of large fragments because of 
lack of specificity, but the application of Staphylococcus aureus pro-
tease often yields peptides of considerable length (Houmard and Drapeau, 
1972). Cleavage of LAP by cyanogen bromide and hydroxylamine produced 
relatively large fragments. These could then be treated as separate 
proteins (actually their size often exceeded that of many naturally 
occurring proteins), and their amino acid sequence determined. The align-
ment of these fragments could then be established by isolation and 
sequencing of overlapping peptides obtained by alternative cleavage 
methods. 
The second factor that determined our strategy involved the methods 
available for sequence determination. Most of the modern methods are 
variations of the original phenylisothiocyanate degradation introduced by 
Edman (1950). They can be performed either manually (Niall and Potts, 
1970; Edman, 1970) or automatically (Edman and Begg, 1967; Laursen, 
1971). The amino acid derivatives resulting from the degradation can be 
identified by thin-layer chromatography, gas liquid chromatography or 
high performance liquid chromatography. A widely used modification of the 
Edman degradation involves labelling of the newly generated N-terminal 
residue with dansyl-chloride (Gray, 1967). The dansyl derivative is libe-
rated by acid hydrolysis and identified by thin-layer chromatography. A 
recent approach to sequence determination makes use of mass spectrometry 
(Morris et al., 1974). While the conventional, manual methods were 
suitable for the sequence determination of relatively small peptides (up 
to 20-25 residues), a significant change in sequence strategy was caused 
by the introduction of instruments for automated sequencing. With the 
liquid phase sequenator (Edman and Begg, 1967; Niall, 1973) and the solid 
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phase sequenator (Laursen, 1971) large stretches of amino acids could be 
determined. However, because we had only occasional access to a liquid 
phase sequenator and because increasing difficulties have been reported 
in the use of the solid phase sequenator (Previero and Coletti-Previero, 
1977), we mainly employed manual Edman and dansyl-Edman techniques. In 
order to obtain relatively small peptides suitable for manual degrada­
tion, the fragments were digested with several enzymes. The most specific 
cleavage can be performed with trypsin. This method also has the advan­
tage that the sites at which cleavage occurs can be modified by blockage 
of the ε-amino groups of lysine by citraconylation (Atassi and Habeeb, 
1972) thus providing useful overlaps of the tryptic peptides. Overlapping 
peptides were also obtained by digestion with chymotrypsin, thermolysin 
and Staphylococcus protease. These enzymes can also be used for further 
cleavage of tryptic peptides which are too large for manual sequencing, 
or whose sequences need extra proof. 
Two conditions must be met in the reconstruction of large sequences 
(see Recommendations (1976) J. Biol. Chem. 251, 11-12). In the first 
place, all residues should be identified at least twice or confirmed by 
an independent method. In the second place, all overlaps used to recon­
struct the sequence should involve at least two residues. A single resi­
due overlap can be used only when the residue in question is the only 
residue of that type involved in the alignment, and substantial evidence 
is provided that an additional fragment, beginning with that residue, 
has not been lost. Only when these conditions are met, reconstruction of 
the amino acid sequence is considered to be conclusive. 
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CHAPTER 2 : EXPERIMENTAL PROCEDURES 
2.1 lioZcution of, LA? á-tom Ьо іпг ¿гпл 
LAP was isolated from bovine lenses according to Hanson et al. 
(1965) with slight modifications. Decapsulated calf lenses (800) were 
stirred for 1 to 3 h at room temperature in 0.9% NaCl solution (2 ml/g 
wet weight). The nuclei were decanted, and the pH of the remaining solu­
tion was brought to 7.3 with 4 M NaOH. Zinc sulfate (12 ml, 1 M) was 
added slowly under vigorous stirring, while the pH was kept between 7.2 
and 7.4. The final concentration of zinc sulfate was 0.006 M. After 
centrifugation for 40 min at 8,000 rpm in a Sorvall centrifuge (GS3 ro­
tor), the clear supernatant was heated at 54 0C for about 20 min until a 
turbid precipitate had formed. The solution was cooled in ice and filter­
ed through paper. Ammonium sulfate was added to the clear filtrate 
(0.34 g/ml final volume) and the pH was brought to 7.0. After 24 to 48 h 
at 4 С the mixture was centrifuged at 8,000 rpm for 40 min. The crystals 
were washed with cold water of pH 5.0 and dissolved in 0.1 M Tris-HCl 
buffer, pH 8.0. Purity was checked routinely by SDS Polyacrylamide gel 
electrophoresis. Occasionally further purification was necessary. After 
centrifugation of the LAP solution at 55,000 rpm in a Spinco centrifuge 
(ТІ60 rotor), the supernatant was concentrated in a Diaflo Ultrafilter 
(Amicon XM50) to approximately 5 ml, and chromatographed on a column 
(140 χ 3.5 cm) of Ultrogel AcA 34 (LKB), eluted with 0.1 M Tris-HCl buf­
fer, pH 8.0, at a flow rate of 30 ml/h. For sequence studies the LAP 
solution was dialyzed against water and lyophilized. Protein concentra­
tion was determined by the method of Lowry et al. (1951). 
2.2 PolyacAyZamidz gel. <¿JÍzcMiophoK.uÍÁ 
SDS gel electrophoresis was carried out according to Laemmli (1970) 
with significant modifications. Acrylamide gels (13%) were prepared in 
tubes or as slab gels. SDS gel electrophoresis in slab gels was carried 
out in a Pleuger apparatus according to Kibbelaar and Bloemendal (1975) 
or in a Biorad model 220 dual vertical slab gel electrophoresis cell 
following the procedure described in detail by de Jong et al. (1978). 
Marker proteins were: bovine serum albumin (MW 67,000), ovalbumin (MW 
45,000), a-crystallin В chain (apparent MW 22,000), a-crystallin A chain 
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(apparent MW 20,000), and cytochrome с (MW 12,400). 
Acidic urea gel electrophoresis was performed in 10% acrylamide gels 
according to Schoenmakers et al. (1969). 
2.3 SecUimrvtcutLon ancLÍyi-u, 
Sedimentation studies were carried out at 20 С in a Beekman Spinco 
model E analytical ultracentrifuge at 64,000 rpm using Schlieren optics. 
2.4 АсХл. -<Ху imcUiuAzmunt 
Activity measurement and determination of kinetic parameters were 
carried out as described previously (van Loon-Klaassen et al., 1979). 
2.5 MoiitiS-tcatccw líacttoni 
Reduction and S-alkylation 
After reduction of possible S-S bridges the cysteines of LAP were 
modified by S-carboxymethylation and S-aminoethylation prior to cleavage. 
Because of resistance of LAP against dissociation (Melbey and Carpenter, 
1971), the reduction time was extended to 4 h and larger excess of 
alkylating reagent was used. LAP (40 mg) was dissolved in 12 ml of 
0.05 M Tris-HCl buffer, pH 8.0, containing 0.01 M EDTA and 8 M urea. Re-
duction was performed at 25 С for 4 h under nitrogen atmosphere with 
100 μΐ B-mercaptoethanol. The pH was brought to 8.5 with 4 M NaOH, and 
280 mg monoiodoacetic acid (Sigma), neutralized with 4 M NaOH, was added. 
Carboxymethylation was performed for 10 m m under nitrogen atmosphere in 
the dark, while the pH was kept constant with 1 M NaOH. The reaction was 
stopped by the addition of excess g-mercaptoethanol, and the solution was 
extensively dialyzed, first against 0.01 M Tris-HCl buffer, pH 8.0, and 
then against water. Finally the solution was lyophilized. 
Reduction and S-aminoethylation was performed according to Raftery 
and Cole (1966) in 0.1 M Tris-HCl buffer, pH 8.6, with a reduction time 
of 4 h. 
Citraconylation of ε-amino groups 
In order to limit cleavage by trypsin to arginyl bonds, the ε-amino 
groups of lysine were modified by citraconylation (Atassi and Habeeb, 
1972). Decitraconylation of the tryptic peptides was obtained by incuba­
tion in IO0-' acetic acid at 37 0C for 2 h. 
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2.6 Chm-Lcal. claavage. 
Cyanogen bromide cleavage 
Reduced and S-alkylated LAP (300 mg) was treated with cyanogen bro­
mide in 70% formic acid for 18 h at room temperature in the dark, at a 
protein concentration of 10 mg/ml using an equal weight of cyanogen bro­
mide. After cleavage, formic acid and excess cyanogen bromide were removed 
by repeated rotary evaporation, and the solution was lyophilized. 
Hydroxy!ami ne cleavage 
Hydroxylamine cleavage of CM-LAP was carried out according to Born-
stein and Balian (1977) with some modifications. Hydroxylamine (Fluka, 
13.9 g) was dissolved in 8 ml water. Under vigorous stirring 8 ml of 
12.5 M NaOH was added in an ice-bath, followed by 20 ml of 1 M KgCO,. The 
pH was adjusted to 9.5 with 4 M NaOH. Guamdine-HCl (57.3 g) was then 
added, and the volume brought to 120 ml by the addition of water. After 
re-adjustement of the pH to 9.5, CM-LAP was added to a concentration of 
2 to 4 mg/ml. After a reaction time of 4 h at 25 С the mixture was 
desalted by extensive dialysis against water and lyophilized. 
2.7 Enzynu.c dLcgeAttoni 
Digestions by trypsin (Worthington TRTPCK), chymotrypsin (Worthing-
ton CBI) and thermolysin (Calbiochem A grade) were carried out in 0.1 M 
NH.HCO,, pH 8.9, at 37 0C. Tryptic and chymotryptic digestion of large 
CB- and HA-fragments was performed for 2 h at a protein concentration of 
10 mg/ml using 1% (w/w) of enzyme initially and an additional 1% after 
1 h. Occasionally 2 M urea was included in the digestion buffer. Thermo-
lytic digestion of CB-fragments was performed for 0.5 h at a protein 
concentration of 15 mg/ml using 1% (w/w) of enzyme. Chymotryptic and 
thermolytic digestion of tryptic peptides was carried out for 0.5 h at a 
sample concentration of 15 to 30 ymol/ml using 0.5° (w/w) of enzyme. 
Digestion of CB- and HA-fragments by Staphylococcus protease (Miles, 
S. сшлгш VS) was carried out for 16 h at 37 0C in 0.05 M NH.HCO^ pH 8.0, 
at a protein concentration of 20 mg/ml using 5% (w/w) of enzyme. Di­
gestion of tryptic peptide T14 of CBI by Staphylococcus protease was per­
formed for 6 h at 40 0C in 0.1 M NH 4HC0 3, pH 8.0, at a peptide concen­
tration of 0.5 mg/ml using 5% (w/w) of enzyme (Austen and Smith, 1976). 
Digestion by aminopeptidase M (Boehringer) was carried out at 37 0C for 
17 
25 h in 0.1 M NH 4HC0 3, pH 8.2, at a peptide concentration of 50 nmol/100 
μ! using 40 μ! of enzyme solution (0.5 mg/μΐ). The digestion mixture was 
lyophilized and applied to the amino acid analyzer. 
All digestions were stopped by freezing and lyophilization, unless 
stated otherwise. 
2.8 SzpaKcuU.on afa ùvtgt {падте.гііл 
Column chromatography of CB- and HA-fragments was performed on 
Sephadex G-100 fine. Approximately 300 mg of cleavage mixture was dis­
solved in 5 ml of 10^ acetic acid containing 6 M urea, and applied to a 
column (200 χ 3.5 cm) of Sephadex G-100 fine. Fragments were eluted with 
the same solvent at room temperature at a flow rate of 10 ml/h and de­
tected by their absorbance at 280 nm (Uvicord II, LKB). Fractions of 5 ml 
were collected, pooled as indicated in each experiment, and desalted on a 
column (30 χ 4.0 cm) of Sephadex G-25 coarse in 10% acetic acid. 
Further purification of CB-fragments was obtained by ion-exchange chroma­
tography on CM-cellulose (Whatman, CM-52) as described by Huang et al. 
(1976). 
2.9 StpoAoJxcin o{¡ pzpti-deA 
Separation of peptides on Sephadex G-50 
Because of the complexity of the peptide mixtures obtained after 
enzymic digestion of large CB- and HA-fragments, a first separation was 
performed by chromatography on Sephadex G-50 superfine. The digestion 
mixture (20 to 40 mg) was dissolved in 0.5 ml of 0.1 M ammonia or 0.05 M 
NH.HC0, and applied to the column (120 χ 1.5 cm). When no clear solution 
was obtained, the insolubilities were removed by centrifugation at 4,000 
rpm in a Christ centrifuge prior to application to the column. Tryptic 
and chymotryptic digestion mixtures of CB1 were applied directly to the 
column. Peptides were eluted with appropriate solvent at room temperature 
at a flow rate of 5 ml/h, and detected by their absorbance at 206 and 280 
nm (Uvicord III, LKB). Fractions of 2.5 ml were collected, pooled and 
lyophilized. 
Separation of peptides on DEAE-cellulose 
Many large peptides obtained from the Sephadex column were further 
purified by ion-exchange chromatography on DEAE-cellulose (Whatman, 
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DE-52) according to Howard et al. (1974). A column of 11.0 χ 1.0 cm was 
used, equilibrated with starting buffer (0.05 M NH.HCOg, pH 7.8). Pepti­
des were eluted at room temperature with a linear gradient established 
by 100 ml (or 200 ml) each of starting buffer and final buffer (0.3 M 
NH.HC0,, pH 7.8) at a flow rate of 12 ml/h. Absorbance was measured at 
206 and 280 nm. Fractions of 4 ml were collected, pooled and lyophilized. 
Separation of peptides on Whatman 3 MM paper 
Peptide mapping was performed by high-voltage electrophoresis 
followed by chromatography in the second dimension. Peptide mixtures were 
dissolved in 50 to 100 μΐ of electrophoresis buffer consisting of 
pyridine/glacial acetic acid/water (25:1:225, by volume, pH 6.5), and 
spotted on a strip (87 χ 15 cm) of Whatman 3 MM paper. High-voltage elec­
trophoresis was performed for 2 h at 46 V/cm in a Savant high-voltage 
electrophoresis apparatus using Varsol as coolant. Arginine and aspartic 
acid were used as markers in the electrophoretic run. After drying the 
paper the area containing the peptides was cut out and sewn into a sheet 
of Whatman 3 MM paper (46 χ 57 cm). Descending chromatography was carried 
out for 19 h in n-butane-1-ol/glacial acetic acid/water/pyridine 
(15.3.12-10, by volume). Peptides containing tryptophan were marked under 
ultraviolet light (254 nm) before staining the maps. Occasionally re-
electrophoresis of some neutral peptides was performed in pyridine/ 
glacial acetic acid/water (1:10:89, by volume, pH 3.5). 
Analytical peptide maps were loaded with 0.1 to 0.2 μπιοί of peptide 
mixture. For preparative isolations up to 0.5 μπιοί of peptide mixture 
was applied per peptide map. Aspartic acid was used as a reference for 
the determination of the mobility of peptides, and their charge was cal­
culated according to Offord (1966). 
Analytical peptide maps were stained with 0.02°» ninhydrin in acetone 
containing 1" acetic acid and 1" pyridine. The color was developed at 
room temperature. Peptides with N-terminal glycine or threonine initially 
revealed a greyish color instead of the usual purple color. Peptides with 
N-terminal proline developed a bright yellow color at 70 0C. Certain 
N-terminal amino acids, especially asparagine, gave bad staining results. 
In this case peptides were detected with 0.2% ninhydrin or by other 
staining methods. Preparative peptide maps were stained with 0.001% 
fluorescamine (Fluram, Roche) in acetone containing 0.05% pyridine (Uden-
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fried et al., 1972). Peptides were visualized by irradiation at 366 nm. 
The Pauly reaction for the detection of peptides containing tyrosine or 
histidine was performed according to Easley et al. (1969). Occasionally 
maps were also stained with the Ehrlich reagent to detect peptides con­
taining tryptophan (Easley et al., 1969). 
Peptides were eluted with 6 И HCl containing 0.025% (w/v) phenol for 
direct hydrolysis, or with 20% acetic acid. When peptides were expected 
to contain an N-terminal glutamine which can easily undergo cyclization, 
thereby blocking the Edman degradation, elution was performed with 0.1 M 
ammonia. The area containing the peptides was cut into little pieces, and 
these were placed in a 2 ml syringe hung into a test tube. Elution was 
performed by wetting the paper with eluens followed by short centrifuga-
tion at 3,000 rpm. The effluent was then transferred to a hydrolysis tube 
or lyophilized. This elution procedure resulted in recoveries of peptides 
ranging from 10 to 50 per cent of the amount applied. 
2.10 Amino add апаіуііл 
Protein samples (approximately 0.2 mg) were hydrolyzed in 0.5 ml of 
6 M HCl containing 0.025% (w/v) phenol for 24, 48 and 72 h in sealed, 
evacuated tubes at П О С Peptide samples (10 to 50 nmol ) were hydro­
lyzed in 0.5 ml of 6 M HCl containing 0.025« (w/v) phenol for 22 h at 
110 C, or for 72 h when they were suspected to contain hydrolysis-
resistant Val-Val, Val-Ile or Ile-Val bonds. Amino acids were determined 
on a Chromaspek amino acid analyzer (Rank Hilger). The amino acid compo­
sition of LAP was determined on a Beekman Multichrom amino acid analyzer. 
Generally values for threonine and serine were extrapolated to zero time 
hydrolysis, and values for valine and isoleucine were taken from the 72 h 
hydrolysate. Cysteine was determined as S-carboxymethylcysteine. Trypto­
phan was determined by the procedures of Benzee and Schmid (1957), of Liu 
and Chang (1971), of Gruen and Nichols (1972) and of Messineo and Musarra 
(1972). However, for CM-LAP none of these methods gave satisfactory re­
sults. 
2.11 VeXeAinLncLtion o¿ Ы-іглтіпаі. кыЫиы 
Of the two methods which have been described for the determination 
of the N-terminal residue of proteins, the procedure of Gray (1972) was 
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not successful. However, the method of Gros and Labouesse (1969) gave 
very good results both on native LAP and on large CB- and HA-fragments. 
The dansylated amino acids were identified as described in the next 
section. 
Determination of the N-terminal residue of peptides was performed by 
dansylation according to Gray (1972). 
2.12 Am-uto аслсі izqumce аеЛолтспаЛл-Оп 
Dansyl-Edman degradation 
The dansyl-Edman technique was performed according to Gray and 
Smith (1970). Sequencing reagents (PITC, TFA, pyridine) were all sequenal 
grade (Pierce). Generally a sample of 5 to 10 nmol was removed after each 
degradation step, and subjected to dansylation. The dansylated peptides 
were hydrolyzed in 6 M HCl at П О С for 4 to 10 h. The hydrolysis time 
was extended to 16 h when either dansyl-Val or dansyl-Ile was expected. 
Dansyl amino acids were identified by two-dimensional thin-layer chroma­
tography on polyamide sheets (Schleicher and Schuil, F1700, 5 χ 5 cm) 
The solvent systems of Woods and Wang (1967) were used, modified by re­
placing benzene of solvent II by the less toxic toluene. Dansyl-histidine 
was identified by a solvent system in which solvent III was replaced by 
a solvent consisting of one volume ethanol and three volumes of pyridine/ 
acetic acid/water (9:16 1000, by volume, pH 4.4) (Jornvall, 1970). 
Direct manual Edman degradation 
For the direct manual Edman degradation the accelerated version of 
Niall and Potts (1970) was used All reagents were sequenal grade from 
Pierce Prior to the first degradation step the peptides (200 to 400 
nmol) were lyophilized several times from triethylamine [ I t ) . The peptides 
were then dissolved in 0.1 ml of coupling buffer (0.4 M DMAA-TFA buffer 
in pyridine/water (3 2, by volume), pH 9.5). The solution was flushed 
with nitrogen and incubated with 5 μΐ PITC for 30 m m at 50 0C with 
occasional mixing. For some of the larger lysyl peptides SPITC was used 
at the first step (Braumtzer et al., 1971), performing coupling of the 
peptides in coupling buffer. After incubation at 50 С for 2 h the 
3-sulfophenylthiocarbamyl peptide was extracted three times with butyl-
chloride, lyophilized and then subjected to the first step of the normal 
PITC coupling procedure After incubation with PITC the solution was 
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extracted three times with 0.3 mi benzene and lyophilized. TFA (50 μΐ ) 
was added, and after flushing with nitrogen incubation was performed at 
50 0C for 7 m m . When no clear solution was obtained another 50 μΐ of 
TFA was added and incubation extended to 12 m m . The solution was occa­
sionally shaken during incubation. When glutamme was expected to be the 
next N-terminal residue, cleavage was performed at room temperature for 
10 m m in order to prevent cyclization to a pyrrolidone structure (Mole 
et al., 1977). The solution was then dried in a nitrogen stream, and 
extracted twice with butylchlonde (0.3 ml). The residue was lyophilized 
before submitting it to a next degradation cycle. The combined butyl-
chloride extracts were evaporated to dryness in a nitrogen stream. 
Conversion was performed under nitrogen atmosphere in 0.1 ml of 1 M HCl 
at 80 0C for 10 min. When threonine or serine were expected, the tempera­
ture was slowly raised from room temperature to 80 С in order to prevent 
destruction of the PTH-denvative. The mixture was extracted three times 
with 0.4 ml ethylacetate. The organic phase was evaporated to dryness in 
a nitrogen stream and the residue was used for identification The 
aqueous phase was lyophilized for identification of the PTH-denvatives 
of histidine and arginine The PTH-denvatives in the organic phase were 
identified by high performance thin-layer chromatography on silicagel 
plates with an internal fluorescence indicator (Kieselgel 60 F254, Merck, 
10 χ 10 cm) The following solvent systems were used in the same di­
rection 1. chloroform/ethanol (98 2, by volume) 
2. chloroform/methanol/ethanol (88.2 1.8 2, by volume). 
For the separation of the PTH-denvatives of the acidic residues aspartic 
acid, glutamic acid and S-carboxymethylcysteine a different solvent was 
used, ethylene chloride/acetic acid/water (60 14 1.3, by volume). After 
locating the spots at 254 nm the plates were sprayed with a 0.1 % (w/v) 
mnhydnn solution in absolute ethanol/collidine/acetic acid (70 2 9 21, 
by volume), and heated at П О С for 10 m m (Roseau and Pantel, 1969) 
Most PTH-amino acids showed specific colors which greatly facilitated 
their identification. Quantification of PTH-amino acids was obtained by 
high performance liquid chromatography (Frank and Strubert, 1973) on a 
liquid Chromatograph equiped with a Vanan detector (254 nm). A column 
(25 χ 4.6 cm) of Nucleosil 50-5 (Schleicher and Schuil) was used. For the 
separation of the PTH-denvatives of Pro, Leu, Ile, Val, Phe, Met, Ala, 
Trp and Gly elution was performed with chloroform/methanol (99.75 0.25, 
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by volume). Chloroform/methanol/DMSO (92:5:3, by volume) was used to 
elute the PTH-derivatives of Lys, Туг, Ser, Thr, Gin and Asn. PTH-Glu, 
PTH-Asp and PTH-CM-Cys were only identified by thin-layer chromatography. 
For identification of PTH-His and PTH-Arg the aqueous phase was subjected 
to chromatography on the above mentioned silicagel plates, developed by 
xylene/95% ethanol/acetic acid (50:50:0.5, by volume) (Inagami, 1973). 
PTH-His was also identified with Pauly reagent (Easley et al., 1969). 
Automated Edman degradation 
Automated Edman degradation was performed in a Beekman spinning cup 
sequenator model 890C using the standard fast protein program. PTH-amino 
acids were identified by thin-layer chromatography on silicagel plates 
developed by xylene/isopropanol (7:2, by volume) (Inagami and Murakami, 
1972). The spots were located at 254 nm and stained with mnhydrin as 
described above. Gas liquid chromatography was performed on a Beekman 
GC45 gas Chromatograph using the conditions described in the Beekman 
Sequencer manual. 
2.13 Amtde. (Ui<ignme.nt 
Amide groups were assigned on the basis of the charge of peptides 
as revealed by their electrophoretic mobility at pH 6.5 (Offord, 1966), 
by direct identification as PTH-derivative in the Edman degradation, or 
by amino acid analysis following digestion by aminopeptidase M. Additio­
nal information was provided by the specificity of Staphylococcus pro­
tease. 
2.14 Pe.ptA.de. пошпс&оЛилг 
Peptides were numbered starting from the N-terminus of the respec­
tive CB- or HA-fragment. Peptides were indicated by prefixes according 
to the type of cleavage by which they were produced: T, tryptic di­
gestion; Tc, tryptic digestion after citraconylation; C, chymotryptic 
digestion; Th, thermolytic digestion; SP, staphylococcal protease di­
gestion. 
2.15 LuruXid pioteolytcc cLcgeAtíon о ¡J ncuU.vz LAP 
Limited proteolysis of native LAP with several enzymes was per-
formed at 37 С in 0.1 M Tris-HCl buffer, pH 8.0, at a protein concen-
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tration of 5 mg/ml using 0.5% (w/w) of enzyme as described previously 
(van Loon-Klaassen et al., 1979). Purification of fragments LT-I and 
LT-II resulting from limited tryptic digestion of native LAP was achieved 
by chromatography on Sephadex G-100 in 10% acetic acid containing 6 M 
urea. 
2.16 Synthzi-u и i L-PhíCH2C¿-HCÍ 
A solution of tert-butyloxycarbonyl-L-phenylalanine (E.65 g) in THF 
(25 ml) and tri ethyl ami ne (1.4 ml) was treated with isobutyl chloro-
formate (1.31 ml) at -10 С The mixture was stirred and allowed to stand 
for a few minutes at -10 C, after which time a precipitate of triethyl-
amine-HCl had formed. Excess ethereal diazomethane was added and the 
mixture allowed to stand overnight. Neutralization was performed by the 
addition of 2 M KHSO», and the solution was extracted with satured NaCl 
solution. After addition of solid ^ S O . the mixture was filtered through 
paper and evaporated to dryness under vacuum. The crude product was 
recrystallized from petroleum ether, bp 60-80 0C. The yield of diazo-
ketone was 1.9 g (66%), mp 94-96 С The diazoketone showed strong peaks 
at 1640 and 2100 cm" . To obtain the chloromethyl ketone derivative the 
diazoketone (200 mg) was treated with excess hydrochloric acid in ethyl-
acetate. The solution was cooled in ice and the resulting crystals were 
filtered off, washed with cold ether, and dried under vacuum. The yield 
of chloromethyl ketone was 140 mg (89%). It decomposed without melting 
at 176-177 0C. 
2.17 Inlvibition oh LAP by L-P(ieCH2C£ 
2+ Inhibition studies with L-PheCH^Cl were performed either on Mn -
2+ 2+ 
activated LAP or on Mg -activated LAP. Activation by Mn ions was per­
formed as described by Fittkau et al. (1974). The enzyme concentration 
in the activation mixture was 0.0129 mg/ml. Activation by Mg ions was 
obtained by incubation at 25 0C and pH 9.5 for 2 h in the following stan­
dard mixture: 50 μΐ of 1 M MgCl2, 850 μ! of 0.235 M Tris-HCl buffer, pH 
9.5, and 100 yl of diluted enzyme solution resulting from 100 μΐ stock 
solution (4.4 mg LAP in 1 ml of 0.1 M Tris-HCl buffer, pH 8.0) plus 3 ml 
of 10 mM Tris-HCl buffer, pH 8.3. In this activation mixture the enzyme 
concentration was 0.0142 mg/ml. Inhibition studies of LAP by L-PheCH?Cl 
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were performed as described by Fittkau et al. (1974) using L-leucine 
hydrazide as substrate. Activities are expressed as mmoles L-leucine 
hydrazide hydrolyzed per minute per mg enzyme, using initial velocities 
only. The type of inhibition was ascertained graphically by means of 
Lineweaver-Burk plots using a series of substrate concentrations ranging 
from 5 to 40 mM. Analyses at each concentration were in duplicate. Plots 
of 1/V versus 1/[S] were linear over the range examined, and standard 
errors for К and V determined by least square regression were within 
m max
 J M 
5% of the values given in the results. 
2.18 Legenda to {¡ідилол and tabiu 
In figures showing gel filtration or ion-exchange elution patterns 
the absorbance at 206 nm is indicated by straight lines and the absor-
bance at 280 nm by underbroken lines, unless stated otherwise. Pooled 
fractions are indicated by horizontal bars. In figures showing peptide 
maps of digestion mixtures the origin is indicated by (+). Tables show 
amino acid compositions of proteins, fragments or peptides. In most 
cases values are given without correction for hydrolytic loss or incom­
plete cleavage. Generally values are the average of at least two indepen­
dent analyses. Values between brackets represent nearest integers, unless 
stated otherwise. Values for homoserine include those of homoserine 
lactone. Cysteine was normally determined as S-carboxymethylcysteine. 
The presence of tryptophan in peptides was based upon ultraviolet 
fluorescence and Ehrlich staining. 
25 

CHAPTER 3 : ISOLATION AND CHARACTERIZATION OF BOVINE LENS LAP 
3.1 ІпХлоаи.сЛл.оп 
When it was recognized that LAP was very abundant in lens tissue, 
attempts were initiated to purify the enzyme. Bovine lenses seemed to be 
the best source, since they displayed a rcitively high LAP activity. 
Initial attempts to purify LAP from bovine lens involved precipitation 
by acetone or ammonium sulfate followed by continuous paper electropho­
resis (Glasser and Hanson, 1962), or, alternatively, zinc sulfate preci­
pitation and chromatography on DEAE-cellulose (Spector, 1963). In 1965 
the first successful crystallization of LAP was reported (Hanson et al., 
1965). The procedure involved a combined zinc-heat treatment of lens 
homogenate followed by ammonium sulfate precipitation. Lenses of young 
animals were used preferentially. Because this procedure provides a con­
venient method, it is especially suited for the routine purification of 
the large amounts of LAP needed for sequence studies. Therefore we used 
essentially the same procedure with only slight modifications. 
Because conflicting reports have appeared concerning the number and 
identity of the subumts of LAP, we investigated the subumt structure 
by means of Polyacrylamide gel electrophoresis, amino acid analysis and 
determination of the N-terminal amino acid sequence. 
3.2 iiolautLon ûj$ LAP fanom bovino. l&nòQJ, 
Treatment of lens homogenate with zinc sulfate resulted in a preci-
pitation of nearly all of the water-soluble crystallins (fig. 3.1,a). 
Heating of the supernatant at 54 С removed the remaining crystallins, 
together with some proteins of higher molecular weight (fig. 3.1,b). 
These proteins were filtered off through paper, and ammonium sulfate 
precipitation of the remaining clear filtrate yielded LAP crystals (fig. 
3.1,c). When no clear filtrate was obtained, as sometimes happened, 
crystallization of LAP proved to be impossible. Following this procedure 
200 to 300 mg LAP was purified routinely from 800 lenses. In most cases 
the isolated LAP crystals appeared to be pure when analyzed by SDS gel 
electrophoresis. However, on several occasions LAP was obtained which 
contained an extra protein of MW 20,000. The amount of this protein, 
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Fig. 3.1 SDS gel eleatrophovesis of the diffe­
rent purification steps of LAP 
(a) zinc sulfate precipitate, (b) heat precipi­
tate, (c) purified LAP crystals. 
a b c 
which was believed to be a γ-crystallin frac­
tion on the basis of amino acid analysis, two-
dimensional gel electrophoresis and determina­
tion of the N-terminal sequence (H.Th. Cuypers, 
unpublished results), varied from less than a 
few per cents to more than 50 per cents. When a 
solution of LAP containing this extra protein 
had been frozen and lyophilized, removal of the 
contaminating protein appeared to be very dif­
ficult. Even chromatography on Sephadex G-100 
in the presence of 7 M urea could not remove it 
completely. Purification could, however, very 
simply be achieved by chromatography of the 
native LAP solution on Ultrogel AcA 34 in 0.1 M 
Tris-HCl buffer, pH 8.0 (fig. 3.2). In this way 
the 20,000 MW protein was removed completely. 
absorbance 
3.0 
2.0 
1.0 
0-
ß-high 
β-low 
LAP 
300 400 500 600 700 800 900 
elutlon volume (ml ) 
Fig. 3.2 Purification of MP on Ultrogel AcA 34 
The column was calibrated with lens crystallins ( — ) . Absorbance was 
measured at 280 nm. 
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The molecular weight of native LAP, estimated from the Ultrogel 
column calibrated with lens crystallins, was approximately 300,000. 
Purified LAP was homogeneous both in SDS gel electrophoresis and sedimen­
tation analysis. In the analytical ultracentrifuge a single symmetrical 
peak was obtained (fig. 3.3). The sedimentation constant calculated for 
LAP in Tris-HCl buffer, pH 8.0 (4.8 mg/ml) was 10.85 + 0.06 S. 
Native LAP in Tris-HCl buffer, pH 8.0, is stable for long periods of time 
without loss of activity if kept at 4 0C. 
Fig. 3.3 Sedimentation analysis 
of native LAP 
3.3 ChcuiacXafbizoution о fa bovine, ¿гпі LAP 
The catalytic activity of LAP was measured after activation by 
manganese ions with L-leucinamide as substrate. The optimal Mn -concen­
tration for activation was determined to be 1 mM. The specific activity 
2+ 2+ 
of Mn -activated LAP was 0.94 mmoles/min.mg enzyme. Mn -activated LAP 
is stable for a few days at 4 0C. Lyophilization of the LAP solution 
leads to inactivation. Kinetic parameters for Mn -activated LAP were 
obtained by means of a Lineweaver-Burk plot (fig. 3.4). The К value was 
m 
29.4 mM, and the maximum velocity was 1.4 mmoles/min.mg enzyme. The 
5 -1 
corresponding к . value was 4.1 χ 10 min . 
cat i Η (mmol"1. min. mg) 
1.5-
1.0-
уО.Ь-
<—•Чтях^'М 
κ 
/ 
I I 
-0.04 | -0.02 
K
m
 = 29.4 
0.02 0.04 0.06 
.•1-, (mmol"1.!) 
Fig. 3.4 Lineweaver-Burk 
plot of the hydro­
lysis of L-leuoin-
amide by LAF after 
activation by 
manganese ions 
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The subumt structure of LAP was investigated by means of gel 
electrophoresis under dissociating conditions either of native LAP or of 
CM-LAP. Fig. 3.5 shows the electrophoretic behavior of native LAP in gels 
containing SDS and in acidic urea gels. In both cases only one band was 
Fig. 3.5 PoЪуастуlamde gel electropho-
•••^  ^
m
 resbs of паЬг е LAP 
****• Left SDS gel electrophoresis 
Right acidic urea gel electrophoresis 
Table 3.1 Automated bdman degra­
dation of LAP 
The repetitive yield was 94%. 
Cycle 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Residue 
Thra 
Lys 
Gly 
Leu 
Val 
Leu 
Gly 
He 
Tyr 
Ser 
Lys 
Glu 
Lys 
Glu 
Glu 
Asp 
Glu 
Pro 
Gin 
Phe 
Thr 
Yield (nmol) 
350 
345 
320 
300 
280 
250 
200 
190 
180 
150 
120 
100 
80 
the N-termmal threonine was 
also identified by dansylation 
found. The molecular weight of the 
subumt of LAP was estimated to be 
54,000. Gel electrophoresis of 
CM-LAP yielded the same result. 
Kleine and Lehmann (1976) reported 
that prolonged standing of LAP or 
CM-LAP in SDS solution with or 
without B-mercaptoethanol resulted 
in the appearance of polypeptide 
chains of MW smaller than 54,000. 
However, on repeating these experi­
ments we did not observe any poly­
peptide chain other than the 
54,000 MW subumt. 
The N-terimnal amino acid sequence 
of LAP was determined by automated 
Edman dagradation (table 3.1). 
Twenty-one amino acids were identi­
fied. 
The amino acid composition of LAP 
is shown in table 3.2. For compari­
son the values reported by Carpen­
ter and Vahl (1973) and by Kett-
mann et al. (1968) are included. 
Some values of the second report 
have been improved (Hanson and 
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Frohne, 1977). Amino acids which occur in low frequence are histidine, 
cysteine, tyrosine and tryptophan. LAP is rich in hydrophobic amino 
acids. The results indicate the presence of approximately 490 amino acid 
residues in the polypeptide chain of LAP. 
Table 3.2 The amino acid composition of bovine lens LAP 
Values are expressed as residues per subunit. Values for 
valine and isoleucine were taken from the 72 h hydroly-
sate, and values for threonine and serine were extrapo­
lated to zero time hydrolysis. Values for the basic re­
sidues are probably too high due to the buffer change. 
(A) present results, (B) values from Carpenter and Vahl 
(1973), (C) values from Kettmann et al. (1968). 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lys i ne 
Arginine 
Tryptophan 
Total 
MW 
(A) 
46.5 
24.1 
29.2 
52.3 
23.8 
42.3 
52.5
a 
6.8a 
33.3 
11.2 
27.4 
38.3 
8.9 
19.2 
8.9 
36.1 
22.4. 
3.8Ь 
487.0 
52,799.7 
(В) 
47 
25 
28 
52 
26 
42 
53 
8 
33 
11 
29 
39 
10 
20 
8 
34 
21 
10 
496 
54,060 
(С) 
43 
22 
26 
48 
25 
39 
48 
8 
30 
10 
25 
35 
8 
18 
8 
32 
20 
7 
452 
48,878 
^determined as S-carboxymethylcysteine 
unreliable value 
3.4 V¿iCLU>iíon 
The isolation procedure described by Hanson et al. (1965) provided 
a convenient method for the large scale purification of LAP from bovine 
eye lens. In most cases essentially pure LAP was obtained. The amount of 
200 to 300 mg LAP isolated from 800 lenses, that is, about one mg of 
enzyme per g lens protein, illustrates the large content of LAP in bovine 
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lens tissue. The presence of a y-crystaThn fraction in some preparations 
is probably an isolation artefact. The purified enzyme was homogeneous 
both in gel electrophoresis and sedimentation analysis. 
The kinetic parameters agree reasonably well with those reported 
earlier. Hanson et al. (1965) reported а К value of 31.25 mM and а к 
/- 1 ГП Cat 
value of 1.66 χ 10 min" . Carpenter and Vahl (1973) determined a К 
value of 33 mM and a V value of 2.04 mmoles/min.mg enzyme. 
ГПЗХ 
The molecular weight of native LAP is 326,000 (Kretschmer and Hanson, 
1965; Melbey and Carpenter, 1971). The number and size of the subumts 
have been the subject of some controvery. Using various techniques in­
cluding chromatography in SDS (Kretschmer,1967), electron microscopy 
(Kretschmer,1968) and sedimentation studies in SDS and urea (Kretschmer 
and Hanson, 1968) the authors concluded that LAP was made up of ten sub­
umts of MW 32,600. On the other hand, Weber and Osborn (1969) and Mel­
bey and Carpenter (1971) arrived at a subumt size of MW 54,000, indica­
ting a hexameric structure. Our results are in accord with the presence 
of six subumts of MW 54,000. We did not observe any decomposition of the 
subumt either in 1% SDS and B-mercaptoethanol or by incubation of 
CM-LAP at 37 C, as was reported by Kleine and Lehmann (1976). 
We showed that the subumts of LAP are identical both in molecular 
weight and charge, and that they have the same N-terminal amino acid 
sequence. Moreover, during our sequence studies we never found any indi­
cation of heterogeneities in the primary structure. We concluded that 
LAP from bovine lens is composed of six identical polypeptide chains 
with an estimated MW of 54,000. 
The amino acid composition of LAP presented here agrees well with 
that of earlier reports. The only serious discrepancy is the value of 
tryptophan, which is notorious for the difficulties encountered in its 
determination. Although we determined the tryptophan content of LAP by 
several methods, we were not able to obtain reproducible results. The 
value of six tryptophanyl residues derived from the total amino acid 
sequence (see addendum) is lower than the values found by Carpenter and 
Vahl (1973) and by Kettmann et al. (1968). The values reported by Kett-
mann et al. (1968) will certainly need correction because they add up to 
a total of 452 amino acid residues, which is too low to account for a MW 
of 54,000. The polypeptide chain of LAP contains about 490 residues. 
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CHAPTER 4 : CYANOGEN BROMIDE CLEAVAGE OF LAP AND AMINO ACID SEQUENCE 
DETERMINATION OF SEVERAL FRAGMENTS 
4.1 Cyanogen ЬкотЫг аіга адг and puAÁ.{¡¿c-cuLion o{, {¡п.адте.п£л 
Cyanogen bromide is a simple chemical reagent permitting almost 
quantitative cleavage of methionyl bonds. Methionine is thereby converted 
to homoserine. Because the amino acid analysis of LAP revealed the pre­
sence of 11 methionines (see table 3.2), at least 12 fragments were 
expected. CM-LAP was treated with cyanogen bromide in 70% formic acid 
using a 50-fold excess of cleavage reagent over methionyl residues. The 
resulting cleavage mixture was analyzed by SDS gel electrophoresis (fig. 
4.1). All of the LAP subunit of MW 54,000 had disappeared and several 
Fig. 4.1 SOS gel electrophoresis of 
the CB-aleavage mixture of 
CM-LAP 
(a) marker proteins, (b) CB-cleavage 
mixture of CM-LAP 
cleavage fragments were generated. The 
main products were fragments of MW 
21,000 and 10,000. The band of MW 
10,000 is somewhat heterogeneous, indi­
cating the presence of several products 
with MW's around 10,000. Two products of MW 43,000 and 35,000 resulted 
from incomplete cleavage. Initial attempts to purify the CB-fragments 
suffered from difficulties related to insoluble material and considerable 
aggregation between the fragments. Therefore, a first separation of the 
CB-fragments was performed on Sephadex G-100 in the presence of 6 M urea 
(fig. 4.2). The contents of the different pools were analyzed by SDS gel 
electrophoresis (fig. 4.3). The shoulder on the first peak (pool I) 
largely contained aggregated fragments and products of incomplete 
cleavage. Thus even in the presence of 6 M urea aggregation still 
occurred, but the quantity of pool I usually was relatively low. The 
first peak (pool II) yielded a fragment which was pure after rechromato-
graphy on the same column. Its molecular weight was estimated to be 
67,000-
45,000-
20,000-
12,400-
-43,000 
-35,000 
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Fig. 4.2 
Chromatography of the 
CB~fragments of CM-LAP 
on Sephadex G-100 
Absorbance was measured 
at 280 nm. 
260 280 340 360 380 
elution volume (ml) 
i. 
— a 
21,000. Automated Edman degradation of this 
fragment gave the same result as found for 
native LAP (see table 3.1). Hence we con­
cluded that this fragment was the N-terminal 
CB-fragment of LAP, and it was designated 
CB1. Occasionally a shortened fragment (a in 
fig. 4.3) was found as a result of the 
cleavage of an Asp-Pro bond in CB1 under the 
acidic conditions of the CB-cleavage reaction 
(Piskiewicz et al., 1970). Tryptic digestion 
of this fragment yielded essentially all 
peptides expected for this shortened CB1 
fragment. Therefore, no further purification 
was performed when CB1 contained small 
amounts of this fragment. Pool III of the 
Sephadex G-100 column, containing a mixture 
of fragments of MW 10,000, was subjected to 
ion-exchange chromatography on CM-cellulose 
(fig. 4.4). Two fractions were obtained con­
taining CB-fragments similar in MW and charge. Pool IV of the Sephadex 
G-100 column contained fragments of MW 6,000 and 5,000. They were puri­
fied by ion-exchange chromatography on CM-cellulose and DEAE-cellulose 
(H. Th. Cuypers, unpublished results). Fractions eluted later from the 
Sephadex column contained smaller fragments. 
At this moment a total of 12 methionyl residues have been identified in 
LAP. A schematic representation of their position in the polypeptide 
ш m m-
I II III IV 
Fig. 4.3 
SDS gel eleatrophoresis 
of pools I-IV of the 
Sephadex G-100 column 
(fig. 4.2). 
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obsorbance (280nm) 
0 6 
40 60 80 100 120 140 
eiulion volume (ml) 
Fig. 4.4 
Fractionation of pool 
III of the Sephadex ao-
limn (fig. 4.2) on CM-
aellulose 
chain of LAP is given in fig. 4.5. The amino acid sequence determination 
of fragment CB1, ranging from the N-terminus up to methionine-171, is 
presented in section 4.2. The characterization of the CB-fragments pre­
sent in fractions I and II of the CM-cellulose column (fig. 4.4) is 
described in section 4.3. These fragments originated from region 306-466 
of the polypeptide chain. From the results of the sequence determination 
of these fragments a partial amino acid sequence of this part of the 
chain could be deduced. 
H2N 
2 13 270 
1 7] 1 7Θ | 267 . 271» 3 
\ 1 \' / / 
3 Θ2 
3 64 ι 399 
\ ' / 
it 53 \ Ц GG / 
section 4.2 
•COOH 
section 4.3 
Fig. 4.5 Schematic representation of the poaition of the mebhionyL 
residues in Lhc polypeptide chain of LAP 
Methionyl residues are indicated by vertical bars. Their position in the 
chain is indicated by numbers above the chain, and was derived from the 
total amino acid sequence of LAP (see addendum). 
4.2 Am¿no acid izqumee d<¿t<¿n.íru.n(xtÍun o¿ C87 
The amino acid composition of CB1 is presented in table 4.1. Automa-
ted Edman degradation of CB1 yielded the same result as shown in table 
3.1 for native LAP, and determined the sequence of the first 21 amino 
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Amino acid 
Aspartic acid 
Threonine 
Serine 
Homoseri ne 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
МЫ 
(A) 
14.8 
5.2 
8.4 
0.7 
25.0 
6.3 
17.7 
17.0 
1.8 
13.4 
7.1 
15.7 
3.7 
5.3 
3.2 
13.8 
8.0 
1.8 
168.9 
18,414 
(B) 
15 
5 
9 
1 
26 
6 
18 
16 
2 
14 
7 
16 
4 
5 
3 
14 
8 
2 
171 
18,637 
Table 4.1 acid residues as follows: 
Amino aoid composition of CB1 as
 х
. , „, ,, , , 
obtained from amino acid analysis Thr-Lys-Gly-Leu-Val-Leu-Gly-Ile-
(A) and from sequence results (B) Tyr-Ser-Lys-Glu -Lys-Glu-Glu-Asp-
Glu-Pro-Gln-Phe-Thr-
The determination of the amino 
acid sequence of CB1 was achieved 
following a strategy which 
involved: 
1. isolation of the tryptic pep­
tides and their complete 
amino acid sequence determina­
tion, 
2. establishment of overlaps be­
tween the tryptic peptides with 
the aid of chymotryptic and 
thermolytic peptides, and of 
citraconyl peptides. 
4.2.1 V-LQUtAon 0^ CB7 by іл.уріш 
Isolation of tryptic peptides 
The complex mixture of peptides obtained by tryptic digestion of CB1 
was fractionated on Sephadex G-50 superfine as a first purification step 
(fig. 4.6). The digestion mixture was applied directly to the column. 
The first peak (pool I) yielded the large peptide T14 in pure form. 
All other peptides needed further purification. Pool II largely contained 
peptide T9, which was purified by ion-exchange chromatography on DEAE-
cellulose (fig. 4.7). All smaller peptides (pool III) were purified by 
peptide mapping (fig. 4.8). Peptides Tl and T7 were not separated on 
the peptide map. They were sequenced as a mixture. Peptide T2 was not 
isolated, probably because of its hydrophobic nature. Since its sequence 
was deduced from the sequenator run on total CB1, no attempts were made 
to isolate this peptide. Because of overlapping between pool II and III 
of the Sephadex column, peptide T9 also appeared on the peptide map, 
although in very low quantities. The neutral peptides T12 and T13 some­
times co-eluted on the map, but they could be separated by re-electropho-
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120 
traction number 
Fig. 4.6 Fractionation of the tryptia peptides of CB1 on Sephadex G-SO 
superfine in 0.1 M ammonia 
Pool I yielded peptide T14 in pure form. Pool II was purified by ion-
exchange chromatography on DEAE-cellulose (fig. 4.7), and pool III by 
peptide mapping (fig. 4.8). Fractions of 2.5 ml were collected. 
Fig. 4.7 
Purification of pool II 
of the Sephadex column 
(fig. 4.6) on DEAE-
cellulose 
Fractions of 4.0 ml were 
collected. 
40 50 
fraction number 
chromatography 
T1<( 
О 
тзо a 
0 T 1 9 ü 
»Ό 
лОтв 
' ' T19 
τιβ /С?тіг 
Т13 
Т4С7 С7Т'6-17 L~ 
ТвС/-5Т1.Т7 г\ 
О (-J ^ l ) T 1 0 ^ T , 6 
Т19Ь <С? 
w electrophoresis -»<-> 
hig. 4.8 
Purification of pool III 
of the Sephadex column 
(fig. 4.0) by peptide 
mapping 
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£g Table 4.2 Amino acid composition of the tryptic peptides of CB1 
Values between brackets are the actual values found in the sequence. Peptides were isolated by gel filtration 
on Sephadex G-50 (A), by peptide mapping (B), after re-electrophoresis at pH 3.5 (C), and by ion-exchange 
chromatography on DEAE-cellulose (D). Peptide T2 was not isolated. 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Homoserine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield (%) 
Charge 
Purification 
Peptide 
Tl 
0.9(1) 
1.0(1) 
2 
25 
+1 
AB 
T3 
2.9(3) 
1.0(1) 
0.9(1) 
5.6(6) 
1.2(1) 
1.0(1) 
1.0(1) 
1.9(2) 
1.9(2) 
18 
38 
-3 
AB 
T4 
0.9(1) 
1.2(1) 
1.0(1) 
0.9(1) 
1.0(1) 
5 
36 
+1 
AB 
T5 
1.0(1) 
1.0(1) 
2 
40 
+1 
AB 
T6 
0.9(1) 
0.9(1) 
1.1(1) 
1.9(2) 
1.2(1) 
1.8(2) 
2.0(2) 
1.0(1) 
11 
50 
0 
AB 
T7 
1.0(1) 
1.0(1) 
1.0(1) 
3 
25 
+1 
AB 
T8 
1.0 
1.0 
2 
26 
+1 
AB 
(1) 
(i) 
T9 
0.9(1) 
1.0(1) 
1.0(1) 
1.0(1) 
1.0(1) 
3.2(3) 
3.2(4)a 
2.3(2) 
0.9(1) 
1.8(2) 
1.0(1) 
1.0(1) 
19 
10 
0 
AD 
T10 
1.0(1) 
1 
18 
+1 
AB 
T10-11 
1.9(2) 
0.9(1) 
4.0(4) 
2.2(2) 
1.1(1) 
1.0(1) 
1.0(1) 
2.0(2) 
+ (1) 
15 
8 
-1 
AB 
TU 
1.8(2) 
1.0(1) 
3.8(4) 
2.0(2) 
1.2(1) 
1.1(1) 
1.0(1) 
1.0(1) 
+ (i) 
14 
30 
-2 
AB 
T12 
1.0(1) 
1.0(1) 
1.0(1) 
1.0(1) 
4 
42 
0 
ABC 
value taken from the 72 h hydrolysate 
Table 4.2 (continued) 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Homoserine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield {%) 
Charge 
Purification 
Peptide 
T13 
1.1(1) 
3.9(4) 
1.0(1) 
1.0(1) 
1.1(1) 
8 
23 
0 
ABC 
T14 
4.5(5) 
0.7(1) 
6.8(7) 
1.9(2) 
2.1(3) 
4.6(5) 
0.8(1). 
2.5(3)a 
1.6(2) 
3.7(4) 
1.8(2) 
1.0(1) 
36 
75 
A 
T15 
1.0(1) 
1.0(1) 
0.9(1) 
3 
11 
+2 
Aß 
T16 
1.0(1) 
1 
18 
+1 
AB 
T16-17 
0.9(1) 
1.0(1) 
2.4(3) 
2.0(2) 
7 
13 
+2 
AB 
T17 
0.8(1) 
1.0(1) 
2.3(3) 
1.1(1) 
6 
24 
+1 
AB 
T18 
1.0(1) 
0.9(1) 
3.6(4) 
0.9(1) 
0.9(1) 
1.0(1) 
1.0(1) 
1.1(1) 
+ (i) 
12 
39 
-1 
AB 
T19 
0.9(1) 
0.9(1) 
1.1(1) 
1.9(2) 
2.1(2) 
0.9(1) 
2.0(2) 
1.0(1) 
1.0(1) 
12 
33 
+1 
AB 
T20 
1.0(1) 
1 
5 
+1 
AB 
T20-21 
0.7(1) 
1.0(1) 
1.0(1) 
3 
15 
+1 
AB 
T21 
0.6(1) 
1.0(1) 
2 
17 
0 
AB 
Total 
15 
5 
8 
1 
26 
6 
16 
16 
2 
13 
6 
14 
3 
5 
3 
13 
8 
2 
162 
value taken from the 72 h hydrolysate 
resis at pH 3.5. Peptide T14* was a mixture of two shortened peptides of 
T14. One was due to a chymotrypsin-like cleavage at a leucine, and the 
other, with C-terminal aspartic acid, resulted from the presence in small 
amounts of a CB-fragment originating from cleavage of an Asp-Pro bond. 
Peptides T19a and T19b resulted from a chymotrypsin-like cleavage at a 
phenylalanyl residue in T19. Two lysyl bonds and one arginyl bond were 
partly split by trypsin, resulting in the appearance of peptides T10-11, 
T16-17 and T20-21. The amino acid compositions of the tryptic peptides 
are listed in table 4.E. 
Amino acid sequence determination of the tryptic peptides of CB1 
The amino acid sequence of the tryptic peptides was determined by 
direct manual Edman degradation and by the dansyl-Edman technique. Some 
tryptic peptides were subdigested by chymotrypsin, thermolysin or Staphy-
lococcus protease. The resulting peptides were purified by peptide map-
ping, identified by amino acid analysis (table 4.3), and in some cases 
sequenced. A summary of the evidence for the sequence determination of 
the tryptic peptides of CB1 is given in fig. 4.9. 
The sequence of peptide T3 was determined up to the penultimate re-
sidue by manual Edman degradation. The C-terminal lysine was confirmed 
by subdigestion of T3 by chymotrypsin and thermolysin. In peptide T3 a 
lysyl bond was not cleaved by trypsin because of the presence of several 
adjacent acidic residues. The amide assignment in peptide T6, based upon 
identification of the residue as PTH-derivative, was confirmed by the 
calculated charges of the two peptides obtained by chymotryptic digestion 
of T6. Because automated Edman degradation of CB1 established the se-
quence of peptide Tl, the sequence of T7 was deduced from dansyl-Edman 
degradation of a mixture of peptides Tl and T7. The sequence of peptide 
T9 was determined by manual Edman degradation up to the penultimate 
residue. The C-terminal lysine was confirmed by peptide T9Th4. Four 
adjacent valines in T9 explain the value of 3.2 found in the analysis 
after a hydrolysis time of 72 h. The sequence Asp-Glu-Gln-Glu in peptide 
Til was difficult to determine because of overlap of the preceding step. 
In this case manual Edman degradation was performed twice. The sequence 
determination of peptide T14 was severely hampered by the presence of 
two glutaminyl residues which blocked the Edman degradation due to 
cyclization to a pyrrolidone structure, causing a rapid decrease in yield 
40 
Table 4.3 Атгпо aczd eompositzons of peptides obtained by thermolytzc (Th), ohymotryptic (C) or 
staphylococcal protease (L>LJ) digestion of some tryptic peptides of CB1 
All peptides were punfied by peptide mapping. 
P e p t i d e 
T3C1 
T3C2 
T3C3 
T3Th 
T6C1 
T6C2 
T9Th] 
T9T)i2 
T9Th3 
T9Th4 
Tl lThl 
TllTh2 
T12 hi 
T12Th2 
T14C1 
T14C2 
UK2 3 
THC3 
T11SP1 
T14SP1 2 
T145P3 
n i s p i 
T14SP5 
ТШС1 
T18C2 
T19C1 
T19C2 
T19C3 
Anino acid 
Asp 
1 2(1) 
1 3(1) 
1 0(1) 
1 0(1) 
0 9(1) 
1 1(1) 
1 9(2) 
1 0(1) 
¿ 8(3) 
2 1(2) 
2 0(2) 
1 2(1) 
1 1(1) 
2 2(2) 
1 6(2) 
1 0(1) 
1 0(1) 
Thr 
0 9(1) 
0 9(1) 
0 8(1) 
Ser 
0 9(1) 
0 7(1) 
0 9(1) 
0 8(1) 
1 0(1) 
0 9(1) 
0 9(1) 
Glu 
4 6(5) 
1 4(1) 
0 8(1) 
1 0(1) 
3 9(4) 
0 9(1) 
5 8(6) 
1 1(1) 
0 9(1) 
2 8(3) 
4 0(4) 
2 2(2) 
1 3(1) 
2 8(3) 
0 9(1) 
1 0(1) 
Pro 
1 0(1) 
1 8(2) 
0 7(1) 
2 0(2) 
0 8(1) 
1 1(1) 
Gl y 
0 8(1) 
1 0(1) 
1 0(1) 
1 0(1) 
1 1(1) 
1 9(1) 
1 2(1) 
2 0(2) 
0 9(1) 
1 0(1) 
1 1(1) 
1 8(2) 
1 0(1) 
1 0(1) 
1 0(1) 
Ala 
0 8(1) 
1 0(1) 
4 7(5) 
4 2(4) 
1 4(1) 
1 0 (1) 
1 0(1) 
0 9(1) 
Cys 
0 8(1) 
0 8(1) 
Val 
3 6 ( 4 ) a 
2 6(3) 
1 2(1) 
1 0(1) 
0 8(1) 
0 9(1) 
I l e 
1 0(1) 
1 0(1) 
1 1(1) 
0 9(1) 
1 9(2) 
1 0(1) 
1 7(2) 
Leu 
1 0(1) 
1 0(1) 
0 9(1) 
1 0(1) 
1 9(2) 
1 0(1) 
1 8(2) 
0 9(1) 
1 0(1) 
1 1(1) 
1 9(2) 
1 2(1) 
1 0(1) 
0 9(1) 
1 1(1) 
Tyr 
0 8(1) 
1 0(1) 
1 9(2) 
1 0(1) 
0 9(1) 
1 0(1) 
Phe 
0 9(1) 
1 0(1) 
1 0(1) 
1 0(1) 
1 0(1) 
1 0(1) 
His 
0 9(1) 
1 0(1) 
0 9(1) 
Lys 
1 0(1) 
1 0(1) 
1 0(1) 
1 2(1) 
1 0(1) 
1 0(1) 
1 1(1) 
1 0(1) 
1 2(1) 
Arg 
1 1(1) 
1 0(1) 
1 0(1) 
Trp 
+ 
+ 
Charge 
> - 3 
-.\ + 1 
+ 1 
+ 1 
0 
- ] 
0 
+ 1 
0 
-2 
-1 
+1 
> -3 
0 
-2 
-2 
-2 
-3 
> 3 
-1 
-1 
-2 
+ 1 
0 
0 
+1 
value taken from the 72 h hydrolysate 
-F* 
Peptide Sequence 
Tl Thr-Lys 
Τ 3 Gl u-Ly^-Gl u-61 U - A S D - G I U- Pro - Gin - Phe-T h r - S e r - A l a-G1y.-Gl u-Asn-Phe-Asn- Lys 
^ T3C1 • T^3C2 ~ —T3C3« 
T4 L e u - V a l - S e r - G l y - L y s 
T5 Leu-Arg 
16 Glu-Ile-Leu-Asn-Ile-Ser-Gly-Pro-Prq-Len-Lys 
T6C1—• T6C2 • 
T7 Ala-Gly-Lys 
T8 Thr-Arg 
T9 Thr-Plie-Tyr-61y-Leu-Hi^-Gln-AsR-Ph^-Prci-Set:-Val,-Val,-Val
<
-Val,-Gly,-Lei^-G^-Lys 
, T9Thl T9Th2 > T9Th3 • - — T 9 T h 4 — -
T10 Lys 
T10-11 Lys-Thr-Ala-Gly-Ile-Asp-Glu-Gln-Glu-Asn-Trp-His-Glu-Gly-Lys 
TU Thr-Al^-Gl^-Il^-Asp-Glu-Gl n-Gli^-Asg-Tra-Hi yGIg-Gly-Lys 
-i—TllThl—- -i TllThZ • 
Τ12 Glu-Asrj-Il^-Arg 
•^-Thl» -^-Th2— 
T13 Al a-Ala-Val-Al a-Ala-Gly-Cys-Arg 
T14 Gln-Ile-Gln-Asp-Leu-Gli4-Il^-Pro-Sei:-VabGlt(-Val.-AsR-Prq-Cys-Gly-Asp-Ala-Gln-
, T14SP1 -
-T14SP1-2 • T14SP3-
—^-т;4а . , , . [ [ [^Ц *-
Al a-Al a-Al a-Glu-Gly-Ala-Val-Leu-Gly-Leu-Tyr-Glu-Tyr-Asp-Asp-Leu-Lys 
• ^ _ T 1 4 C 2 — T14C3 • 
Τ"'
 ) ' —ТЦС2-^-^ . ~Τ 
• -, T14SP4 • T14SP5 • 
Τ14Ι; „ , • 
TIS Gln-Lys-Arg 
Τ16 L^s 
Τ16-17 Lys-Val-Val-Val -Ser-Al a-Lys^ 
Τ17 Val-Val-Val-Ser-Al a-Lys 
T18 Leu-Hi s-Gly-Ser-Gl i^-Asp-Gl n-Gl i^ -Al yTrg-Gl γ Arg^ 
-ι T18C1 • »T18C2» 
Τ19 Gly-Val-Leu-Phe-Ala-Ser-Gly-Glg-Asii-Leu-AU-Arg 
-ι Tl9a • T19b » 
T^19C1 T19C2 •~T19C3~ 
T20 Ar^ 
T20-21 Arg-Leu-Hse 
T21 Leu-Hse 
Fig. 4.9 (opposite) 
Amino acid sequence determination of the tryptio peptides of CB1 
Amino acid sequences were determined by direct manual Edman degradation 
(—'), by the dansyl-Edman technique (—7), or by both methods (—>). 
Some tryptic peptides were subdigested by chymotrypsin (C), thermolysin 
(Th) or by Staphylococcus protease (SP). The amino acid compositions of 
these peptides are listed in table 4.3. 
of the next PTH-amino acids. For this reas η only the first fourteen 
residues could be identified. Chymotryptic digestion of T14 yielded four 
peptides. Edman degradation of T14C1 suffered from the same problem as 
T14 itself: identification of PTH-amino acids was impossible beyond 
residue 14. The C-terminal part of T14 was determined with the aid of 
peptides T14C2, T14C2-3 and T14C3. Subdigestion of T14 by Staphylococcus 
protease yielded peptides only in low yield, but dansyl-Edman degradation 
of peptide T14SP3 extended the N-terminal sequence of T14 by two resi­
dues. The identification of a cysteine at position 15 offered the possi­
bility to complete the sequence: this residue, when modified by S-amino-
ethylation instead of S-carboxymethylation, is susceptible to tryptic 
cleavage. Peptides T14a and T14b were isolated from a tryptic digestion 
mixture of CB1 from AE-LAP by 
peptide mapping. Both peptides 
had a high negative charge. Their 
amino acid compositions are 
listed in table 4.4. Direct Edman 
degradation of T14a and T14b com­
pleted the amino acid sequence 
of peptide T14 (see fig. 4.9). 
Peptide T18 also contained a dif­
ficult sequence. In order to 
obtain conclusive evidence for 
the identification of amide 
and acidic residues, manual Edman 
degradation was performed twice. 
Two peptides containing a homo-
seryl residue were found as a re­
sult of the partial splitting of 
an Arg-bond by trypsin. 
Table 4.4 Amino acid composition 
of T14a and Τ14b 
Peptides were isolated by peptide 
mapping. Values between brackets 
are the actual values. 
Amino acid 
Aspartic acid 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Lysine 
Total 
T14a 
2.1(2) 
0.9(1) 
4.2(4) 
2.0(2) 
0.9(1) 
1.8(2) 
1.9(2) 
1.1(1) 
15 
T14b 
2.9(3) 
3.2(3) 
2.7(3) 
5.1(5) 
1.1(1) 
2.5(3) 
1.7(2) 
l.i(l) 
21 
determined as S-AE-cysteine 
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4.2.2 Oiquòtion o¿ CBJ by chymotxypiin 
CBl was digested by chymotrypsin and the resulting digestion 
mixture chromatographed directly on Sephadex G-50 (fig. 4.10). Pool I 
yielded the large peptide C14 in pure form. Pools II, III and IV were 
purified by peptide mapping (fig. 4.11). All peptides were well-separa-
ted, except C3 and C15 which were sequenced as a mixture. The amino acid 
compositions of the chymotryptic peptides are listed in table 4.5. 
Several peptide bonds were partly split by chymotrypsin, resulting in 
the appearance of peptides Cl-2, C2-3, Cll-12 and C12-13. Only one 
peptide containing a homoserine was found, which indicated that this 
peptide was the C-terminal chymotryptic peptide of CBl. 
The chymotryptic peptides were only sequenced when an overlap between 
tryptic peptides had to be proved, or when additional evidence was needed 
for certain difficult sequences. The amino acid sequence of most of the 
chymotryptic peptides was determined by the dansyl-Edman method. Peptide 
C18 was sequenced by manual Edman degradation in order to obtain conclu-
sive evidence for the identification of acidic and amide residues of the 
sequence Glu-Asp-Gln-Glu. The results of the amino acid sequence deter-
mination of the chymotryptic peptides of CBl are included in fig. 4.15. 
absorbance 1 
0 . 8 -
0 6 
0 4 
Ο Σ ­
Ο 
2 0 0 250 300 350 4 0 0 
elution volume (ml) 
Fig. 4.10 Fractionation of the ehymotryptic peptidee of C31 on Sephadex 
G-bO superfine in 0.1 M ammonia 
Pool I yielded peptide C14 in pure form. Pools II, III and IV were puri­
fied by peptide mapping (fig. 4.11). 
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Fig. 4.11 Vuvifiaation of spools II, III and IV of the 
Sephadex aolu/rm (fig. 4.10) by peptide mapping 
(A) pool II, (B) pool III, (C) pool IV. 
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Table 4.5 Amino aeid composition of the chymotrypttc peptides of CB1 
All peptides were purified by a combination of gel filtration and peptide mapping, except peptide C14 
which was already pure after the gel filtration procedure. 
Peptide 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Homoseri ne 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isol eue i ne 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
CI 
1.0(1) 
0.9(1) 
1.1(1) 
1.0(1) 
Cl-2 
0.8(1) 
1.0(1) 
1.1(1) 
1.9(2) 
1.0(1) 
C2-3 
1.2(1) 
1.0(1) 
0.9(1) 
1.0(1) 
0.9(1) 
C3 
1.0(1) 
1.0(1) 
0.9(1) 
C4 
1.9(2) 
1.0(1) 
1.7(2) 
6.0(6) 
0.9(1) 
0.9(1) 
1.0(1) 
2.0(2) 
1.8(2) 
C5 
1. 
1. 
1. 
•0( 
.0( 
•0( 
;i) 
:i) 
:i) 
C6 
1.0(1) 
1.0(1) 
1.2(1) 
1.0(1) 
1.0(1) 
1.9(2) 
1.2(1) 
1.0(1) 
C7 
1.0(1) 
1.0(1) 
2.1(2) 
1.1(1) 
1.0(1) 
1.2(1) 
C8 
1.9(2) 
1.1(1) 
1.2(1) 
1.1(1) 
1.9(2) 
1.0(1) 
C9 
1.0(1) 
C10 
0.9(1) 
0.9(1) 
1.1(1) 
1.0(1 
2.0(2) 
3.5(4)a 
1.9(2) 
1.1(1) 
1.2(1) 
Total 
Yield (%) 
Charge 
4 
22 
+1 
6 
11 
+1 
5 
19 
0 
3 
15 
0 
18 
35 
>-3 
3 
31 
+1 
9 
20 
+1 
7 
11 
0 
8 
8 
+3 
1 
12 
0 
14 
26 
-1 
value taken from the 72 h hydrolysate 
Table 4.5 (continued) 
Peptide 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Homoseri ne 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Cll 
1.9(2) 
1.1(1) 
3.1(3) 
2.0(2) 
1.2(1) 
1.0(1) 
1.8(2) 
+ 
Cll-12 
2.0(2) 
1.1(1) 
3.0(3) 
1.9(2) 
1.2(1) 
1.1(1) 
1.0(1) 
2.0(2) 
+ 
C12-13 
1.0(1) 
2.0(2) 
1.2(1) 
2.1(2) 
1.0(1) 
0.9(1) 
0.9(1) 
1.1(1) 
1.1(1) 
C14 
3.0(3) 
0.6(1) 
5.6(6) 
1.8(2) 
2.6(3) 
6.5(7) 
1.8(2) 
2.7(3) 
1.8(2) 
1.9(2) 
1.0(1) 
C15 
1.0(1) 
0.8(1) 
1.0(1) 
C16 
1.9(2) 
0.9(1) 
1.0(1) 
1.0(1) 
C17 
0.9(1) 
1.0(1) 
2.6(3)a 
1.0(1) 
1.0(1) 
C18 
1.2(1) 
0.9(1) 
2.9(3) 
1.1(1) 
1.1(1) 
0.9(1) 
+ 
C19 
1.0(1) 
1.1(1) 
0.9(1) 
1.0(1) 
1.0(1) 
1.0(1) 
C20 
1.0(1) 
0.9(1) 
1.2(1) 
1.0(1) 
1.1(1) 
0.9(1) 
C21 
0.8(1) 
1.1(1) 
1.0(1) 
2.0(2) 
Total 
Yield (%) 
Charge 
13 
8 
-1 
14 
14 
0 
11 
13 
+1 
32 
80 
3 
35 
0 
5 
8 
-3 
7 
25 
+1 
9 
17 
-2 
6 
17 
+ 1 
6 
22 
0 
5 
8 
+2 
value taken from the 72 h hydrolysate 
-t. 
CD 
Table 4.6 Amino acid composition of the thermolytic peptides of CBÌ 
All peptides were purified by peptide mapping (fig. 4.12). 
Peptide 
Amno acid 
Aspart ic acid 
Threonine 
Serine 
Homoserme 
Glutamic acid 
Prol ine 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
H i s t i d i ne 
Lysine 
Arginine 
Tryptophan 
Ш 
0.9(1) 
1.1(1) 
1.0(1) 
Th2 
1.1(1) 
0.7(1) 
2.0(2) 
Th3 
1.2(1) 
1.0(1) 
5.2(5) 
1.0(1) 
0.7(1) 
0.9(1) 
1.9(2) 
rh4 
1.2(1) 
0.9(1) 
1.0(1) 
1.1(1) 
1.1(1) 
1.0(1) 
1.0(1) 
Th5 
1, 
0. 
1. 
•0( 
.9( 
•1( 
; i ) 
: i ) 
: i ) 
Th5-6 
1. 
1 
0 
1 
.0(1) 
.0(1) 
.9(1) 
.0(1) 
Th6-7 
0.9(1) 
1.0(1) 
0.9(1) 
1.0(1) 
1.0(1) 
Th/ 
0.8(1) 
1.1(1) 
0.9(1) 
1.0(1) 
Th8 
1.0(1) 
1.1(1) 
0.9(1) 
Th9 
1.1(1) 
0.9(1) 
1.1(1) 
ThlO 
1.1(1) 
2.0(2) 
1.0(1) 
1.0(1) 
ThlO-l I 
2.0(2) 
0.9(1) 
1.9(2) 
2.0(2) 
1.0(1) 
0.9(1) 
1.1(1) 
1.9(2) 
0.9(1) 
Thl2 
1.0(1) 
0.9(1) 
0.9(1) 
Thl3 
1.1(1) 
0.9(1) 
1.1(1) 
0.9(1) 
1.0(1) 
1.0(1) 
1.0(1) 
Total 
Yield ("„) 
Charge 
3 
15 
+1 
4 
19 
0 
12 
8 
-3 
7 
17 
-1 
3 
21 
+ 1 
4 
7 
+ 1 
5 
18 
+ 1 
4 
11 
+ 1 
3 
14 
0 
3 
15 
0 
5 
14 
0 
13 
10 
+3 
3 
17 
0 
7 
17 
-1 
value taken from the 72 h hydrolysate 
Table 4.6 (continued) 
Peptide 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Homosenne 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Thl4 
0.9(1) 
3.5(4) 
Thl5 
1.0(1) 
1.0(1) 
a 
1.2(1) 
2.1(2) 
Thl6 
1.0(1) 
1.0(1) 
Thl6-17 
3.1(3) 
4.8(5) 
2.0(2) 
1.1(1) 
1.0(1) 
1.0(1) 
1.0(1) 
+ 
Thl8 
1.9(2) 
1.0(1) 
1.0(1) 
Thl9 
0.8(1) 
1.2(1) 
2.0(2) 
0.9(1) 
1.0(1) 
1.0(1) 
Th20 
1.1(1) 
1.0(1) 
0.9(1) 
Th20-21 
2.9(3) 
0.8(1) 
4.7(5) 
1.9(2) 
1-7(2) 
4.6(5) 
0.8(1) 
2.8(3) 
1-7(2) 
0.7(1) 
Th22 
2.1(2) 
1.8(2) 
1.0(1) 
2.8(3) 
2.1(2) 
3.1(3) 
0.9(1) 
Th23 
0.9(1) 
1.2(1) 
2.6(3)a 
0.9(1) 
Th24 
1.0(1) 
0.9(1) 
4.1(4) 
2.0(2) 
1.1(1) 
0.8(1) 
0-9(1) 
0.9(1) 
+ 
Th25 
1.1(1) 
1.0(1) 
1.2(1) 
1.0(1) 
1.0(1) 
1.0(1) 
Th26 
1.0(1) 
0.9(1) 
1.9(2) 
Th27 
0.8(1) 
1.0(1) 
Total 
Yield (%) 
Charge 
5 
17 
0 
5 
15 
+2 
2 
15 
0 
15 
19 
-3 
4 
13 
+ 1 
7 
18 
0 
3 
6 
-1 
25 
19 
>-3 
14 
13 
+ 1 
6 
12 
+ 1 
13 
9 
-1 
6 
18 
0 
4 
15 
+2 
2 
19 
0 
avalue taken from the 72 h hydrolysate 
4.2.3 O-tgutcun o¡{ CB7 by ікглтоіуі^п 
Cßl was digested by thermolysin and the resulting peptides were 
purified by peptide mapping (fig. 4.12) All peptides were separated 
except peptides Thl6 and Th25 which were sequenced as a mixture. The 
amino acid compositions of the thermolytic peptides are listed in table 
4.6. The sequence of most thermolytic peptides was determined by the 
dansyl-Ednian method. Peptides Thl6-17, Thl9 and Th20 were sequenced by 
direct Edman degradation. The results are shown in fig. 4.15. 
chromatography 
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Fig. 4.12 Purtfzaatton of the thermolytzc peptbdes 
of CB1 by peptbde тар гпд 
4.2.4 VA-QUtcon 0(5 CAXAaconylcUed СБ/ by t>iypn.n 
After modification of the ε-amino groups by citraconylation, CB1 
was digested by trypsin, and the resulting digestion mixture was chroma-
tographed on Sephadex G-50 (fig. 4.13). Pools I and II were purified by 
ion-exchange chromatography on DEAE-cellulose (fig. 4.14). Pool I 
yielded three peptides, namely Tel, Tc3 and Tc5, and pool II yielded 
peptides Tc2 and Tc6. Pools III and IV were analyzed by peptide mapping. 
Pool III yielded only one peptide, namely Tc7, and pool IV yielded Tc4, 
free arginine (Tc8) and the C-terminal peptide Leu-Hse (Tc9). The amino 
acid compositions of the citraconyl peptides are listed in table 4.7. 
The N-temimal residue was determined by dansylation. In some cases the 
peptides were again digested by trypsin after decitraconylation. 
50 
Peptides Tc2 and Тсб were subdigested by thermolysin and chymotrypsin, 
respectively. The citraconyl peptides are included in fig. 4.15. 
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Fractionation of the 
tvyptio peptides of ci-
traaonylated CB1 on Se-
phadex G-50 superfine 
in 0.05 M МІ.НСО 
4 ύ 
Pool I and II were puri­
fied by ion-exchange 
chromatography on DEAE-
cellulose (fig. 4.14), 
and pool III and IV were 
analyzed by peptide 
mapping. 
6 0 70 s o 
fraction number 
Table 4.7 Amino aoid composition of the tryptic peptides of 
citraconylated CB1 
Peptides were purified by gel filtration (fig. 4.13) followed by 
ion-exchange chromatography (fig. 4.14) or peptide mapping. 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Honrasen ne 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
H i s t i d i n e 
Lysine 
Arginine 
Tryptophan 
Total 
N-termi nus 
Peptide 
Tel 
2 . 9 ( 3 ) 
1.7(2) 
2 . 8 ( 3 ) 
6 . 0 ( 6 ) 
0 . 8 ( 1 ) 
4 . 0 ( 4 ) 
0 . 9 ( 1 ) 
1.9(2) 
1.0(1) 
3 . 9 ( 4 ) 
1.0(1) 
2 . 0 ( 2 ) 
4 . 9 ( 5 ) 
1.0(1) 
36 
Thr 
Tc2 
1.0(1) 
1.0(1) 
0 . 9 ( 1 ) 
0 . 8 ( 1 ) 
1.8(2) 
2 . 0 ( 2 ) 
1.2(1) 
1.9(2) 
2 . 0 ( 2 ) 
1.7(2) 
0 . 9 ( 1 ) 
16 
Glx 
Tc3 
3 . 9 ( 4 ) 
2 . 1 ( 2 ) 
1.2(1) 
6.Οι 6) 
1 . 0 1 ) 
5.0 5) 
1.3 1) 
3 . 8 ( 4 ) a 
1.8(2) 
2-3(2) 
1.2(1) 
2 . 0 ( 2 ) 
1.9(2) 
3 . 0 ( 3 ) 
1.0(1) 
( 1 ) 
38 
Thr 
Tc4 
1 
4 
1 
1 
1 
8 
A 
1(1) 
1(4) 
0 ( 1 ) 
0 ( 1 ) 
0 ( 1 ) 
a 
Tc5 
5 . 1 ( 5 ) 
1.2(1) 
7.5(8) 
2 . 0 ( 2 ) 
2 . 8 ( 3 ) 
4 . 6 ( 5 ) 
0 . 9 ( 1 ) 
2 . 8 ( 3 ) 
2 . 0 ( 2 ) 
3 . 8 ( 4 ) 
1.8(2) 
2 . 0 ( 2 ) 
1.0(1) 
39 
Glx 
Тсб 
1.1(1) 
1.8(2) 
3 . 7 ( 4 ) 
1.0(1) 
1.9(2) 
2 . 7 ( 3 ) a 
1.0(1) 
1.0(1) 
2 . 0 ( 2 ) 
1.0(1) 
(1) 
19 
Lys 
Tc7 
1.1(1) 
0 . 8 ( 1 ) 
1.0(1) 
1.7(2) 
2 . 1 ( 2 ) 
1.0(1) 
2 . 0 ( 2 ) 
1.1(1) 
1.0(1) 
12 
Gly 
Tc8 
1.0(1) 
1 
Arg 
Tc9 
0 . 9 ( 1 ) 
1.0(1) 
2 
Leu 
value taken from the 72 h hydrolysate 
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Fig. 4.14 Purification of pool I and II of the Sephadex column 
(fig. 4.13) on' DEAE-cellulose 
Top: pool I , bottom: pool I I . Fractions of 4.0 ml were col lected. 
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4.2.5 Compíate ameno acid ¿equeuce ο{, C8Î 
A summary of the sequence results providing the evidence for the 
total amino acid sequence of CB1 is presented in fig. 4.15. The order of 
the tryptic peptides in the primary structure was deduced from chymo-
tryptic, thermolytic and citraconyl peptides. 
Although peptide T2 was not isolated, its sequence was derived from the 
results of automated Edman degradation of total CB1, and further evidence 
was provided by chymotryptic and thermolytic peptides. Most overlaps 
between tryptic peptides involved two or more residues. The overlap 
between T3 and T4 involved only a leucyl residue in the chymotryptic and 
thermolytic peptides. Evidence for the overlap was provided by citraconyl 
peptide Tel. Peptide Tc2 with N-terminal Glx determined the order of 
peptides T6, T7 and T8. Additional evidence was supplied by peptides C8 
and ThlO-11. Peptide C8 also proved the overlap T8-T9. The order 
T9-T10-T11 was proved by peptides С П and Thl5. The overlap T15-T16-T17 
could not be deduced from the chymotryptic or thermolytic peptides: the 
Lys-Val bond (res. 138-139) was split not only by thermolysin, but also 
by chymotrypsin. However, the chymotryptic peptide Lys-Gln-Lys-Arg-Lys 
was not found probably because of its high positive charge which caused 
it to run off the paper during high-voltage electrophoresis. Evidence for 
the overlap came from citraconyl peptide Tc6, the only citraconyl peptide 
with N-terminal lysine. This peptide also proved the overlap T17-T18. 
All other overlaps between tryptic peptides were firmly established. 
Trypsin failed to cleave two lysyl bonds, namely Lys-Glu (res. 13-14) and 
Lys-Arg (res. 136-137). Chymotrypsin appeared to split a Lys-Val bond 
(res. 138-139) and a Val-Ala bond (res. 93-94). A His-Glu bond (res. 
83-84) was partly split by chymotrypsin. 
All residues in CB1 were identified by two independent methods or 
in different peptides, and all overlaps between tryptic peptides were 
proved. CB1 contains 171 amino acid residues. The sum of the individual 
amino acids obtained from the sequence results is in good agreement 
with the amino acid composition of CB1 obtained from amino acid analysis 
(see table 4.1). 
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-Tc5-
-ТсбСІ-
150 160 170 
Val-Ser-Ala-Lys-Leu-His-Gly-Ser-Glu-Asp-Gln-Glu-Ala-Trp-Gln-Arg-Gly-Val-Leu-Phe-Ala-Ser-Gly-Gln-Asn-Leu-Ala-Arg-Arg-Leu-Hse 
-T17-
-C17-
—T18-
-C18--
-T19-
-C19-
-C20-
•-T20-^T21— 
-C21 • 
-Th23-
-Th24-
-Tc&-
-Th25-
-Гс7— 
-Th26 •^-тиг?-
Tc8 ~-Tc9-~ 
-Tc6C2- — »ТсбСЗ-
Fig. 4.15 (opposite) 
Proposed атъпо аога sequence of the ü-tevrmnal cyanogen bromide fragment 
of Ъо гпе lens Іеисгпе amnopeptidase 
The tryptic peptides Tl to T21, of which the sequence determination is 
depicted in fig. 4.9, are indicated by arrows directly below the 
sequence. Overlaps between the tryptic peptides were established by 
analysis of chymotryptic (C) and thermolytic (Th) peptides, and of 
tryptic peptides of citraconylated CB1 (Tc). Residues were identified by 
automated Edman degradation (—"), manual Edman degradation (—'), 
dansyl-Edman degradation (—7), or by both manual methods (—>). 
4.2.6 -іЛ&иЬшісоп о{) diaJigzd and hydAophob-tc келЫаол -tu CBJ 
Because amino acids at the surface of globular proteins are 
largely hydrophilic, the higher the percentage of such amino acids in a 
protein, the lower the stability of folded structures and the more the 
protein will be motile (Williams, 1979). This author divided the amino 
acids in proteins into three classes. Hydrophobic, leucine, valine, 
isoleucine, alanine, proline, methionine, cysteine, phenylalanine, tyro­
sine, tryptophan and threonine. Charged, lysine, arginine, glutamic acid 
and aspartic acid. The intermediate class comprises glycine, serine, 
asparagine, glutamine and histidine. Because the amino acid sequence of 
CB1 revealed the presence of several clusters of identical or closely 
related amino acids, it seemed worthwile to make a complete analysis 
of the distribution of charged and hydrophobic residues (fig. 4.16). 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 
ι ι ι ι Ι ι ι I I 1 I I ι ' I ι L 
a J IUI U L J II III I M l I I II I III I ||_ 
hi mu im ι ι mi ι и IM ι пни ι пни ιιιι ιιιιιι ι ιιιιι ιι mi mi 
Fig. 4.16 Dbstnb jLbon of charged and hy Irophobio rjniao 
aczd resid íes гп CBl 
The first line indicates the position of the residues in 
CBl. The classification of the residues is according to 
Williams (1979) : (a) charged residues, (b) hydrophobic 
residues. 
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A cluster of charged residues is present in region 11-17, containing 
five acidic and two basic residues. Another cluster of charged amino 
acids is present in region 129-138, namely three acidic and four almost 
consecutive basic residues. The N-terminal region of CB1 is hydrophobic. 
Six out of nine residues are hydrophobic, separated by only one charged 
residue. Region 61-72 contains four consecutive valyl residues, and four 
alanines are present in region 91-95. Region 116-123 contains five 
alanyl residues, and three consecutive valines are present in region 
139-141. 
Table 4.8 shows the percentage of charged and hydrophobic residues in 
CB1, the ratio of hydrophobic to charged amino acids, and the proline 
plus glycine content. For comparison the values for LAP obtained from the 
total amino acid sequence (see addendum) have been included The values 
for CB1 do not differ much from those of the total protein. The ratio 
of hydrophobic to charged residues in CB1 is somewhat lower than the 
ratio of these residues in the total protein. This might indicate that 
the N-terminal part of LAP represents a more motile region than the 
remaining part of the molecule. 
Comparison with the values reported for a wide range of proteins (see 
Williams, 1979, table 3, p. 397) revealed that the values of LAP are in 
the same range as those of enzymes like elastase, trypsinogen, papain, 
ribonuclease and alcohol dehydrogenase. These are all globular proteins, 
and contain relatively few charged amino acids and a correspondingly 
high percentage of hydrophobic residues. For many proteins the content 
of proline plus glycine is 13 ± 3 % 
Table 4.8 Ammo аага аотрозг гоп (%) of t pi and ГАГ 
Values for CB1 were derived from the sequence results 
(fig. 4.15), and values for LAP were taken from the 
total amino acid sequence (see addendum). The classi­
fication of the residues was according to Williams 
(1979). 
CB1 
LAP 
charged 
28 
24 
hydrophobic 
46 
52 
ratio H/C 
1.7 
2.2 
Pro+Gly 
14.0 
13.8 
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4.2.7 Ouycuii-Lon 
The amino acid sequence of the largest cyanogen bromide fragment 
of LAP has been determined completely. It is the N-terminal fragment 
comprising 171 amino acid residues, and represents approximately 
one-third of the polypeptide chain of LAP. Conclusive evidence has been 
presented for the identification of all residues, and all overlaps 
between the tryptic peptides have been proved. The results are in accord 
with the amino acid composition calculated from analysis of an acid 
hydrolysate of CB1. The molecular weight of CB1 calculated from the amino 
acid sequence is 18,637. However, from SDS gel electrophoresis a molecu­
lar weight of 21,000 was estimated. Also when 6 M urea was included in 
the gel, the mobility of CB1 was lower than that of the α-crystal 1 in 
A and В chains, which comigrate in this system. The use of SDS gel elec­
trophoresis in the determination of protein molecular weights is based 
upon a relationship of electrophoretic mobility of proteins in SDS gels 
and their molecular weight, indicating a constant charge per unit mass 
for most SDS-protein complexes (Weber and Osborn, 1975). This constant 
charge results from the binding of 1.4 g SDS per g of protein (corres­
ponding to about one molecule of SDS per two amino acid residues) which 
generally swamps out the intrinsic charge of the proteins (Pitt-Rivers 
and Impiombato, 1968, Reynolds and Tanford, 1970). However, several pro­
teins show anomalous behavior in SDS gel electrophoresis. For instance, 
a decrease in SDS binding can be caused by different factors. Glyco­
proteins show impaired binding because only the protein component is 
believed to bind SDS (Pitt-Rivers and Impiombato, 1968). Negative maleyl, 
succinyl or carboxymethyl groups induce a lower binding of SDS by elec­
trostatic repulsion, causing an increase of up to 20% in apparent MW 
(Tung and Kmght, 1972, Tagaki et al., 1975). Many membrane proteins bind 
higher amounts of SDS due to their hydrophobic character (Miyake, 1978) 
Histones, although binding the normal amount of SDS, show atypically low 
mobilities due to their high net positive charge (Panyim and Chalkley, 
1971). Several homologous proteins with identical MW's have different 
mobilities in SDS gels. The a-crystallin A and В chains are a well-known 
example of this phenomenon. De Jong et al (1978) reported differences in 
mobility of a-crystallin A chains differing in primary structure only by 
one or a few amino acid residues. Thus, a complex interplay of net charge, 
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abnormal SOS binding, conformational factors and molecular length may 
govern the electrophoretic mobility. In CB1 the introduced carboxymethyl 
groups may cause a decrease in SDS binding, resulting in a higher appa­
rent molecular weight. Other factors may also play a role. As it appears, 
care must be taken in interpreting the results of molecular weight deter­
mination from SDS gel electrophoresis. 
The presence of hydrophobic clusters in CB1 is of interest in view 
of the hypothesis that substrates of LAP are bound in a hydrophobic 
pocket (Lasch, 1978), but at present there is no indication which parts 
of the polypeptide chain of LAP are involved in the interaction with the 
substrate. The ratio of hydrophobic to charged residues in CB1 and LAP 
calculated from the sequence results revealed a value typical of many 
enzymes. 
4.3 PaAtial am-ino acid izqumcz агХглтиюХхоп oft izvetial ovCiZappuig 
c.tjanoge.n Ьіотлае ^».agmcnti 
The mixture of CB-fragments of approximate MW 10,000 was separated in 
two fractions by ion-exchange chromatography on CM-cellulose (see fig. 
4.4). The characterization of these two fractions is described in section 
4.3.1 and 4.3.2, respectively. 
4.3.1 Chan.actQJu.za.t¿on of, the f^actton I CB-gagmentò 
Initially we believed that fraction I of the CM-cellulose column 
contained a pure CB-fragment. But when the sequence determination proceded 
it became clear that more than one CB-fragment was present. Attempts to 
separate these fragments were not successful. However, we obtained much 
information on the amino acid sequence of LAP by digestion of the mixture 
of CB-fragments by trypsin, chymotrypsin, thermolysin and Staphylococcus 
protease. By manual Edman degradation we were able to identify the 
N-terminal fourteen residues: 
Pro-Ser-Gly-Lys-Ala-Asn-Lys-Pro-Gly-Asp-Val -Val-Arg-Ala-
This indicated that a large percentage of the fraction I CB-mixture con-
sisted of fragments with the same N-terminus. 
4.3.1.1 Ό* дел tic η by ілурып 
The fraction I CB-fragments were digested by trypsin and the re-
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suiting peptide mixture was analyzed by peptide mapping (fig. 4.17). The 
neutral peptides were subjected to re-electrophoresis at pH 3.5. Peptides 
Tl and Til revealed a bright yellow color upon ninhydrin staining, indi­
cating the presence of N-terminal proline. Peptides T9 and T16 were UV-
positive, and peptides T6, Til and T15 showed positive Pauly staining. 
chromatography 
Тб'М • T11 
.Ym 
T9 
deam 
TO 
¿-'<»'"" T4\J 
electrophoresis -+(-) 
(04-
n60o T6 
10 
electrophoresis 
-*• (-) 
Fig. 4.17 A Analytiual peptide map of the oolubLe Lryptio 
peptides of the fraction I CB-fragmir.ic 
В Re-eleatrophoresis of the neutral vepbidea at 
pH 3.5 
For preparative isolation of the tryptic peptides, a first purification 
step was performed on Sephadex G-50 (fig. 4.18). Although considerable 
precipitation occurred during the chromatographic run, a reasonably 
clear pattern was obtained. Pool I could not be purified further due to 
insolubility. Pool II was purified by ion-exchange chromatography on 
DEAE-cellulose (fig. 4.19). Four peptides were obtained in pure form, 
namely T14, T6, T5 and T12. Pools III and IV of the Sephadex column were 
purified by peptide mapping, yielding all smaller peptides also found on 
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о 
0 4 -
200 240 
elution volume (ml) 
Fig. 4.18 Fractionation of the trypLio peptides of the fraction I 
CB-fragments on Sephadex G-50 superfine in 0.1 M ammonia 
Pool I I was p u r i f i e d by ion-exchange chromatography on DEAE-cellu-
lose ( f i g . 4.19), and pools I I I and IV were p u r i f i e d by peptide 
mapping. 
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Fig. 4.19 Purification of pool II of the Sephadex coLunn (fiq. 
4.18) on PEAt-'eelLulose 
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Table 4.9 Amino acid compositions of the soluble tryptic peptides of the fraction I CB-fragments 
Peptides were purified by gel filtration (A) followed by ion-exchange chromatography (B) or peptide 
mapping (C). Values between brackets are the actual values found in the sequence. Peptide T7 was 
not isolated. Peptide T4. is the deamidated form of peptide T4. 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Homoserme 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield ( ) 
Charge 
Purification 
Peptide 
Tl 
0. 
0 
1 
1 
4 
36 
+ 1 
AC 
9(1) 
8(1) 
2(1) 
0(1) 
T2 
2 0(2) 
1 1(1) 
1 1(1) 
1 1(1) 
1 2(2) 
1.0(1) 
0 8(1) 
9 
43 
+ 1 
AC 
T3 
1 0(1) 
1 0(1) 
2 
48 
• 1 
AC 
T4 
0.9(1) 
1-1(1) 
1 0(1) 
3 
32 
+ 1 
AC 
T4 deam. 
0.7(1) 
1 2(1) 
0 8(1) 
3 
4 
0 
AC 
T5 
3-1(3) 
2.0(2) 
2 0(2) 
1.0(1) 
1-0(1) 
1.3(1) 
1 3(1) 
0 9(1) 
12 
32 
-2 
AB 
16 
1 9(2) 
1 0(1) 
0.7(1) 
2.9(3) 
0 7(1) 
i.Ui) 
3.2(3) 
0.9(1) 
1.0(1) 
1.0(1) 
1 0(1) 
16 
23 
0 
AB 
T8 
1.0(1) 
0 9(1) 
0 9(1) 
2 0(2) 
1.0(1) 
0 9(1) 
0.9(1) 
0.9(1) 
1 1(1) 
1 0(1) 
11 
19 
-2 
AC 
T9 
0 9(1) 
1.0(1) 
* (i) 
3 
12 
+ 1 
AC 
TÍO 
0 8(1) 
1 
16 
0 
AC 
ш 
ι 1(1) 
1.1(1) 
1.2(1) 
1 2(1) 
0.7(1) 
1.2(1) 
1.0(1) 
0.9(1) 
8 
5 
+ 1 
AC 
T12 
3.8(4) 
2.0(2) 
1.0(1) 
0-9(1) 
0.8(1) 
1 9(2)^ 
1.8(2)a 
0.9(1) 
1 0(1) 
15 
21 
-2 
AB 
T13 
0.9(1) 
1.0(1) 
2 
21 
+ 1 
AC 
Τ14 
1 0(1) 
0 9(1) 
1 1(1) 
4 9(5) 
0.8(1) 
1.1(1) 
1.0(1) 
1.0(1) 
12 
36 
0 
AB 
TIS 
0.9(1) 
1 0(1) 
1.0(1) 
1.0(1) 
1 1(1) 
1 0(1) 
0.9(1) 
7 
20 
+ 1 
AC 
T16 
1.0(1) 
0.7(1) 
1.0(1) 
2 1(2) 
0.9(1) 
ι od) 
1.1(1) 
1.0(1) 
* го 
10 
6 
0 
AC 
value taken from the 12 h hydrolysate 
the analytical peptide map (fig. 4.17). All peptides were isolated in 
excellent yields, except peptides Til and T16. The amino acid composi­
tions of the isolated tryptic peptides are listed in table 4.9. 
Two peptides containing homoserine were found, namely T10 (free homo-
serine) and T16. 
The amino acid sequence of the tryptic peptides was determined by manual 
Edman degradation and by the dansyl-Edman method (fig. 4.20). 
Fig. 4.20 Amino acid sequence deterivimrtion of the tryptij peptides 
of the fraction J CB-fragments 
Residues were identified by manual Edman degradation (—>), by the 
dansyl-Edman method (—τ-), or both (—>). Some tryptic peptides were 
subdigested by thermolysin (Th). 
Tl Pro-Ser-Gly-Lys 
T2 Ala-Asn-Lys-Pro-Gly-Aso-Val-Val-Arg 
T3 Ala-Arg 
T4 Asn-Gly-Lys 
T5 Thr)-Il^-Gl^-Val-AsR-Asn-Thr-AsD-(Ala,Glu,Gly)-Arg 
T6 Leu-11e-Leu-A1a-Aso-Ala-Leu-Cys-Tyr-Ala-Hi s-Thr-Phe-Asn-Pro-Lys 
T6Th • 
T8 Leu-Phe-Glu-Ala-Ser-Ile-Gln-Thr-Gly-Asp-Arg 
T9 Val-Trp-Arg 
T10 Hse 
Til Pro-Leu-Phe-Glu-His-Tyr-Thr-Arg 
Τ12 Gin-Val-Ile-AsD-Cys-Gln-Leu-Ala-AsR-Va\-Asn-Asn-Ile-Gly-Lys 
T12Thl • T12Th^ • - — T 1 2 T h 3 — 
T13 Tyr-Arg 
T14 Ser-Ala-Gly-Ala-Cys-Thr-Ala-Ala-Ala-Phe-Leu-Lys 
T15 Glu-Phe-Val-Thr-His-Pro-Lys 
T16 Trp-Ala-His-Leu-Asp-Ile-Ala-Gly-Val-Hse 
Peptide T4 was positively charged, indicating the presence of asparagine. 
The finding of the deamidated form of T4 illustrates the ease of deamida-
tion of asparagine in Asn-Gly sequences. Peptide T6 was subdigested by 
thermolysin, yielding a positively charged peptide which identified 
the Asx-residue as asparagine. The sequence of peptide T12 was very 
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difficult to determine. Dansyl-Edman degradation established the sequence 
up to the alanyl residue. Manual Edman degradation was impossible beyond 
the second glutamine due to cyclization to a pyrrolidone structure. In an 
attempt to solve the problem by taking advantage of the presence of a 
cysteine in T12, we isolated CB-fragments from AE-LAP. However, the 
aminoethylcysteine in T12 was not cleaved by trypsin. But fortunately, 
the yield of this peptide was rather high, and by eluting it from the 
peptide map with ammonia instead of acetic acid, cyclization of glutami-
nyl residues was largely prevented, and the sequence could be extended to 
the tenth residue (valine) by manual Edman degradation. The remaining 
part of the sequence was established with the aid of the thermolytic pep-
tides of T12. The amino acid compositions of these peptides are given in 
table 4.10. The charge of peptide T12Th2 indicated the presence of one 
aspartic acid and two asparagines. Because Edman degradation determined 
the position of the acidic residue, the two remaining asparagines are 
positioned. Dansyl-Edman degradation of peptide T12Th3 completed the 
sequence of T12. 
Not all tryptic peptides were sequenced up to their C-terminal ends. 
Further information was obtained from chymotryptic, thermolytic and 
staphylococcal protease peptides. 
Table 4.10 Amino acid aompositions of' the 
thermolytic peptides of T12 
Peptides were isolated by peptide mapping. 
Amino acid 
Aspartic acid 
Glutamic acid 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Lysine 
Total 
Charge 
Peptide 
T12Thl 
1.0(1) 
1.8(2) 
0.8(1) 
0.6(1) 
0.5(1) 
6 
0 
T12Th2 
3.2(3) 
0.9(1) 
1.0(1) 
0.7(1) 
6 
-1 
T12Th3 
1.0(1) 
0.8(1) 
1.1(1) 
3 
+ 1 
determined as S-aminoethylcysteine 
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Table 4.11 Атгпо асга, аопрозъігопз of the chymotryptzc pepttdes of the fraction I CD-fragments 
Peptides were isolated by peptide mapping (fig. 4.21). 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Honrasen ne 
Glutamic acid 
Prol ine 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield ('0 
Charge 
Peptide 
C2 
2 8(3) 
1 9(2) 
2 0(2) 
1 0(1) 
1 1(1) 
0 8(1) 
0 8(1) 
1 0(1) 
1 0(1) 
13 
7 
-2 
C3 
1 
1 
0 
1 
6 
6 
0(1) 
9(2) 
8(1) 
9(2) 
I 
C4 
0 8(1) 
1 0(1) 
2 
7 
-1 
C5 
0 9(1) 
1 0(1) 
1 0(1) 
0 9(1) 
4 
23 
+1 
C7 
0 9(1) 
0 7(1) 
1 0(1) 
1 2(1) 
4 
27 
0 
C8 
0 
1 
1 
1 
4 
20 
+ 1 
9(1) 
0(1) 
0(1) 
0(1) 
C9 
1 1(1) 
1 0(1) 
0 9(1) 
2 1(2) 
1 0(1) 
1 0(1) 
0 9(1) 
1 0(1) 
1 0(1) 
+ 
11 
12 
-2 
СП 
3 8(4) 
0 9(1) 
2 0(2) 
1 0(1) 
1 0(1) 
0 8(1) 
1 6(2) 
1 6(2) 
1 0(1) 
0 8(1) 
1 0(1) 
0 9(1) 
18 
11 
-1 
C12 
0 9(1) 
0 9(Г 
1 0(1) 
4 8(5) 
0 9(1) 
1 0(1) 
1 0(1) 
11 
16 
0 
C13 
0 9(1) 
0 8(1) 
1 0(1) 
1 0(1) 
4 
27 
0 
C14-15 
0 8(1) 
1 0(1) 
1 0(1) 
0 9(1) 
1 0(1) 
1 9(2) 
1 0(1) 
+ 
9 
14 
+2 
CIS 
0 
1 
1 
3 
8 
+ ' 
8(1) 
0(1) 
0(1) 
1
C16 
1 0(1) 
0 8(1) 
1 0(1) 
1 0(1) 
0 9(1) 
1 0(1) 
6 
16 
-1 
4.3.1.2 V-igut^on by скутоілурл^п 
The fraction I CB-fragments were digested by chymotrypsin and the 
resulting peptides were purified by peptide mapping (fig. 4.21). 
chromatography 
es Г ) С 1 3 
Q O c l 6 0 C 1 2 
C2 
C g С11 
b 0 о-
О « 
ьО о 
о 
Fig. 4.21 
Purification of the ahy-
motryptic peptides of 
the fraction I CB-frag­
ments by peptide map­
ping 
W·«- electrophoresis -• (-) 
The amino acid compositions of the isolated chymotryptic peptides are 
listed in table 4.11. The peptides were only sequenced in case they were 
needed to establish an overlap between tryptic peptides, or to confirm 
or complete the sequence of the tryptic peptides. The sequence results 
are shown in fig. 4.26. 
4.3.1.3 V-LQQj,tA.on by theMnolyiin 
The fraction I CB-fragments were digested by thermolysin and the 
resulting peptide mixture was chromatographed on Sephadex G-50 as a 
first purification step (fig. 4.22). Pool I was purified by ion-exchange 
Fig. 4.22 
Fractionation of the thermo-
lytic peptides of the frac­
tion I CB-fragments on Sepha­
dex G-50 superfine in 0.1 M 
ammonia 
Pool I was purified by ion-
exchange chromatography (fig. 
4.23) and pools II and III by 
peptide mapping (fig. 4.24). 
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Table 4.12 Amino acid conpositions of the thermolytic peptides of the fraction I CB-fragmenis 
Peptides were isolated by gel filtration (A) followed by ion-exchange chromatography (B) or 
peptide mapping (C). 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Homoseri ne 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield {%) 
Charge 
Purification 
Peptide 
Thl-2 
2.8(3) 
0.9(1) 
0.8(1) 
2.0(2) 
3.0(3) 
1.7(2) 
1.7(2)a 
2.6(3) 
1.8(2) 
19 
40 
>+3 
AC 
Th2 
0.8(1) 
0.8(1) 
0.9(1) 
1.0(1) 
1.0(1) 
1.0(1) 
6 
11 
+2 
AC 
Th3 
2.9(3) 
1.0(1) 
1.9(2) 
1.0(1) 
1.0(1) 
0.9(1) 
1.0(1) 
1.0(1) 
1.0(1) 
12 
25 
neg. 
AB 
Th4 
1.0(1) 
1.9(2) 
0.9(1) 
1.2(1) 
5 
11 
-1 
AC 
Th5 
0.8(1) 
1.0(1) 
2 
6 
-1 
AC 
Th6 
1.0(1) 
1.1(1) 
1.0(1) 
1.0(1) 
4 
10 
+1 
AC 
Th4-5-6 
1.3(1) 
1.0(1) 
2.8(3) 
1.0(1) 
0.9(1) 
1.8(2) 
1.0(1) 
1.0(1) 
11 
25 
neg. 
AB 
Th7 
1.0(1) 
1.0(1) 
1.0(1) 
1.0(1) 
1.0(1) 
5 
19 
+1 
AC 
Th8 
1.0(1) 
0.9(1) 
2 
33 
0 
AC 
Th9 
1.0(1) 
0.8(1) 
1.0(1) 
1.2(1) 
1.0(1) 
5 
28 
0 
AC 
ThlO 
1.0(1) 
0.9(1) 
1.0(1) 
1.0(1) 
1.1(1) 
5 
28 
0 
AC 
value taken from the 72 h hydrolysate 
Table 4.12 (continued) 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Homoserine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield {"',) 
Charge 
Purification 
Peptide 
Thll 
0.9(1) 
1.1(1) 
1.0(1) 
3 
33 
+1 
AC 
Thl2 
1.0(1) 
1.0(1) 
0.8(1) 
0.6(1) 
0.6(1) 
5 
34 
-2 
AC 
Thl3 
2.7(3) 
1.0(1) 
1.1(1) 
1.0(1) 
6 
23 
-1 
AC 
Thl4 
0.8(1) 
1.1(1) 
0.9(1) 
1.1(1) 
1.0(1) 
1.0(1) 
6 
22 
+2 
AC 
Thl5 
1.0(1) 
1.1(1) 
2.8(3) 
0.8(1) 
6 
25 
-1 
AC 
Thl6 
1.9(2) 
1.0(1) 
3 
38 
0 
AC 
Thl7 
1.0(1) 
0.8(1) 
1.1(1) 
1.0(1) 
4 
16 
0 
AC 
Thl8 
1.0(1) 
1.0(1) 
1.0(1) 
1.1(1) 
1.0(1) 
+ 
6 
21 
+2 
AC 
Thl9-20 
1.0(1) 
1.0(1) 
1.0(1) 
1.0(1) 
4 
5 
0 
AC 
Th20-21 
1.0(1) 
1.0(1) 
1.0(1) 
1.0(1) 
0.9(1) 
5 
26 
-1 
AC 
Th22 
0.8(1) 
1.0(1) 
2 
10 
0 
AC 
N K j H C C L j f W ) 
2 0 4 0 6 0 ΘΟ 1 0 0 120 
e i u l i o n v o l u m e ( m l ) 
Fig. 4.23 Purification of pool I of the Sephadex column 
(fig. 4.22) on DEAE-oellulose 
chromatography 
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Fig. 4.24 Purification of pools II and III of the Sephadex 
column (fig- 4.22) by peptide mapping 
(A) pool II, (B) pool III. 
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chromatography on DEAE-cellulose (fig. 4.23), and pools II and III were 
both purified by peptide mapping (fig. 4.24). Pool I yielded two peptides, 
namely Th3 and Th4-5-6. Pools II and III yielded many peptides in pure 
form. Peptide Thl-2 only became visible after ninhydrin staining. The 
amino acid compositions of the isolated thermolytic peptides are listed 
in table 4.12. The amino acid sequence of most peptides was determined 
by the dansyl-Edman technique. Because the charge of peptide Thl2, which 
was determined to be -2, indicated the presence of two acidic residues, 
one of which is carboxymethylcysteine, and of one amide residue, this 
peptide was also sequenced by manual Edman degradation. This established 
the position of aspartic acid and glutamine. Further evidence was ob-
tained by digestion of Thl2 by aminopeptidase M yielding the following 
result after amino acid analysis: 
CM-Cys 0.9, Asp 1.0, Gin 0.8, Val 1.0, Ile 1.0. 
The results of the sequence determination of the thermolytic peptides 
are given in fig. 4.26. 
4.3.1.4 Oigution by Staphylocuccu-i pìiotecuc 
The fraction I CB-fragments were digested by Staphylococcus protease 
and the resulting peptides were purified by peptide mapping (fig. 4.25). 
Six peptides were obtained in pure form. They were characterized by amino 
acid analysis (table 4.13) and sequenced by the dansyl-Edman technique 
(fig. 4.26). 
chromatography 
O' 
( • ) « -
SP6 
о 
S P 4 0 
О 
SP 
CD SP5 
O s P 3 
electrophoresis 
-• (-
Fig. 4.25 Purification of some staphylococcal protease pep­
tides of the fraction I CB-fragments by peptide 
mapping 
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Table 4.13 Атгпо асга ^опрозг ъоп of some staphylococaal 
peptides of the fvactxon I CB-fragments 
Peptides were isolated by peptide mapping (fig 4.25). 
Peptide 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Homoserine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield (%) 
Charge 
SPI 
1.0(1) 
0.8(1) 
0.9(1) 
0.5(1) 
0.5(1) 
1 2(1) 
0.9(1) 
1.0(1) 
8 
20 
0/+1 
SP2 
0.9(1) 
1.0(1) 
1.1(1) 
0.8(1) 
1.0(1) 
5 
18 
-2 
SP3 
2.2(2) 
0.9(1) 
0.8(1) 
2.3(2) 
3.0(3) 
0.9(1) 
1.2(1) 
1.0(1) 
1.1(1) 
1.0(1) 
1.0(1) 
15 
10 
+1 
SP4 
1.0(1) 
1.9(2) 
1.0(1) 
1.0(1) 
1.0(1) 
6 
12 
0 
SP5 
1.0(1) 
0.9(1) 
1.2(1) 
1.0(1) 
1.0(1) 
1.0(1) 
0.8(1) 
2.1(2) 
1.1(1) 
+ 
11 
22 
+2 
4.3.1.5 PaAttal curu.no atud inquzmiz o{¡ thz (¡icict^on I C5 {¡fiagmznti 
A summary of the sequence results providing the evidence for the 
partial amino acid sequence of the fraction I CB-fragments is given in 
fig. 4.26. Several tryptic peptides could not be sequenced up to their 
C-terminal ends, but in most cases the sequence could be completed with 
the aid of peptides obtained from other enzymic digestions. This was not 
the case for peptide T5, where more information is needed to complete 
the sequence. Manual Edman degradation of the mixture of CB-fragments 
determined the order of peptides Tl, T2 and T3. Additional evidence was 
obtained from peptide Thl-2. Peptide CI resulting from an anomalous 
cleavage of a Lys-Thr bond (res. 324-325) was not isolated, probably 
because of its length. Peptide Th2 proved the overlap T3-T4. The overlaps 
T4-T5 and T5-T6 only involved one residue, namely threonine and leucine, 
0.8(1) 
1 0(1) 
1.1(1) 
0.9(1) 
0.9(1) 
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Fig. 4.26 ParUal атьпо асга oeqvenae of the fractzon I CB-fragments 
Residues were numbered according to their position in the primary struc­
ture (see addendum). Residues were identified by manual Edman degradation 
(—'), dansyl -Edman degradation (—7), or both (—Ь). 
310 315 320 325 
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respectively. Thus, these overlaps still need proof. Following peptide 
T6 one or more tryptic peptides were not isolated. Peptide Th7 shows 
that a valyl residue follows T6, and from peptide C8 it is clear that 
a lysyl residue precedes T8. The positioning of peptides C7, Th8 and Th9 
in this region will be discussed later (section 4.3.3). The overlap 
T8-T9 was proved by chymotryptic peptide C9. Evidence for the positioning 
of peptide T10 (free homosenne) will be given later. The remaining part 
of the sequence was determined from the tryptic, thermolytic and staphy­
lococcal protease peptides. Peptide SP5 was important to provide evi­
dence for the weak overlap between T15 and T16, which only involved a 
tryptophanyl residue in peptides C14-15 and Thl8. Despite the low amount 
of peptide SP5 available we were able to perform ten steps of dansyl-
Edman degradation, because only at steps 1 and steps 8, 9 and 10 samples 
were removed for dansylation. All other overlaps were rigidly established. 
4.3.2 ChanactM-Lzcutton о ¡J the. {¡ΊαοΧΛ,οη II CB-^agmznt 
Fraction II of the CM-cellulose column (see fig. 4.4) was digested 
by trypsin and thermolysm and the resulting peptide mixtures were ana­
lyzed by peptide mapping (fig. 4.27 and 4.28, respectively). In both 
cases many peptides also found on the corresponding peptide maps of the 
fraction I CB-fragments (see fig. 4.17 and 4.24) were present. For 
clarity, these peptides have been assigned the same numbers as the frac­
tion I peptides. Several extra peptides were found, denoted T., T R and T r 
for the tryptic peptides and Th. and ThR for the thermolytic peptides. 
Their amino acid compositions are listed in table 4.14. 
Peptide T. contained a methionyl residue which was not converted to homo-
serme and not cleaved by cyanogen bromide. Peptide T R contained an 
internal homosenne. Dansyl-Edman degradation of these peptides yielded 
the following result 
Τ . Met-Pro-Leu-Phe-Glx 
T B · Trp-Ala-His-Leu-
T
c
 Lys. 
Comparison with the sequence results of the fraction I CB-fragments 
(fig. 4.26) revealed that T. represents Til with an N-terminal extension 
of a methionyl residue. Thus, instead of peptides T10 and Til peptide T. 
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Fig. 4.27 Tryptia peptide map of the fraction J ГЗ-frajmpnt 
Peptides not found on the pept ide map of the f r a c t i o n I CB-frag-
ments ( f i g . 4.17) are hatched. 
chromatography 
T h 2 0 - 2 1 
О 
Th12 
Th13 
o§0 
T h 1 5 T h * 
T h 1 6 
+ 
( • ) « -
T h 1 0 
,Th17 
T h 1 9 - 2 0 
Th18 
тми 
electrophoresis 
О 
Th 14 
The 
0 
-• (-) 
Fig. 4.28 rhermolybic peptide map of the fraction II CB-fvagmeno 
Peptides not found on the peptide map of the fraction I CB-frag-
ments (fig. 4.24) are hatched. 
was present, indicating that the CB-fragment in fraction II resulted from 
non-cleavage of methionine-399. Peptide T R had the same N-terminal 
sequence as peptide T16, but it is much longer. This indicates that 
methionine-453 was not cleaved. T R thus represents peptide T16 with a 
C-terminal extension. The sequence of this extension was deduced from 
the thermolytic peptides. Dansyl-Edman degradation of these peptides 
yielded the following result: 
Th. : Val-Hse-Thr-Asx-Lys-Asx-Glx-Val-Pro-Tyr. 
Th R : Leu-Arg-Lys-Gly-Hse. 
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Table 4.14 Amino acid compositions of the tryptia and 
thermolytie peptides of the fraction IT CB-
fraqment noL found in the fraction I CB-frag-
ments 
Peptides were isolated by peptide mapping (figs. 4.27 
and 4.28). 
Amino acid 
Aspartic acid 
Threonine 
Homoseri ne 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield (%) 
Charge 
Peptide 
TA 
1.0(1) 
1.1(1) 
1.0(1) 
0.8(1) 
1.0(1) 
0.8(1) 
1.0(1) 
0.9(1) 
1.1(1) 
9 
25 
+1 
TB 
2.9(3) 
0.9(1) 
0.7(1) 
1.0(1) 
1.0(1) 
0.9(1) 
2.1(2) 
1.9(2) 
1.0(1) 
2.0(2) 
0.8(1) 
1.0(1) 
1.0(1) 
1.0(1) 
+ 
20 
7 
0/-1 
Tc 
1.0(1) 
1 
27 
+ 1 
ThA 
2.1(2) 
1.0(1) 
0.8(1) 
1.0(1) 
0.9(1) 
1.8(2) 
0.8(1) 
1.0(1) 
10 
7 
-1 
ThB 
0.8(1) 
1.1(1) 
0.8(1) 
1.0(1) 
1.0(1) 
5 
8 
+2 
The partial amino acid sequence of the fraction II CB-fragment is presen-
ted in fig. 4.29. The N-terminal sequence of this fragment could not be 
determined due to the fact that a tryptic peptide preceding T8 was not 
found. The remaining part of the sequence was deduced from a combination 
of the results presented in fig. 4.26 and those presented in this 
section. All overlaps were rigidly established, except the overlap T9-T.. 
The fraction II CB-fragment overlaps for a large part with the CB-frag-
ments present in fraction I, but it has a C-terminal extension of 
thirteen residues due to the fact that the bond between residues 453 and 
454 was not cleaved by cyanogen bromide. This bond is a Met-Thr bond 
which is known to be badly cleaved by cyanogen bromide (Schroeder et al., 
1969). The C-terminal tryptic peptide Gly-Hse was not found on the pep-
tide map for reasons not clear. 
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Fig. 4.29 Partial amino acid sequence of the fraction II 
CB-fragment 
Peptides also found in the fraction I CB-fragments are numbered 
as in fig. 4.26. Residues are numbered according to their posi­
tion in the primary structure (see addendum). Residues were 
identified by the dansyl-Edman method (— 7 ) . 
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Leu-Phe-Glu-Ala-Ser-Ile-Glu-Thr-Gly-Asp-Arq-Val-Trp-Arg-Met-Pro-Leu-Phe-Glu-His-
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-Th20-21-
-
T
r 
4.3.3 O-u>cuAi<Lon 
Due to the fact that a number of methionyl bonds present in region 
307-466 were partly cleaved by cyanogen bromide, several fragments with 
overlapping sequences were isolated from this part of the chain. These 
fragments are schematically presented in fig. 4.30. The amino acid 
sequence of the regions 307-353 and 383-466 was completely determined, 
with only three weak overlaps which need additional proof. These are the 
overlaps Lys-Thr (res. 324-325), Arg-Leu (res. 336-337) and Arg-Met (res. 
398-399). The amino acid residues present in region 353-383 could not 
be identified in these CB-fragments. The positioning of peptides Th8 and 
Th9 in this region was based upon the fact that they were absent in the 
fraction II CB-fragment. More information will be needed to identify the 
residues present in region 353-383. We did not consider it very likely 
that this information could be obtained from the CB-fragments. (The 
impossibility to separate the CB-fragments from this part of the poly-
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307 353 364 383 399 453 466 
• • — ι • 1 1 1 
-II-
Fig. 4.30 Schematic representation of the position of the 
CB-J'ragments present in Fractions I and II 
This representation is based upon the sequence results presented 
in figs. 4.26 and 4.29, and the final sequence results of this 
part of the polypeptide chain of LAP (see addendum). The heavy 
vertical bars represent methionyl residues. Dotted lines repre­
sent sequences which could not be identified in the CB-fragments. 
peptide chain of LAP can be explained by their similarity in molecular 
weight and charge, which can now be concluded from the final sequence 
results presented in the addendum. The fragments range in molecular 
weight from approximately 7,500 to 10,500, and they are all positively 
charged). 
The identification of an Asn-Gly sequence (res. 322-323) in the CB-
fragments offered the possibility of cleavage by hydroxylamine. As will 
be described in the next chapter, a hydroxylamine fragment was isolated 
which provided further evidence for the weak overlaps in the CB-fragments, 
as well as additional information concerning the residues present in 
region 353-383. 
76 
CHAPTER 5 CLEAVAGE OF LAP BY HYDROXYLAMINE AND AMINO ACID SEQUENCE 
DETERMINATION OF FRAGMENT HA-II 
5.1 IntnoducXiOn 
About a decade ago the use of hydroxylamine as a cleavage reagent in 
the determination of the primary structure of proteins became increasing­
ly appreciated when Bornstein (1969) and Butler (1969) reported that 
several Asn-Gly bonds in collagen α chains were cleaved by this reagent. 
A mechanism for the cleavage reaction was proposed by Bornstein and 
Balian (1977) which involved the cyclic imide derivative of the Asn-Gly 
sequence. Cleavage occurs by attack of hydroxylamine on the cyclic imide 
leading to the generation of a fragment ending with aspartyl hydroxamate 
and a fragment with N-terminal glycine. The relative ease of formation 
of the cyclic imide of Asn-Gly sequences explains the substantial deami-
dation reported for these sequences, as well as the difficulties caused 
by Asn-Gly sequences in the Edman degradation resulting from the formation 
of ß-aspartyl peptide bonds Because Asn-Gly sequences do not occur very 
often in most proteins, cleavage by hydroxylamine provides a suitable 
method for the production of relatively large fragments. However, the 
method also has some disadvantages. Beside cleavage, the cyclic imide can 
undergo saponification Therefore, the pH of the reaction mixture is of 
great importance. Cleavage is enhanced by complete denaturation of the 
protein, and thus the reaction is usually performed on reduced and alky-
lated protein in the presence of a denaturing reagent. Other asparaginyl 
bonds can be cleaved, although usually to a low extent. 
We decided to use hydroxylamine cleavage as an extra method of producing 
relatively large fragments of LAP, possibly providing evidence for the 
alignment of the CB-fragments. 
5.2 Hydnoxylamnt сіеа адг о^ LA? 
CM-LAP was treated with hydroxylamine and the products were analyzed 
by SDS gel electrophoresis (fig 5.1). Two products were generated with 
apparent MW's of 39,000 and 15,000. The cleavage percentage was between 
40 and 60% after a cleavage time of 4 h. Shorter reaction times resulted 
in substantially lower cleavage percentages, while longer reaction times 
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67,000-
45,000-
20,000. 
12,400-
зг* 
54,000 
39,000 
15,000 
Fig. 5.1 
SDS gel electrophoresis of CM-LAP 
after cleavage by hydvoxylamine 
(a) marker proteins, (b) CM-LAP, 
(c) hydroxylamine-treated CM-LAP. 
resulted in an increase of aspecific cleavages. The fragments were puri­
fied by gel filtration under dissociating conditions, because we found 
that under non-dissociating conditions uncleaved CM-LAP and the 15,000 
MW fragment eluted together. Both HA-fragments could be separated in a 
single step on Sephadex G-100 in 10% acetic acid containing 6 M urea 
(fig. 5.2). The N-terminal amino acid residue of the 39,000 MW fragment 
was determined to be threonine, which proved it to be the N-terminal 
fragment. The N-terminal residue of the 15,000 MW fragment was glycine. 
The fragments were named HA-I and HA-II.respectively. No other fragment 
was found, indicating that only one Asn-Gly bond was cleaved. The 
C-terminal fragment was the more interesting of the two fragments because 
absorbance (280nm) 
О 8 
Fig. 5.2 
Purifieation of the HA-
fragments of CM-LAP on 
Sephadex G-'lOO in 10% 
асеъіа acid containing 
6 M area 
700 
elution volume (ml) 
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it could provide information on the amino acid sequence of the C-terminal 
part of the polypeptide chain of LAP, which was already established for 
a large part with the aid of CB-fragments. 
5.3 AmA.no ttc-td iequznce deteAmindtcon o{¡ HA-II 
The amino acid composition of HA-II is listed in table 5.1. The 
N-terminal amino acid sequence was determined by automated Edman degra-
dation: 
Gly-Lys-Thr-Ile-Gln-Val-Asp-Asn-Thr-Asp-Ala-Glu-Gly-Arg-
Leu-Ile-Leu-Ala- ? -Ala-Leu- ? -Tyr-Ala-His-Thr-Phe-Asn-
The first 28 residues were identified except positions 19 and 22. 
The partial amino acid sequence of HA-II was determined with the aid of 
tryptic, chymotryptic and staphylococcal protease peptides. 
5.3.1 OiQUtion 0(5 HA-Π by tAypun 
Following tryptic digestion of HA-II an analytical peptide map was 
made in order to obtain a first analysis of the tryptic peptides (fig. 
5.3). Because the digestion mixture did not become clear even after a 
digestion time of 2 h, the insoluble material was removed by centrifu-
gation. 
chromatography 
T5 0 -~ 
ö т,0(й 8т7 eb 
Т 1 5 С Г Til 
, т і з О 
Fig. 5.3 
A Analytical peptide map 
of the soluble tryptic 
peptides of HA-II 
В Re-eleotvophovesis of 
the neutral peptides 
'ПО and 'Г12 at pH 3.5 
(.)«- electrophoresis -+ (-) 
• (-) 
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Table 5.1 Лтъпо aaid aomposition of HA-II 
Values for threonine and serine were extrapolated 
to zero time hydrolysis, and values for valine and 
isoleucine were taken from the 72 h hydrolysate. 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
19.0 
12.2 
7.1 
11.2 
4.9 
11.7 
19.7 
2.7 
8.3 
3.5 
8.0 
12.2 
3.3 
7.4 
4.2 
8.5 
8.4 
19) 
12) 
7) 
И) 
5) 
12) 
20) 
3) 
8) 
4) 
8) 
12) 
3) 
7) 
4) 
9) 
8) 
Total 152.4 (152) 
n.d. = not determined 
Peptides T10 and T12 which co-chromatographed in this system were sub­
jected to re-electrophoresis at pH 3.5. Thirteen tryptic peptides were 
isolated, but some peptides were obtained in low yields, especially T3 
and T12. In order to improve the solubility of HA-II during digestion, 
2 M urea was included in the digestion buffer. When the digestion mixture 
was then chromatographed on Sephadex G-50 or DEAE-cellulose, considerable 
precipitation occurred. HA-II probably contains at least one tryptic 
peptide which is very hydrophobic. However, the yield of the soluble 
tryptic peptides was greatly improved by this procedure, so that they 
could be isolated in amounts sufficient for sequence analysis. 
The amino acid composition of the soluble tryptic peptides is listed in 
table 5.2. Their amino acid sequence was determined by the dansyl-Edman 
method (fig. 5.4). Many of these tryptic peptides were also present in 
the CB-fragments described in chapter 4 section 4.3. Thus HA-II overlaps 
for a large part with these CB-fragments. 
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Table 5.2 Amino acid composition of the solvble tryptic peptides of HA-II 
Peptides were isolated by peptide mapping (fig. 5.3). Peptides T4 and T14 were not isolated. 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Prol ine 
Glycine 
Alanine 
Cysteine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield (') 
Charge 
Peptide 
Tl 
0 9(1) 
1.0(1) 
2 
28 
+ 1 
T2 
2 9(3) 
1.9(2) 
2 0(2) 
1.2(1) 
1 1(1) 
0.9(1) 
0.9(1) 
1 0(1) 
12 
21 
-2 
T3 
2.1(2) 
1 1(1) 
0.9(1) 
3 0(3) 
0 8(1) 
1.0(1) 
2.9(3) 
1.0(1) 
1 1(1) 
1.0(1) 
1.0(1) 
16 
8 
0 
T5 
1.1(1) 
0 9(1) 
0.9(1) 
2.1(2) 
1.0(1) 
1.1(1) 
1.0(1) 
0.9(1) 
1.0(1) 
1.0(1) 
11 
20 
-2 
T6 
0 9(1) 
1.0(1) 
+ 
3 
22 
+ 1 
T7 
1.0(1) 
1.1(1) 
1.0(1) 
0.8(1) 
1.0(1) 
0.8(1) 
1 0(1) 
0.9(1) 
1.0(1) 
9 
30 
+ 1 
T8 
3.6(4) 
2 0(2) 
0.9(1) 
1.0(1) 
0.6(1) 
1.8(2)a 
1.8(2)a 
0.9(1) 
1.0(1) 
15 
19 
-2 
T9 
0.8(1) 
1.0(1) 
2 
40 
+ 1 
T10 
0.9(1) 
1.0(1) 
1.2(1) 
4.6(5) 
0.7(1) 
1.1(1) 
0.9(1) 
1.0(1) 
12 
35 
0 
Til 
1.0(1) 
1.0(1) 
0.9(1) 
1.0(1) 
1.0(1) 
1.0(1) 
1.1(1) 
+ 
7 
19 
+ 1 
T12 
2.6(3) 
0.8(1) 
1.0(1) 
0.9(1) 
1.0(1) 
1.8(2) 
1.7(2) 
0.7(1) 
0.8(1) 
1.8(2) 
0.7(1) 
1.0(1) 
0.9(1) 
1.1(1) 
20 
9 
0 
T13 
1.0(1) 
1 
35 
+ 1 
T15 
1.1(1) 
1.9(2) 
1.0(1) 
1.0(1) 
0.9(1) 
6 
14 
-1 
Total 
14 
8 
4 
10 
4 
6 
14 
3 
7 
2 
6 
9 
4 
6 
4 
7 
6 
2 
116 
valae taken from the 72 h hydroíysate 
Fig . 5.4 Amino aaid sequence détermination of the soluble tryptic 
peptides of HA-II 
Peptides were sequenced by the dansyl-Edman technique ( — 7 ) . 
Tl 
T2 
T3 
T5 
T6 
T7 
T8 
T9 
TÍO 
Til 
T12 
T13 
T15 
Gly-Lys^ 
Thr-Ile-Gln-Val-Asp-Asn-Thr-Asp-Ala-Glu-Gly-Arg 
Leu-lie-Leu-Ala-Asp-Ala-Leu-Cys-Tyr-Ala-His-Thr-Phe-Asn-Pro-Lys 
Leu-Phe-Glu-Ala-Ser-Ile-Glu-Thr-Gly-Asp-Arg 
Val-Trp-Arg 
Met-Pro-Leu-Phe-Glu-His-Tyr-Thr-Arg 
Gln-Val-Ile-Asp-Cys-Gln-Leu-Ala-Asp-Val-Asn-Asn-Ile-Gly-Lys 
Ту r-Arg 
Ser-Ala-Gly-Ala-Cys-Thr-Ala-Al a-Ala-Phe-Leu-Lys 
Glu-Phe-Val-Thr-His-Pro-Lys 
Trp-Ala-His-Leu-Asp-Ile-Ala-Gly-Val-Met-Thr-Asx-Lys-Asx-Glx-Val-
Pro-Tyr-Leu-Arg 
Ljrs 
Phe-Ser-Glx-Asx-Ser-Ala 
Fig. 5.5 Fractionation of the chymotryptic peptides of HA-II on 
Sephadex G-50 superfine in 0.1 M ammonia 
Pool I I and IV were p u r i f i e d on DEAE-cellulose ( f i g . 5 . 6 ) , and pool V 
and VI by p e p t i d e mapping ( f i g . 5 . 7 ) . 
absorbance 
200 240 
elution volume (ml) 
82 
5.3.2 O-tguticn o£ HA-II by chymoViypbln 
Analysis of the peptide mixture obtained by chymotryptic digestion 
of HA-II by means of an analytical peptide map showed that this digestion 
suffered from the same difficulties as observed in the tryptic digestion 
of HA-II : an apparent low extent of cleavage and a poor solubility of 
some of the peptides. To overcome this problem digestion was again per-
formed in the presence of 2 M urea. The digestion mixture was chromato-
graphed on Sephadex G-50 (fig. 5.5). The first peak mostly contained 
Fig. 5.6 Purification of pools II and IV of the Sephadex 
column (fig. 6.5) on DEAE-cellulose 
(A) pool II, (B) pool IV. 
absorbance 
150 200 
elution volume (mi) 
0 05 
75 100 
elution volume (ml) 
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undigested HA-II. Pools II, III and IV were subjected to ion-exchange 
chromatography on DEAE-cellulose. It appeared that the peptide(s) present 
in pool III precipitated on the column, and no pure peptide could be 
obtained. The elution patterns of pools II and IV are shown in fig. 5.6. 
Pool II yielded one peptide which was shown to be the N-terminal peptide 
by three steps of dansyl-Edman degradation. Pool IV yielded three pep­
tides, namely C5, C18 and C9. Pools V and VI of the Sephadex column were 
purified by peptide mapping (fig. 5.7). Pool VII of the Sephadex column 
contained only one peptide namely the small peptide C14. In some cases 
it also contained peptide C16 resulting from cleavage of a tryptophanyl 
bond. Many chymotryptic peptides were thus isolated. Digestion of HA-II 
in the presence of 2 M urea greatly improved the extent of cleavage, and 
many peptides could be obtained in amounts sufficient for sequence deter­
mination. The amino acid compositions of the chymotryptic peptides are 
listed in table 5.3. The amino acid sequence of most of the chymotryptic 
peptides was determined by the dansyl-Edman technique. Peptides C9 and 
C18 were also sequenced by manual Edman degradation. The results of the 
sequence determination are included in fig. 5.9. 
chromatogra phy 
t 
С 17°ж U 
О CD Π ^ 
^S C17 L / C 13 
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СП 
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electrophoresis - » • (-) 
Fig. 5.7 
Puv'ification of pools V 
and VI of thf Sephadex 
col am (fi-J. b.b) by 
peptide naprina 
(A) pool V, (B) pool VI. 
chromatography 
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Table 5.3 Amino acid composition of the chymotryptic peptides 
of HA-II 
Peptides were purified by gel filtration (A) followed by ion-
exchange chromatography (B) or peptide mapping (C). 
Amino acid 
Aspart ic acid 
Threonine 
Serine 
Glutamic acid 
Prol ine 
Glycine 
Alanine 
Cysteine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
H i s t i d i n e 
Lysine 
Arginine 
Tryptophan 
Total 
Y ie ld (?) 
Charge 
P u r i f i c a t i o n 
Peptide 
Cl-2 
3.8(4) 
2.1(2) 
2.2(2) 
1.8(2) 
3.0(3) 
0.9(1) 
1.3(1) 
1.8(2) 
2.7(3) 
0.9(1) 
0.9(1) 
1.0(1) 
23 
21 
neg. 
AB 
C2 
1.0(1) 
2.0(2) 
0.8(1) 
0.7(1) 
2.0(2) 
0.9(1) 
8 
10 
-2 
AC 
C3 
1.0(1) 
1.1(1) 
1.1(1) 
1.0(1) 
4 
10 
+ 1 
AC 
C5 
1.1(1) 
1.9(2) 
1.0(1) 
3.9(4 
2.8(3 
1.0(1) 
0.9(1) 
1.0(1) 
1.0(1) 
0.9(1) 
16 
25 
neg. 
AB 
C6 
1. 
0. 
1. 
+ 
5 
8 
0 
лс 
0(1) 
/ ( i ) 
8(2) 
C8 
0.8(1) 
0.9(1) 
1.2(1) 
1.0(1) 
4 
18 
+ 1 
AC 
C9 
1.2(1) 
1.1(1) 
0.9(1) 
2.2(2) 
1.0(1) 
1 0(1) 
1 0(1) 
1.0(1) 
1.0(1) 
+ 
11 
19 
neg. 
AB 
CIO 
1.0(1) 
1 0(1) 
0.9(1) 
1 1(1) 
0.8(1) 
1 KD 
1 0(1) 
1.0(1) 
8 
13 
+ 1 
AC 
СП 
1.0(1) 
0.7(1) 
2.0(2) 
0.9(1) 
0 6(1) 
0.6(1) 
1.0(1) 
1 0(1) 
9 
11 
-1 
AC 
Table 5.3 (continued) 
Amino acid 
Aspart ic ac id 
Threonine 
Serine 
Glutamic acid 
Pro! ine 
Glycine 
Alanine 
Cysteine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
H i s t i d i n e 
Lysine 
Arginine 
Tryptophan 
Total 
Y ie ld ( ) 
Charge 
P u r i f i c a t i o n 
Peptide 
C l l - 1 2 
3.9(4) 
0.8(1) 
1 9(2) 
1.0(1) 
0.9(1) 
0.8(1) 
1.7(2) 
1.6(2) 
1 0(1) 
0 9(1) 
1.0(1) 
0 9(1) 
18 
17 
-1 
ЛС 
C13 
1.0(1) 
1.0(1) 
0 9(1) 
4.7(5) 
0 9(1) 
1 Hi) 
0.9(1) 
11 
25 
0 
AC 
C14 
0 9(1) 
0.9(1) 
1 0(1) 
1 0(1) 
4 
28 
0 
AC 
C15-16 
1.0(1) 
0.8(1) 
1.0(1) 
0.9(1) 
1.0(1) 
1 9(2) 
1.1(1) 
+ 
9 
10 
+ 2 
AC 
C16 
1 0 ( 1 ) 
1 0(1) 
1-0(1) 
3 
12 
+ 1 
AC 
C17 
1.0(1) 
0.9(1) 
1 KD 
0.9(1) 
0 7(1) 
1.0(1) 
6 
10 
-1 
AC 
C18 
2 1(2) 
1 0(1) 
1 4(1) 
1 Ц 1 ) 
1 0(1) 
1 0(1) 
1 0(1) 
8 
23 
neg. 
AB 
C19 
1 0(1) 
1 0(1) 
1 0(1) 
1 0(1) 
1 0(1) 
5 
6 
+ 2 
AC 
C21 
1 . 2 ( 1 ) 
1 - 8 ( 2 ) 
0 8 ( 1 ) 
J 8 ( 1 ) 
5 
12 
-1 
AC 
5.3.3 Vigtition o¿ HA-II by Staphylo со ест pKotzaot 
HA-II was digested by Staphylococcus protease and the resulting 
peptide mixture was purified by peptide mapping after removal of the 
insoluble material (fig. 5.8). Two acidic and one neutral peptide were 
isolated in good yield. The amino acid compositions of these peptides 
are listed in table 5.4. Five steps of Edman degradation were performed 
on peptide SP3. The 
staphylococcal protease 
peptides are included in 
fig. 5.9. 
chromatography 
O 2 Q: 
O p 1 
( • ) « - electrophoresis 
-* (-) 
Fig. 5.8 
Purifiaation of some sta-
phylooooeal protease pep­
tides of HA-II by peptide 
mapping 
Table 5.4· Amino acid compositions of some 
staphylococcal peptides of HA-II 
Peptides were purified by peptide mapping 
(fig. 5.8). 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Valine 
Methionine 
Isoleucine 
Leucine 
Phenylalanine 
Lysine 
Arginine 
Tryptophan 
Total 
Yield {%) 
Charge 
Peptide 
SPI 
2.9(3) 
2.0(2) 
2.2(2) 
1.0(1) 
1.1(1) 
1.1(1) 
1.0(1) 
1.0(1) 
12 
11 
-2 
SP2 
0.9( 
l.Of 
1.2( 
1.0( 
4 
32 
-1 
1) 
1) 
1) 
1) 
SP3 
1.1(1) 
0.8(1) 
1.2(1) 
1.0(1) 
1.1(1) 
0.9(1) 
0.8(1) 
1.0(1) 
1.1(1) 
1.9(2) 
+ 
12 
16 
0 
5.3.4 ?oJVtAjrf атл.по а.сл.а sequence о ¡5 НА-11 
A summary of the sequence results providing the evidence for the 
partial amino acid sequence of HA-II is presented in fig 5.9. This 
summary also takes into account the results of the sequence determina­
tion of the CB-fragments described in chapter 4 section 4.3. Automated 
Edman degradation identified the N-terminal sequence and established the 
order of tryptic peptides Tl, T2 and T3. Further evidence was provided 
by chymotryptic peptide Cl-2. This also proved the overlaps Lys-Thr 
(res. 324-325) and Arg-Leu (res. 336-337), which only involved one resi­
due in the CB-fragments (see fig. 4.26). As was the case in the CB-frag­
ments, no tryptic peptide was isolated from region 353-384 This proba­
bly represents a very hydrophobic sequence, which would explain the 
precipitation during chromatography observed both in HA-II and the CB-
fragments. A large part of the amino acids present in this region could 
be derived from peptide C5. The positioning of peptide C6 in this region 
will be discussed later (section 5.4). The order of peptides T5, T6 and 
T7 was established by peptides C9 and CIO, and by peptide SP3. Peptide 
SP3 thus provided evidence for the overlap Arg-Met (res 398-399) which 
was not proved in the CB-fragments. The overlaps T8-T9 and T9-T10 which 
only involve one residue in HA-II were already proved in the CB-frag­
ments (see fig. 4.26). The large peptide T12 was also present in the 
fraction II CB-fragment (see fig. 4.29). Edman degradation of peptide 
C18 identified the amide and acidic residues in peptide T12. Peptide 
T14 starting with Gly-Met was not isolated from HA-II. The reason for 
this is not clear. Peptide T15 which lacked a lysyl or an arginyl resi­
due was believed to be the C-terminal peptide of HA-II. This was also 
evidenced by peptide C21 ending with an alanine, a residue normally not 
susceptible to chymotryptic attack. The finding of alanine as C-terminus 
of HA-II (and not aspartate hydroxamate), indicated that this alanyl 
residue is also the C-terminal residue of LAP. 
At present a total of 145 amino acid residues have been identified in 
HA-II. 
5.4 СопсІіх. А.ип 
Fig. 5 10 shows the partial amino acid sequence of the C-terminal 
part of the polypeptide chain of LAP as determined with the aid of 
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Fig. 5.9 Proposed partial amino acid sequence of /Μ-ΓΙ 
By a combination of the results presented in this chapter and the se­
quence results of the CB-fragments described in chapter 4 section 4.3 
(for a summary see figs. 4.26 and 4.29) a partial amino acid sequence 
of HA-11 was deduced. Residues were identified by automated Edman degra­
dation (—*), manual Edman degradation (— v), dansyl-Edman technique 
( — 7 ) , or by both manual methods (—)). For clarity the residues have 
been numbered according to their position in the primary structure of 
LAP (see addendum). 
325 31П 335 340 
Gll-Ly^-Thi:,-IU-G1a-Val„-AsB,-Asn-Thr-AsB-Alc|,-(;1g,-G1y i-Arg,-Le4-Ili^-Leg,-Ala„-Asp-A1^-LeqrCys-
-T2 — ТЗ;; 
Cl-2 
-SPI-
SIS 350 360 365 
Tyr-Ala.-His.-Thr-Ph^-Asn-Pro-Lys-Val Ala-Thr Leu-Thr-Gly-Ala-Met-Asp-1 le-Ala-Leu-
- T 3 — 
-C3 C5-
370 375 380 3B5 
G l y - S e r - ( T h r , G l y , G l y , A l a , V a l , P h e ) - - - T h r - A s n - S e r - S e r - T r p Asn-Lys-Leu-Phe-Glu-Ala-Sei -
T5
-
-C5 • C6 — Til • — — 
5P2— 
390 395 400 105 410 
I le-Glu-Thr-Gly-Asp-Arg-Val-Trp-Arg-Met-Pro-Leu-Phe-Glu-His-Tyr-Thr-Arcj-Gln-Val- I le-Asp-
-T5 T6 ~- Τ 7- TS;; 
— C9 • CIO - « СП • 
-5P3 • Cl 1-12-
415 420 425 430 
Cys-Gln-Leu-Ala-Asp-Val -Asn-Asn-I le-Gly-Lys-Tyr-Arq-Ser-Ala-Gly-Ala-Cys-Thr-Ala-Al a-Al a-
-T8 • ~- T9-
C 1 3 -
- C l l - 1 2 • 
435 440 445 450 455 
Phe-Leu-Lys-Glu-Phe-Val-Thr-His-Pro-Lys-Trp-Ala-His-Leu-Asp-I le-Aia-Gly-Val-Met-Thr-Asn-
-T11 — -T12-
—C14- C15-16 • C17-
460 465 
Lys-Asp-Glu-Val-Pro-Tyr-Leu-Arg-Lys-Gly-Met Phe-Ser-Glx-Asx-Ser-Ala 
T12 •-T13- T15 
Fig. 5.10 Proposed partial amino acid sequence of the C-terminal 
part of ihr polypeptide chain of LAP 
The one-letter notation for amino acids has been used: A, alanine; 
C, cysteine; D, aspartic acid; E, glutamic acid; F, phenylalanine; 
G, glycine; H, histidine; I, isoleucine; K, lysine; L, leucine; 
M, methionine; N, asparagine; P, proline; Q, glutamine; R, arginine; 
S, serine; Τ, threonine; V, valine; W, tryptophan; Y, tyrosine. 
Cleavage points for cyanogen bromide and hydroxylamine are indicated 
by vertical arrows above the sequence, and the resulting CB- and 
HA-fragments are shown by arrows below the sequence. 
HA CB 
310 320 I 330 340 350 360 I 
ι ι | ι ι ι ι | 
PSGKANKPGDVVRARNGKTLQVDNTDAEGRLILADALCYAHTFNPKV--AT—LTGAMDI 
-CB8-
-CB8-9-10-
-M-II-
CB CB 
370 380 J 390 И00 410 
ALGS(T,G,G,A,V,F)TNSSWM-NKLFEASIETGDRVWRMPLFEHYTRQVIDCQLADVN 
-CB9 CB11-
CB8-9-10 • 
-CB10-11-12-
-HA-II-
CB CB 
420 430 440 450 I 460 I 
ι ι ι ι • ι \ Γη 
NIGKYRSAGACTAAAFLKEFVTHPKWAHLDIAGVMTNKDEVPYLRKGM FS^SA. 
CB11 •- CB12- — 
-CB10-11-12-
-HA-II-
CB-fragments and the C-terminal HA-fragment. We can now conclude that the 
CB-fragments present in fraction I represent CB8, CB8-9-10 and CB11. The 
CB-fragment in fraction II can be identified as CB10-11-12. The small CB-
fragments CB9 and CB12 were isolated and characterized by H. Th. Cuypers 
(unpublished results). Fragment CB9 indicated that another methionyl 
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residue was present, and it also determined the position of peptide C6 
in HA-II, which could not be placed on the basis of evidence from HA-II. 
Thus, due to the fact that a number of methionyl bonds were partly split 
by cyanogen bromide, CB-fragments with large stretches of overlapping 
sequences were isolated from this part of the polypeptide chain of LAP. 
Fragment HA-II overlapped for a large part with the CB-fragments, and 
provided much additional information for the amino acid sequence of the 
C-terminal part of LAP. 
At this moment a total of 160 amino acid residues has been identified 
in this part of the polypeptide chain of LAP. Together with the sequence 
results of CB1 (see fig. 4.15) approximately 65% of the amino acid resi-
dues in LAP has been identified. 
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CHAPTER 6 LIMITED PROTEOLYSIS OF NATIVE LAP 
6.1 IntAudiLCÙion 
The term "limited proteolysis" introduced by Desnuelle and Rovery 
(1956) denotes a proteolytic process whereby from a very large number of 
potentially susceptible bonds in a native protein only a very limited 
number is split. Early developments in thi field included the conversion 
of zymogens (pro-enzymes) to the physiologically active form (par example 
trypsinogen). Later also pro-proteins of hovrnones and regulatory proteins 
were identified. Limited proteolysis also served to separate hydrophobic 
leader sequences from the functional protein after the passage of certain 
nascent secretory proteins (pre-proteins) through membranes. There is now 
widespread evidence that in many cases the initial product of messenger 
translation is larger than the physiological protein, and that this pro-
duct is post-translationally cleaved by specific proteases. Thus it 
appears that limited proteolysis constitutes an important fundamental 
regulatory mechanism (Neurath, 1979). 
Limited proteolytic reactions have been extensively reviewed by 
Mihalyi (1978). Two types of reaction may be distinguished. In the first 
type one or more peptides are removed either from terminal regions or 
from exposed loops of the polypeptide chain. The activation of proenzymes 
and other precursor molecules belongs to this class. Alternatively, the 
scissile bond(s) may be located in a region which connects preformed 
domains. X-ray crystallographic studies have shown that many globular 
proteins are organized into distinct structural domains comprising 
between 100 and 200 amino acid residues. It was proposed that protein 
folding occurs independently in separate parts of the molecule, and that 
these domains are then organized together to give the native tertiary 
structure (Wetlaufer, 1973, Grippen, 1978). It may be argued that these 
compact domains are less susceptible to proteolytic action than random 
segments, and that proteolysis is therefore directed to interconnecting 
segments of protein domains, liberating these domains as large frag-
ments. The action of proteolytic enzymes on native proteins also provides 
a useful tool for monitoring conformational changes in proteins. Because 
only those parts of the protein that are sufficiently exposed are suscep-
tible to proteolytic attack, any change in the surface topology of the 
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protein involving segments where available sites for proteolytic attack 
are present, will be reflected by a change in susceptibility. In the same 
sense limited proteolysis can be used to detect changes in the degree of 
exposure of certain groups in the protein. 
We performed limited proteolysis of native LAP for two reasons: 
in order to obtain large fragments that could be useful for the alignment 
of CB-fragments, and to obtain information on the structure of native LAP. 
The results of limited proteolysis of native LAP are described in the 
next sections. Possible implications for the structure of native LAP are 
discussed in section 6.4. 
6.2 L¿mvted р>іоіе.оІуіы о¡5 native. LAP 
Native LAP in 0.1 M Tris-HCl buffer, pH 8.0, was digested by several 
proteolytic enzymes for varying periods of time. The resulting digestion 
mixtures were analyzed by SDS gel electrophoresis (fig. 6.1). Under these 
conditions native LAP is dissociated into its subunits of MW 54,000 (b). 
Following tryptic digestion two products of MW 37,000 and 17,000 became 
apparent after less than two minutes with a concomitant decrease of LAP 
subunits (c). This fractionation continued until nearly all of the sub-
(A) (B) 
·» mm mm- mm mm ' 
a b c d e f g h i j a o c d e f y n i j 
Fig. 6.1 SOS gel eleatrophoretic analysts of native LAP after limited 
proteolytio digestion 
Native LAP in Tris-HCl buffer, pH 8.0, was incubated with 0.5% (w/w) of 
trypsin (A), or of chymotrypsin, plasmin or thrombin (B). Samples were 
taken from the digestion mixture before addition of enzyme (b), and 
after digestion times of 2 min (с), 5 min (d), 10 min (e), 20 min (f), 
30 min (g), 60 min (h), and 180 min (i), (a) and (j) are marker pro­
teins. Because the digestion patterns for chymotrypsin, plasmin and 
thrombin were the same, only the chymotryptic pattern is shown. 
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unit had dissappeared after a digestion time of 3 h (с to i). The same 
digestion pattern was obtained using other enzyme/substrate ratios (0.05-
1%, w/w, of trypsin). When digestion was performed by chymotrypsin, 
plasmin or thrombin no cleavage occurred. Thus, of several enzymes only 
trypsin was able to produce a cleavage in native LAP. The two products 
were not digested further by trypsin. When native LAP was first activated 
by incubation with 1 mM MnCU for 2 h at 40 0C or inactivated by incuba­
tion with 10 mM EDTA, essentially the same rattern as shown in fig. 6.1A 
was obtained after tryptic digestion. 
The samples from the tryptic digestion mixture were assayed for 
hydrolytic activity against L-leucinamide (fig. 6.2). Even after a 
digestion period of 60 min when most of the LAP subunit was split into 
two fragments, all of the hydrolytic activity was retained. This may have 
Fig. 6.2 
Aosay of hydrolytic actiuity 
of native LA? after United 
digestion by trypsin 
L-leucinamide was used as 
substrate. 
О 10 20 30 aO 50 6 0 70 
DigesLion t ime (mm) 
two causes: either the LAP aggregate remains intact despite the splitting 
of a bond and therefore retains its activity, or, alternatively, when the 
structure of LAP is changed or the aggregate falls apart, catalytic 
activity is retained in one or both of the fragments. To discriminate 
between these possibilities the chromatographic and sedimentation 
behavior of trypsin-treated LAP was compared to that of native LAP. 
When LAP treated with trypsin for 30 min or 3 h was chromatographed 
on Ultrogel AcA 34, it eluted in a homogeneous peak at exactly the same 
position as native LAP, reflecting a molecular weight of about 300,000. 
No change was observed in the sedimentation behavior of LAP after treat­
ment with trypsin (fig. 6.3). Both native LAP and trypsin-treated LAP 
revealed a sharp, homogeneous peak in the analytical ultracentrifuge. 
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Fig. 6.3 
Sedimentation analysis of 
native LAP (left) and of 
LAP treated with trypsin 
for 60 min (right) 
The calculated sedimentation constants were 10.85 ± 0.06 S and 10.79 
± 0.05 S for native and trypsin-treated LAP, respectively, in 0.1 M Tris-
HC1 buffer, pH 8.0. These results point to the first possibility indicated 
above. Also the fact that prolonged dialysis could not remove the frag­
ments from the aggregate (dissociation could only be achieved in 6 M urea), 
sustained the idea that cleavage of native LAP by trypsin does not result 
in dissociation of the LAP aggregate. 
To investigate whether cleavage of native LAP by trypsin has any 
influence on the active site, we determined the kinetic parameters К and 
m 
V
max
 o f t ryP s l' n- t r e ated LAP after activation by manganese ions, and 
compared them to those of native LAP (fig. 6.4). In both cases the К 
m 
native LAP 
trypsin-treated LAP 
K
m 
mmol .1" 
29 
29 
V 
max 
mmol/mi η.mg 
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•1- (mmor1. min. mg) 
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Fig. 6.4 Lineweaver-Burk plot of the hydrolytia activity of 
native LAP (o o) and of trypsin-treated LAP f · — щ ) 
Substrate: L-leucinamide; act ivat ion by manganese ions 
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value was found to be 29 mM, indicating that substrate binding was not 
affected. The V values differed slightly, but the difference lies well 
max 
within the standard error of five per cent inherent in this method. 
We concluded that tryptic cleavage of native LAP has no effect on sub­
strate binding nor on the actual catalytic step. 
When the time course of the activation of LAP by manganese ions was 
2+ investigated, it appeared that LAP was optimally activated by 1 mM Mn 
after an incubation period of approximately 2 h (fig. 6.5). On the other 
hand, when LAP was first digested by trypsin for 1 h, activation by 
manganese was already optimal after less than 30 min. Thus, the splitting 
of a bond in LAP by trypsin accelerated activation by manganese ions. 
Fig. 6.5 
Aativation of native LAP 
(o O/l and of trypsin-
treated LAP (Щ ij by manga­
nese ions 
Activities are expressed as 
percentages of the optimal 
value. 
¿ u \ 1 ] τ 
О 30 60 90 120 
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6.3 OztMMÍncutíon o<S thz tAyptic ctzavage. i-ute. 
In order to determine the position of the trypsin-susceptible bond 
in the polypeptide chain of LAP, the tryptic fragments were isolated and 
characterized. Because separation of the fragments could only be achieved 
under dissociating conditions, column chromatography was performed on 
Sephadex G-100 in 10% acetic acid containing 6 M urea (fig. 6.6). By this 
procedure the 37,000 MW fragment (pool III) and the 17,000 MW fragment 
(pool IV) were obtained in pure form. Determination of the N-terminal 
amino acid residue yielded lysine for the 37,000 MW fragment and threo-
nine for the 17,000 MW fragment. Since threonine is the N-terminal resi-
due of native LAP (see table 3.1), the 17,000 MW fragment was concluded 
to be the N-terminal fragment, and was named LT-I. The 37,000 MW fragment 
was designated LT-II. 
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Fig. 6.6 
Purification of the frag­
ments of limited tryptic 
digestion of native LAP 
on Sephadex G-100 in 10% 
acetic acid containing 
6 M urea 
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After reduction and S-carboxymethylation LT-I was digested by trypsin and 
the resulting peptide mixture was analyzed by peptide mapping (fig. 6.7). 
Comparison with the tryptic peptide map of the N-terminal cyanogen bro­
mide fragment (see fig. 4.8) revealed that peptides Tl to T15 were pre­
sent in LT-I. The tryptic peptides of LT-I were also characterized by 
amino acid analysis. This yielded exactly the same result as given in 
table 4.2 for peptides Tl to T15. Instead of peptide T14 which is too 
large to appear on the peptide map, a peptide T14* was found resulting 
from a chymotrypsin-like cleavage at a phenylalanyl residue in T14. 
These results, combined with the fact that lysine is the N-terminal resi­
due of LT-II, indicated that the cleavage site for trypsin in native LAP 
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Fig. 6.7 Analytical peptide map of the tryptio peptides of LT-l 
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is between arginine-137 and lysine-138 in the polypeptide chain (see 
fig. 4.15). The amino acid composition of LT-I obtained by analysis of an 
acid hydrolysate agrees well with the sum of residues 1 to 137 (table 
6.1). Thus, LT-I comprises the N-terminal 137 amino acid residues of LAP, 
and LT-II represents the remaining C-terminal part of the chain. As can 
be seen from fig. 4.15 the tryptic cleavage site is contained in a 
cluster of basic residues (Lys-Gln-Lys-Arg-Lys, res. 134-138). 
Table 6.1 Amino acid composition of LT-T 
Values for threonine and serine were extrapolated 
to zero time hydrolysis, and values for valine 
and isoleucine were taken from the 72 h hydro-
lysate. Tryptophan was not determined. For compa-
rison the sum of residues 1 to 137 is included. 
Amino acid 
Aspartic acid 
Threonine 
Serine 
Glutamic acid 
Proline 
Glycine 
Alanine 
Cysteine 
Valine 
Methionine 
Isoleucine 
Leucine 
Tyrosine 
Phenylalanine 
Histidine 
Lysine 
Arginine 
Tryptophan 
Total 
LT-I 
13.2 
4.8 
5.6 
22.0 
5.7 
14.9 
13.0 
1.9 
9.3 
0.0 
7.1 
12.0 
3.9 
4.1 
2.2 
12.7 
5.4 
n.d. 
137.8 
13) 
5) 
6) 
22) 
6) 
15) 
13) 
2) 
9) 
0) 
7) 
12) 
4) 
4) 
2) 
13) 
5) 
138) 
res. 1-137 
13 
5 
6 
21 
6 
15 
13 
2 
9 
0 
7 
12 
4 
4 
2 
12 
5 
1 
137 
6.4 T.mpíÁ.catioM {¡on thz itnuctuAe. o{¡ LAP 
In the previous sections we showed that the specific cleavage of an 
Arg-Lys bond in native LAP by trypsin does not cause a dissociation of 
the LAP aggregate, resulting in a retainment of catalytic activity. 
Cleavage of this bond is independent of the presence or the nature of 
the activating metal ion, since the same digestion pattern was obtained 
for native LAP, Mn -activated LAP and inactivated LAP. It has been 
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stated that native LAP possesses two non-equivalent metal binding sites 
per subunit (Thompson and Carpenter, 1976). The zinc ion in the structu-
ral site can be exchanged only with extreme difficulty, indicating that 
it might be buried inside the molecule. The zinc ion in the activation 
site can be easily replaced, and this site is probably located near the 
surface of the molecule. Our results of limited tryptic digestion of LAP 
are in accord with this hypothesis. Thus, the splitting of a bond near 
the surface of the molecule has no effect on the structural site believed 
to be buried in the molecule (as evidenced by the fact that no change in 
kinetic parameters was observed), but it does affect the activation by 
manganese ions. A possible explanation is that the splitting of this bond 
in some way facilitates the exchange of a zinc ion in the activation site 
by manganese. However, the binding of the metal ion itself in the activa-
tion site is not affected. The fact that the splitting of the Arg-Lys 
bond is complete after approximately 3 h, indicates that this bond is 
split in all six subunits. Consequently the surface topology around the 
susceptible bond probably is identical in all subunits. Investigations 
of the quaternary structure of LAP have shown that to each of the sub-
units an additional, elongated "tail" is attached (Ludewig et al., 1977). 
These tails, extending from the molecule, may be especially susceptible 
to attack by proteolytic enzymes. Alternatively, the trypsin-susceptible 
bond may be located in a region connecting distinct domains. The N-termi-
nal part of LAP thus may represent a distinct structural domain com-
prising about a quarter of the molecule. The size of LT-I (about 140 
residues) corresponds well with that of separate domains found in many 
proteins (between 100 and 200 residues). The remaining C-terminal part of 
LAP (LT-II) may comprise one or more domains. In view of the hypothesis 
that LAP contains at least two separate structural domains the finding of 
Taylor et al. (1979) that the subunits of LAP are bilobal with a princi-
pal and a minor lobe, is of special interest. However, the hypothesis of 
the existence of distinct domains in LAP can only be verified by a 
detailed X-ray structural analysis of this enzyme. 
The finding that the LAP aggregate remains intact after limited 
tryptic digestion indicates that the fragments are held together either 
by disulfide bonds or by strong secondary interactions. The fact however, 
that LT-I and LT-II can be separated without prior reduction, excludes 
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the possibility of disulfide bonds holding the fragments together. As can 
be seen from fig. 4.15, two cysteines are present in LT-I, namely 
Cys-97 and Cys-133. Neither of these is bound by an S-S bridge to a 
cysteine farther away in the primary structure. Carpenter and Vahl (1973) 
and Frohne (1977) found that of the 8 cysteines thought to be present in 
each subunit of LAP, six were in the sulfhydryl form, and hence they 
concluded that one S-S bridge is present. Our results of the limited 
tryptic digestion of native LAP point to two possibilities: either both 
cysteines in LT-I are in the sulfhydryl form, or these residues form one 
14 
disulfide bridge. Future investigations using [ CJ-monoiodoacetic acid 
will discriminate between these two possibilities. 
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CHAPTER 7 . INHIBITION STUDIES WITH L-PHENYLALANINE CHLOROMETHYL KETONE 
7.1 CuMizwt itati od knowlcdiga o{¡ thz enzyme, тгекмилт о^ LAP 
Many investigators have speculated on the relation between the 
structure of LAP and the function of this enzyme (Bryce and Rabin, 1964, 
Frohne, 1977; Lasch, 1978). Information on the active center has been 
obtained mainly with the aid of substrate analogues and inhibitors, and 
by means of chemical modification of specific amino acid residues in the 
enzyme. In an early study of LAP Bryce and Rabin (1964) proposed a mecha­
nism of action involving the mediation of a metal ion in the binding of 
substrate to the enzyme and the existence of secondary interactions be­
tween substrate and protein. The metal ion involved in substrate binding 
is believed to be the zinc ion in the structural site (Carpenter and 
Vahl, 1973, Kettmann and Hanson, 1970), since the activating metal ions 
have no influence on substrate binding (Lasch et al , 1973). The most 
likely sites of interaction with the metal ion are the uncharged α-amino 
group of the substrate and the carbonyl oxygen atom of the peptide bond 
to be cleaved. The preference of LAP for substrates with hydrophobic side 
chains indicates that the secondary interactions between substrate and 
protein are of hydrophobic nature. The inability of several chloromethyl 
ketone derivatives of amino acids to alkylate the enzyme (Fittkau et al., 
1974, Birch et al., 1972) was given as evidence for a mechanism of 
binding in which a water molecule is interposed between the substrate and 
a nucleophilic group on the enzyme. The role of the zinc ion in the cata­
lytic step is not clear. As a Lewis acid it might cause a polarization 
of the carbonyl group and thereby facilitate nucleophilic attack on the 
peptide bond. The activating metal ions have no influence on substrate 
binding, but they take part directly or indirectly in later steps of the 
catalytic event (Lasch et al., 1973). Frohne (1977) has suggested that 
activation of LAP by these metal ions is caused by a considerable change 
in conformation in the protein, resulting in an optimal orientation of 
the active center residues. Investigations of the pH-dependency of the 
catalytic reaction and chemical modification reactions have indicated the 
involvement of the side chains of histidine, cysteine and tyrosine as es­
sential groups in the catalytic process (Frohne et al., 1973, Ludewig et 
al., 1975, Frohne and Hanson, 1969b; Frohne and Kettmann, 1976). The re-
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suits of these studies have led Frohne (1977) to propose the following 
models for the active center of LAP (fig. 7.1): 
native LAP 
Mn -activated LAP 
Fig. 7.1 Proposed models for the active center of native 
LAP and of manganese-activated LAP (from Frohne, 
19/7). 
The substrate is bound in the structural site through its amino acid side 
chains by interaction with hydrophobic groups in the enzyme, and through 
its amino group and carbonyl oxygen to the essential zinc ion. Cysteine 
and histidine are believed to be the binding groups for the zinc ion. 
Nucleophilic attack on the peptide bond could be performed by an OH ion 
or a nucleophilic group of the enzyme. A proton-donating group in the 
neighborhood of the peptide NH-group may have a rate-enhancing effect on 
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the catalytic step. On the basis of kinetic experiments on the pH-depen-
dency of the reaction and of modification studies, this effect may be 
exerted by a tyrosyl residue. The change in conformation believed to pro­
ceed upon activation by Mn or Mg ions probably results in a more 
effective orientation of essential amino acid residues, for instance by 
bringing the tyrosine much nearer to the peptide bond. Different amino 
acid residues serve as binding groups for Mn and Mg ions, respective-
2+ ly. In the binding of Mn groups with pK values of 7.5 and 8.0 are im-
2+ portant, whereas the binding of Mg involves groups with pK values of 
8.4 and 9.1 (Frohne, 1977). Histidine side chains may serve as binding 
groups for Mn ions, as evidenced by the fact that modification of his­
tidine causes a lowering of activation (Ludewig et al , 1975). Cysteines 
may also participate in the binding of manganese. The nature of the amino 
acids participating in the binding of magnesium ions remains unclear, but 
cysteines are not very likely to act as ligands for Mg ions in view of 
their weak binding to this metal (Jocelyne, 1972). 
This model of the active center of LAP provides a basis for the 
study of reversible and irreversible inhibitors, as well as investiga­
tions with active site directed reagents. 
7.2 Jnlu-b-ct-ion ofr LAP by L-phznyiaZa.vu.ne с Id слеш tlujt feeione [L-PIKCH„CL) 
One of the different types of modification experiments that may 
reveal the presence and/or function of reactive groups at the active 
sites of enzymes involves the use of affinity labels (Jacoby and Wilchek, 
1977). Halomethyl ketones have been widely used as such (Powers, 1977; 
Shaw, 1970). Since halomethyl ketones are potentially reactive with many 
nuclephilic groups in proteins, there is a good chance that modification 
of some residue within the active site will occur, provided that the 
reagent has an affinity for the active site. In early attempts to find 
suitable affinity labels for LAP, inhibition studies were performed with 
the chloromethyl ketone derivatives of phenylalanine and leucine, which 
possess the desired active site directed binding properties (Fittkau et 
al., 1974, Fittkau, 1972, Birch et al., 1972). These compounds were found 
to be strong inhibitors of LAP, but in a competitive manner. In both 
cases the inhibitors were reported to act reversibly on native LAP (Birch 
et al., 1972) and on Mn2+-activated LAP (Fittkau et al., 1974) Thus, the 
change in conformation which is believed to occur upon activation, does 
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not bring a nucleophilic group in LAP sufficiently close to the inhibitor 
to become alkylated. However, the situation of LAP activated by magnesium 
ions may be entirely different. In the first place, while histidine and 
cysteine side chains most likely serve as binding groups for Mn ions, 
the nature of the amino acids participating in the binding of Mg may be 
different. Thus, in Mg -activated LAP, specific histidines may be suscep­
tible to alkylation. In the second place, the change in conformation 
effected by Mg -activation may cause an orientation of specific amino 
acid residues differing from the orientation in Mn -activated LAP. Thus, 
nucleophilic groups in the active site of Mg -activated LAP may well be 
susceptible to alkylation by chloromethyl ketone inhibitors. We compared 
the inhibition kinetics of the action of phenylalanine chloromethyl 
ketone on Mn -activated LAP and on Mg -activated LAP, respectively. 
7.2.1 S'mthLS-ib ο$ L-PheCH^l-HCl 
The chloromethyl ketone derivative of L-phenylalamne was prepared 
as described in chapter 2 section 2.16. The tert-butyloxycarbonyl deriva­
tive of L-phenylalamne was treated with isobutyl chioroformate in the 
presence of triethylamine to generate in situ the corresponding anhydride. 
This compound, on reaction with diazomethane, yielded a product which was 
shown by infrared analysis to be the corresponding diazoketone derivative 
(fig. 7.2). The diazoketone showed strong peaks at 1640 and 2100 cm 
Transmittance (%) 
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The diazoketone was then treated with hydrochloric acid in ethylacetate, 
which removed the protecting group and also converted the diazoketone 
moiety to the chloroketone. 
7.2.2 InUb^tion 0(5 LAP by L-PII<LCH2C¿ 
In order to enable comparison of our results to those reported by 
Fittkau et al. (1974), the inhibition experiments were performed with 
L-leucine hydrazide as substrate under the standard conditions described 
in chapter 2 section 2.17. Difficulties such as decomposition and poly-
merization, inherent in the use of a-amino chloromethyl ketones under 
alkaline conditions, were avoided by solubilizing the inhibitor 
immediately before adding it to the assay mixture, and by taking into 
account only the initial phase of the reaction. 
Fig. 7.3 shows the Lineweaver-Burk plot for the inhibition of Mn -
activated LAP by L-PheCH?Cl. The inhibition is clearly competitive. This 
result is comparable to that of Fittkau et al. (1974), who also showed 
that this inhibition is reversible. The kinetic parameters for the 
uninhibited reaction are shown in table 7.1. They agree well with the 
values reported by Fittkau et al. (1974). The К value for the inhibition 
by L-PheCH„Cl was 0.80 mM which is larger than the value of 0.33 reported 
by these authors 
Fig. 7.4 shows the Lineweaver-Burk plot for the inhibition of Mg -
activated LAP by L-PheCH,Cl. In contrast to the situation with Mn -
2+ 
activated LAP, the inhibition of Mg -activated LAP by this inhibitor is 
noncompetitive. The К value for the uninhibited reaction (table 7.1) is 
2+ 
approximately the same as for Mn -activated LAP, indicating that the 
nature of the activating metal ion has no effect on the binding of sub­
strate. However, this type of Lineweaver-Burk plot does not exclude the 
possibility of irreversible inhibition, which also causes a lowering of 
V with increasing inhibitor concentrations. We investigated the possi­
bility of irreversible inhibition in two ways. In the first place, irre­
versible inhibition and reversible noncompetitive inhibition can be 
distinguished by investigating the kinetics of hydrolysis with increasing 
enzyme concentrations in the presence and in the absence of inhibitor. 
A plot of V versus [E]. , where [E]. represents total units of enzyme 
JIIQ A L I* 
activity added to the assay mixture, will yield a curve with a slope 
that is smaller in the presence of a noncompetitive inhibitor than in its 
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Table 7.1 ¿ineti-j paraneters of bo June lens I -V 
The kinetics of hydrolysis of L-leucine hydrazide were determined 
for manganese-activated LAP and for magnesium-activated LAP. 
Mn2+-activated LAP 
Mg2+-activated LAP 
Nn 
(mM) 
20 
19 
V 
max 
(mmoles/min.mg) 
0.71 
0.82 
kcat 
(min"1) 
2.3 χ IO5 
2.7 χ IO5 
absence. If an irreversible inhibitor is present, the "plus" inhibitor 
curve will have the same slope as the control curve, but will intersect 
the horizontal axis at a position equivalent to the amount of enzyme that 
is irreversibly inactivated. Such a plot of V versus ГСІ, is shown in J K
 max
 L J
 t 
fig. 7.5. No clear curve of either reversible noncompetitive or irrever­
sible inhibition was obtained. 
The second way of investigating the possibility of irreversible 
inhibition involved experiments with [ C]-PheCH9Cl with the radioactive 2+ label in the chloromethyl ketone moiety. Incubation of Mg -activated LAP 
with different concentrations of radioactive inhibitor resulted in the 
incorporation of varying amounts of radioactivity. The solubility of LAP 
in the assay buffer was thereby substantially decreased. Attempts to iso­
late tryptic or chymotryptic peptides of Mg +-activated LAP incubated with 
radioactive inhibitor were unsuccessful because of resistance against en­
zymatic digestion and precipitation on the column during chromatography. 
vmax (mmoles . min-1. mg-1 ) 
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7.2.3 - ьсиАілоп 
In the previous section it was confirmed that L-PheCH9Cl acts as a 
2+ 
competitive inhibitor on Mn -activated LAP. The action of this inhibitor 
was shown to be reversible both on native LAP by dialysis experiments 
(Birch et al., 1972) and on Mn2+-activated LAP using [14C]-PheCH2Cl 
(Fittkau et al., 1974). The action of the chloromethyl ketone derivative 
of L-phenylalamne on Mg -activated LAP is less clear. A true non­
competitive inhibitor has no effect on substrate binding (Segel, 1975). 
Inhibitor and substrate bind reversibly and independently at different 
sites, but the inhibitor probably distorts the structure of the enzyme 
sufficiently to prevent a proper positioning of the catalytic center, 
resulting in a nonproductive complex. Thus, the presence of a noncompeti­
tive inhibitor has no effect on К , but it causes a lowering of the 
m
 J 
V value, as if less enzyme were present. The action of L-PheCHLCl on 
magnesium-activated LAP is clearly different from the action of this 
inhibitor on manganese-activated LAP or native LAP, because in the latter 
two cases the binding of substrate to the enzyme is influenced by the 
2+ inhibitor, while the binding of substrate to the enzyme in case of Mg -
activated LAP is not affected. 
However, a substance that irreversibly inactivates an enzyme may 
exert the same effect as a noncompetitive inhibitor, that is, a lowering 
of the V value, and is therefore sometimes confused with a noncompeti-
max
 r 
tive inhibitor. From fig. 7.5 we concluded that L-PheCH9Cl does not act 
2+ 
as a true noncompetitive inhibitor of Mg -activated LAP. From the 
experiments with radioactive inhibitor it can be concluded that at least 
some residues in Mg -activated LAP were irreversibly modified. We 
believe that the modification of these residues, which are probably 
located at the surface of the molecule, causes a decrease in solubility 
of LAP, and thereby a lowering of the V value. 
J 3
 max 2+ 
It is not clear why the action of this inhibitor on Mg -activated 
LAP is different from the action on native and Mn -activated LAP. 
But the results of our studies show that phenylalanine chlorometyl ketone 
is not a suitable affinity label for the specific modification of active 
center residues of LAP. 
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SUMMARY 
The main part of this thesis is concerned with the determination 
of the amino acid sequence of leucine aminopeptidase (LAP) from bovine 
eye lens. This enzyme belongs to the class of aminopeptidases which are 
present in many tissues of animals and plants, and in micro-organisms. 
The aminopeptidases represent the last main class of proteolytic 
enzymes of which no primary structure has been determined, and of which 
the exact mechanism of action is not known in detail. 
LAP from bovine lens has a molecular weight of 326,000 and consists 
of six subunits of molecular weight 54,000. It splits off N-terminal 
amino acid residues from peptides and proteins, and has its highest acti-
vity toward hydrophobic residues. Chapter 1 gives a survey of the proper-
ties of LAP from bovine lens, and these are compared to those of a number 
of other aminopeptidases, some of which have often been confused with 
LAP. A possible role for LAP in the breakdown of proteins in the eye 
lens is also discussed. 
Chapter 3 describes the isolation and characterization of LAP 
from bovine lenses. We showed that the six polypeptide chains of LAP are 
identical both in molecular weight and charge, and that they have the 
same N-terminal amino acid sequence. We concluded that LAP consists of 
six identical polypeptide chains of approximately 490 amino acid resi-
dues. After reduction and S-alkylation the polypeptide chain of LAP was 
cleaved with cyanogen bromide (chapter 4) and hydroxylamine (chapter 5). 
The amino acid sequence of the N-terminal cyanogen bromide fragment 
(CB1) comprising 171 amino acid residues has been determined completely 
by sequencing peptides obtained after digestion of CB1 by trypsin, chymo-
trypsin and thermolysin, and after tryptic digestion of citraconylated 
CB1 (chapter 4 section 4.2). In the C-terminal part of the polypeptide 
chain of LAP a number of methionyl bonds was partly split by cyanogen 
bromide, leading to the generation of fragments with large stretches 
of overlapping sequences (chapter 4, section 4.3). From the results of 
the sequence determination of these fragments a partial amino acid 
sequence of this part of the chain was deduced. 
Additional information on the amino acid sequence of the C-terminal 
part of LAP was obtained from the smallest of the two fragments produced 
by cleavage of LAP by hydroxylamine. This fragment overlapped for a large 
109 
part with the cyanogen bromide fragments described in chapter 4 section 
4 3. Combination of the results of the sequence determination of this 
hydroxy!ami ne fragment and of the cyanogen bromide fragment enabled us 
to propose a partial ammo acid sequence of the C-terminal part of the 
polypeptide chain of LAP 
In this way approximately 65% of the amino acid residues in LAP has 
been identified. The amino acid sequence determination of LAP has been 
nearly completed by H.Th. Cuypers (see addendum). The results provide 
a basis for the determination of the structure of the native enzyme, for 
instance by X-ray crystallographic analysis. 
In chapter 6 the results of limited proteolytic digestion of native 
LAP are described. Of several enzymes tested only trypsin was able to 
produce a cleavage in native LAP. The specific splitting of the bond 
between arginine-137 and lysine-138 by trypsin did not effect the cata-
lytic properties of LAP due to the fact that the LAP aggregate remained 
intact. The splitting of the Arg-Lys bond caused an acceleration of 
the activation of LAP by manganese ions. The results indicate that the 
trypsin-susceptible bond may be located in a segment connecting distinct 
domains. The possible existence of structural domains in LAP is discussed 
in relation to the current knowledge of the tertiary and quaternary 
structure of the enzyme. 
Chapter 7 describes an investigation of the action of L-phenyl-
alamne chloromethyl ketone on LAP activated by manganese and magnesium 
ions, respectively. This study was undertaken to test the suitability of 
this inhibitor as an active site directed reagent. We showed that while 
this chloromethyl ketone derivative acted as a reversible competitive 
inhibitor on manganese-activated LAP, its action on magnesium-activated 
LAP was completely different. Although the reason for this different 
action is not clear, we believe that phenylalanine chloromethyl ketone 
irreversibly modifies some amino acid residues (probably located at the 
surface of the molecule), and that these modifications result in a 
decrease in solubility of the enzyme, and hence in a decrease of the 
maximum velocity of the hydrolysis reaction. 
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SAMENVATTING 
Een groot gedeelte van dit proefschrift gaat over de opheldering 
van de aminozuurvolgorde van leucine aminopeptidase (LAP) geïsoleerd uit 
runderooglenzen. Dit enzym behoort tot de klasse van aminopeptidasen 
die voorkomen in verschillende weefsels van dierlijke en plantaardige 
oorsprong, alsmede in micro-orgamsmen. Deze klasse van aminopeptidasen 
is de enige grote klasse van proteolytische enzymen waarvan nog geen 
aminozuurvolgorde bepaald is, en waarvan het werkingsmechanisme nog niet 
in detail bekend is. 
LAP uit runderooglens heeft een molekuulgewicht van 326.000 en be-
staat uit zes subeenheden met molekuulgewicht 54.000. Het is in staat om 
N-terminaal aminozuurresiduen af te splitsen van eiwitten en peptiden, 
en is vooral aktief ten opzichte van hydrofobe aminozuren. Hoofdstuk 1 
geeft een overzicht van de eigenschappen van dit enzym, en deze worden 
vergeleken met de eigenschappen van een aantal andere aminopeptidasen, 
waarvan sommige vaak verward worden met LAP. De mogelijke rol van LAP in 
de afbraak van lenseiwitten wordt ook besproken. 
Hoofdstuk 3 geeft een beschrijving van de isolatie en de karakteri-
sering van LAP uit runderooglenzen. Er wordt aangetoond dat de zes eiwit-
ketens van LAP een identiek molekuulgewicht en een identieke lading be-
zitten, en dat hun N-terminale aminozuurvolgorde hetzelfde is. Wij kon-
kludeerden dat LAP uit zes identieke polypeptiden-ketens bestaat die 
opgebouwd zijn uit ongeveer 490 aminozuurresiduen Voor de volgorde-
bepaling werd de polypeptiden-keten van LAP gesplitst met behulp van 
cyanogeenbromide (hoofdstuk 4) en hydroxylamine (hoofdstuk 5). 
De aminozuurvolgorde van het grootste cyanogeenbromide-fragment, 
namelijk het N-terminale fragment (CB1) werd volledig opgehelderd. De 
volgorde van de 171 aminozuren werd bepaald met behulp van tryptische, 
chymotryptische en thermolytische peptiden, en met behulp van tryptische 
peptiden verkregen na blokkering van lysine door citraconylering (hoofd-
stuk 4, sektie 4.2). In het C-terminale gedeelte van de polypeptiden-
keten van LAP werden een aantal methiomne-bindingen slechts gedeelte-
lijk gesplitst door caynogeenbromide, hetgeen resulteerde in fragmenten 
die voor een groot gedeelte met elkaar overlapten (hoofdstuk 4, sektie 
4.3). Uit de resultaten van de volgordebepaling van deze fragmenten 
kon een gedeeltelijke aminozuurvolgorde voor dit gedeelte van de keten 
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opgesteld worden. 
Verdere informatie met betrekking tot de aminozuurvolgorde van het 
C-terminale gedeelte van LAP werd verkregen met behulp van het kleinste 
van de twee fragmenten na splitsing van LAP met hydroxy!ami ne. Dit frag-
ment overlapte voor een groot gedeelte met de cyanogeenbromiüe-fragmen-
en beschreven in hoofdstuk 4, sektie 4.3. De gekombineerde resultaten 
van de volgordebepaling van deze cyanogeenbromide-fragmenten en van 
het C-terminale hydroxylamine-fragment (HA-II) stelden ons in staat om 
een bijna volledige aminozuurvolgorde op te stellen voor het C-terminale 
gedeelte van de plypeptiden-keten van LAP (hoofdstuk 5). 
In totaal werd ongeveer 65°' van de aminozuren in LAP geïdentifi-
ceerd. Op dit moment is de volgordebepaling van LAP zo goed als voltooid 
door H.Th. Cuypers (zie het addendum). De resultaten kunnen een basis 
vormen voor de bepaling van de struktuur van het natieve enzym, bijvoor-
beeld door middel van rontgenkristallografie. 
In hoofdstuk 6 zijn de resultaten beschreven van de beperkte pro-
teolytische vertering van natief LAP. Van verschillende enzymen was 
alleen trypsine in staat om een splitsing te bewerkstelligen in het 
natieve enzym. De specifieke splitsing van de binding tussen argimne-
137 en lysine-138 door trypsine had geen invloed op de katalytische 
eigenschappen van LAP. Dit was het gevolg van het feit dat het aggregaat 
van LAP intakt blijft na de splitsing. De splitsing van de Arg-Lys-bin-
ding veroorzaakte alleen een versnelling van de aktivering door mangaan-
lonen. De resultaten geven aan dat de trypsine-gevoelige binding mogelijk 
gelegen is in een segment dat afzonderlijke domeinen verbindt. Het be-
staan van dergelijke strukturele domeinen in LAP wordt besproken in sa-
menhang met de huidige kennis van de tertiaire en quaternaire struktuur 
van het enzym. 
In hoofdstuk 7 is een onderzoek beschreven naar de invloed van 
L-phenylalamne-chloromethyl keton op de katalytische eigenschappen van 
LAP na aktivering door mangaan- en magnesium-ionen respektievelijk. 
Dit onderzoek werd ondernomen om na te gaan of deze remmer geschikt was 
voor de specifieke modifikatie van aktief centrum-residuen. Aangetoond 
werd dat dit chloromethyl keton-denvaat een reversibele kompetitieve 
remmer is van LAP geaktiveerd door mangaan-ionen, maar dat de invloed 
van deze remmer op LAP geaktiveerd door magnesium-ionen van een heel 
andere aard is. Hoewel hiervoor op dit moment geen verklaring voorhanden 
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is, hebben wij redenen om aan te nemen dat deze remmer een irreversibele 
modifikatie van enige residuen, waarschijnlijk gelegen aan het oppervlak 
van het molekuul, teweegbrengt, en dat door deze modifikatie het enzym 
minder oplosbaar wordt en daardoor een lagere maximum hydrolyse-snelheid 
vertoont. 
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ADDENDUM 
The investigations described in this thesis were part of a research 
project supported by the Netherlands Foundation of Chemical Research 
(SON). The sequence studies presented in chapters 4 and 5 were performed 
in collaboration with H.Th. Cuypers. In order to make the sequence re-
sults presented in these chapters more comprehensible, the total amino 
acid sequence of bovine lens leucine aminopeptidase is presented in this 
addendum. The results completing the amino acid sequence will be 
published by H.Th. Cuypers. 
The numbering of the amino acid residues in chapters 4 and 5 of this 
thesis was according to this scheme. 
*The sequence of these residues remains to be established. 
**This overlap is not yet confirmed. 
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10 20 
Thr-Lys-Gly-Leu-Val-Leu-Gly-Ile-Tyr-Ser-Lys-Glu-Lys-Glu-Glu-Asp-Glu-Pro-Gln-Phe-Thr-Ser-Ala-Gly-Glu-Asn-Phe-
30 40 
Asn-Lys-Leu-Val-Ser-Gly-Lys-Leu-Arg-Glu-Ile-Leu-Asn-Ile-Ser-Gly-Pro-Pro-
50 
Leu-Lys-Ala-Gly-Lys-Thr-Arg-Thr-Phe-
60 70 80 
Tyr-Gly-Leu-His-Glu-Asp-Phe-Pro-Ser-Val-Val-Val-Val-Gly-Leu-Gly-Lys-Lys-Thr-Ala-Gly-Ile-Asp-Glu-Gln-Glu-Asn-
90 100 
Trp-His-Glu-Gly-Lys-Glu-Asn-ne-Arg-Ala-Ala-Val-Ala-Ala-Gly-Cys-Arg-Gln-ne-Gln-Asp-Leu-Glu-Ile-Pro-Ser-Val-
110 120 130 
Glu-Val-Asp-Pro-Cys-Gly-Asp-Ala-Gln-Ala-Ala-Ala-Glu-Gly-Ala-Val-Leu-Gly-Leu-Tyr-Glu-Tyr-Asp-Asp-Leu-Lys-Gln-
140 150 
Lys-Arg-Lys-Val-Val-Val-Ser-Ala-Lys-Leu-His-Gly-Ser-Glu-Asp-Gln-Glu-Ala-
170 180 
Gly-Gln-Asn-Leu-Ala-Arg-Arg-Leu-Met-Glu-Thr-Pro-Ala-Asn-Glu-Met-Thr-Pro-
160 
Trp-Gln-Arg-Gly-Val-Leu-Phe-Ala-Ser-
Thr-Lys-Phe-Ala-Glu-Ile-Val-Glu-Glu-
190 200 210 
Asn-Leu-Lys-Ser-Ala-Ser-Ile-Lys-Thr-Asp-Val-Phe-Ile-A^g-Pro-Lys-Ser-Trp-Ile-Glu-Glu-Gln-Glu-Met-Gly-Ser-Phe-
220 230 
Leu-Ser-Val-Ala-Lys-Gly-Ser-Glu-Glu-Pro-Pro-Val-Phe-Leu-Glu-Ile-His-Tyr-
240 
Lys-Gly-Ser-Pro-Asn-Ala-Ser-Glu-Pro-
250 260 270 
Pro-Leu-Val-Phe-Val-Gly-Lys-Gly-Ile-Thr-Phe-Asp-Ser-Gly-Gly-Ile-Ser-Ile-Lys-Ala-Ala-Ala-Asn-Met-Asp-Leu-Met-
280 290 
Arg-Ala-Asp-Met-Gly-Gly-Ala-Ala-Thr-Ile-Cys-Ser-Ala-Ile-Val-Ser-Ala-Ala-Lys-Leu-Asp-Leu-Pro-Ile-Asn-11 e-Val-
300 310 320 
Gly-Leu-Ala-Pro-Leu-Cys-Glu-Asn-Met-Pro-Ser-Gly-Lys-Ala-Asn-Lys-Pro-Gly-Asp-Val-Val-Arg-Ala-Arg-Asn-Gly-Lys-
330 340 350 
Thr-Il e-Gl η-Val-Asp-Asn-Thr-Asp-Ala-Glu-Gly-Arg-Leu-Il e-Leu-Ala-Asp-Ala-Leu-Cys-Tyr-Ala-His-Thr-Phe-Asn-Pro-
360 370 
Lys-Val-Il e-Ile-Asn-Ala-Ala-Thr-Leu-Thr-Gly-Ala-Met-Asp-Il e-Ala-Leu-Gly-Ser-(Thr,Gly,Gly,Ala,Val,Phe)-Thr-Asn-
380 390 400 
Ser-Ser-Trp-Met-Asn-Lys-Leu-Phe-Glu-Ala-Ser-Ile-Glu-Thr-Gly-Asp-Arg-Val-Trp-Arg-Met-Pro-Leu-Phe-Glu-His-Tyr-
410 420 430 
Thr-Arg-Gln-Val-Ile-Asp-Cys-Gln-Leu-Ala-Asp-Val-Asn-Asn-Ile-Gly-Lys-Tyr-Arg-Ser-Ala-Gly-Ala-Cys-Thr-Ala-Ala-
440 450 
Ala-Phe-Leu-Lys-Glu-Phe-Val-Thr-His-Pro-Lys-Trp-Ala-His-Leu-Asp-Ile-Ala- Gly-Val-Met-Thr-Asn-Lys-Asp-Glu-Val-
460 470 ^ 
Pro-Tyr-Leu-Arg-Lys-Gly-Met-Ala-Gly-Arg-Pro-Thr-Arg-Phe-Ser-Gln-Asp-Ser-Ala. 

STELLINGEN 
I 
Serum leucine-armnopeptidase is geen leucme-armnopeptidase. 
II 
De indeling van cytoplasmatische en nncrosomale aminopeptidasen in twee 
afzonderlijke klassen is voorbarig. 
Enzymt NunencZcLtuAt (1973) Elsevier Scientific Publishing Company, 
Amsterdam, pg. 232. 
Ill 
De konklusie van Basha et al. dat de subeenheden van de door hen geïso-
leerde aminopeptidasen identiek zijn, wordt onvoldoende gerechtvaardigd 
door hun experimenten. 
Basha, S.M.M., Horst, M.N., Bazer, F.W. en Roberts, R.M. (1978) 
Afich. B-iochm. B-ioplujo. 185, 174-184. 
IV 
Bij hun konklusie dat één van de vier door hen onderzochte nijlpaarden 
heterozygoot is in het cytochroom с gen, hebben Thompson et al. geen 
rekening gehouden met de mogelijkheid dat de heterogeniteit in de pri­
maire struktuur van cytochroom с veroorzaakt is door duplikatie van het 
cytochroom с gen. 
Thompson, R.B., Borden, D., Tarr, G.E. en Margoliash, E. (1978) 
J. BÍOZ. Chm. 253, 8957-8961. 
V 
De overeenkomst in intensiteit van banden van endogeen Mo-MuLV en 
Mo-MuLV geïntegreerd in tumorweefsel kan m e t als argument gebruikt 
worden voor de homogeniteit van de tumor. 
Jähner, D., Stuhlmann, H. en Jaemsch, R. (1980) V<AoZugij 101, 
111-123. 
VI 
Het is onwaarschijnlijk dat bij de synthese van geaktiveerde peptide­
derivaten volgens de nieuwe methode van Ogura et al. geen racemisatie 
optreedt. 
Ogura, H., Kobayashi, T., Shimizu, K., Kawabe, K. en Takeda, K. 
(1979) Tetnahedhon ІШелл 49, 4745-4746. 
VII 
Om de resultaten van wetenschappelijke onderzoekingen, zoals gepresen­
teerd in proefschriften, ook toegankelijk te maken voor anderen dan de 
direkt betrokkenen, dient de wetenschapper pogingen te ondernemen een 
samenvatting toe te voegen gesteld in voor de geïnteresseerde leek 
begrijpel ijke taal. 
VIII 
Het is op zijn minst verwonderlijk dat, terwijl het beroep van bioche-
misch analist gekwalificeerd wordt als een interessant beroep voor 
vrouwen, deze kwalifikatie onthouden wordt aan het beroep van biochenncus. 
IX 
Het zou een aanmerkelijke verhoging van het leesgenot betekenen wanneer 
schrijvers en bewerkers van boeken de voetnoten ook werkelijk aan de voet 
van de betreffende bladzijde zouden plaatsen, en m e t - zoals vaak 
gebeurt - achterin het boek. 
zie bijv. de bewerking van Multatuli's Woo-ieAije Pietzue. door 
M. Stapert-Eggen. 
12 juni 1980 Lucy A.H. Klaassen 


